data_1k3q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k3q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.498 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' CG ' HD23 ' A' ' 141' ' ' LEU . 1.3 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 90' ' ' GLN . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.568 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.452 ' HA ' HG12 ' A' ' 43' ' ' ILE . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.525 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 88' ' ' HIS . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HG2' HG11 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 21.5 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.413 ' N ' HD22 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 125' ' ' SER . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.418 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.442 HD23 ' CG ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 141' ' ' LEU . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.79 0.329 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.513 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.4 t60 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG13 ' C ' ' A' ' 88' ' ' HIS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 ' N ' HD22 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.485 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 125' ' ' SER . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.575 0.226 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 92' ' ' LEU . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.524 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.778 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.426 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 91' ' ' ILE . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.905 0.383 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.646 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.785 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.785 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.646 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 145' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.571 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.733 0.301 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.571 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.425 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.6 t60 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' HD23 ' A' ' 124' ' ' LEU . 1.4 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 125' ' ' SER . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.427 ' N ' HG21 ' A' ' 140' ' ' ILE . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.454 ' HB3' HG21 ' A' ' 40' ' ' THR . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.646 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CH2' ' A' ' 66' ' ' TRP . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.704 0.288 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.516 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.508 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 40' ' ' THR . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.644 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG22 ' CE2' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 92' ' ' LEU . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.627 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.556 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.475 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.667 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' A' ' 65' ' ' VAL . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.437 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.7 tm? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.462 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.414 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 145' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.657 0.265 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.546 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 43' ' ' ILE . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.524 -0.035 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 76' ' ' TYR . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.665 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 120.759 0.314 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' N ' HD12 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.418 HG13 ' CE1' ' A' ' 68' ' ' PHE . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.852 0.358 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 122' ' ' GLN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.441 ' N ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.476 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.5 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.947 0.403 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG23 ' CE1' ' A' ' 76' ' ' TYR . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.519 HG23 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.581 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.605 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 92' ' ' LEU . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.605 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.536 ' HG2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HB3' HG12 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 90' ' ' GLN . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.519 ' OG ' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 92' ' ' LEU . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.589 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 88' ' ' HIS . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.591 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.332 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 125' ' ' SER . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.449 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 110' ' ' TRP . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 40' ' ' THR . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.435 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.517 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 92' ' ' LEU . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.3 t-20 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.739 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 91' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.526 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.499 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 145' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.908 0.385 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 76' ' ' TYR . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.628 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.628 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.525 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 21.8 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' GLN . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.814 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 125' ' ' SER . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.404 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.478 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 145' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.799 0.333 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.63 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 92' ' ' LEU . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.8 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.832 0.349 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 125' ' ' SER . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.495 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.675 0.274 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.4 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.666 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 120' ' ' SER . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.432 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 125' ' ' SER . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.622 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.565 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.622 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.4 ' N ' HD12 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.48 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.48 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.573 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.668 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' A' ' 43' ' ' ILE . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 88' ' ' HIS . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.769 0.318 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.56 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.831 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.831 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.462 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.541 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG2' HG21 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.555 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.823 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 40' ' ' THR . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.437 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 146' ' ' PHE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.547 HG22 ' CB ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.717 0.294 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG13 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 91' ' ' ILE . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.014 0.435 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.544 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.788 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 125' ' ' SER . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.494 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.547 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.415 ' CG1' ' CD2' ' A' ' 124' ' ' LEU . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.509 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.476 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 76' ' ' TYR . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' ILE . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.2 m120 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.1 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.4 mm-40 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 147' ' ' ILE . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.509 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 145' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.447 HG12 HD22 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' CB ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.624 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.771 0.32 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.776 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' CD2' ' CD1' ' A' ' 76' ' ' TYR . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.434 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.776 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.844 0.354 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.514 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.789 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.487 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.493 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.487 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.518 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 145' ' ' ILE . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.57 75.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -70.09 -47.01 63.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -76.03 -46.77 27.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 64.92 -75.07 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.54 121.87 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.01 110.98 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.42 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.634 0.731 . . . . 0.0 111.647 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 48.77 18.61 Favored Glycine 0 C--N 1.313 -0.726 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.124 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -56.21 -46.81 79.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.681 0.277 . . . . 0.0 111.352 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.19 35.23 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' CG ' HD23 ' A' ' 141' ' ' LEU . 1.3 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.03 141.89 28.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -82.95 140.7 32.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.057 0.456 . . . . 0.0 111.187 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 mt -64.16 -45.67 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.88 -39.33 74.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.0 110.555 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 44.5 mm-40 -68.47 -36.92 79.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.518 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.29 -45.62 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.909 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tp -71.05 -30.39 66.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -80.45 -43.03 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.021 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.96 137.05 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.25 30.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.15 35.87 2.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 p 60.83 26.05 15.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.024 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -179.28 134.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.96 -65.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt -147.33 133.03 18.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG11 ' HG2' ' A' ' 90' ' ' GLN . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.568 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.452 ' HA ' HG12 ' A' ' 43' ' ' ILE . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.525 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 88' ' ' HIS . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.486 ' HG2' HG11 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 21.5 tp -125.08 124.66 42.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.35 -136.55 2.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.543 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.28 -178.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -31.56 69.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 43.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -139.14 170.69 15.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.97 157.22 21.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.838 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.838 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.413 ' N ' HD22 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 125' ' ' SER . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.418 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.457 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.442 HD23 ' CG ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 141' ' ' LEU . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -87.19 108.74 19.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.03 -27.5 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.228 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -45.95 92.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -58.69 -44.17 90.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -36.21 76.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.91 -43.22 91.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -64.7 -46.0 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.041 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.23 -35.88 80.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.98 -41.75 97.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -84.49 -33.08 23.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.78 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.635 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 157' ' ' GLN . 29.5 mttt -88.06 122.81 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.1 p -93.35 125.25 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.034 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.61 102.17 14.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.68 -56.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.19 129.19 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.893 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.38 114.62 5.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -171.3 -60.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 34.2 t -106.03 158.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.4 140.49 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.72 167.76 20.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.163 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.44 167.29 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.57 126.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 72.1 p -84.09 145.54 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -105.69 48.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 11.2 m -140.7 97.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.917 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.2 m -129.42 -68.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -60.67 -43.85 97.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -81.01 -26.81 36.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 65.82 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.58 129.37 39.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -90.07 106.27 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.45 138.36 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.683 0.754 . . . . 0.0 111.773 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.13 28.96 57.47 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.82 -35.52 78.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.709 0.29 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 177.8 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.77 141.85 23.08 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 5.7 m-20 -84.97 139.12 32.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.207 0.527 . . . . 0.0 111.302 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 mt -64.4 -45.2 96.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.436 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.75 -40.86 76.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.875 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 14.1 mt-30 -68.47 -36.89 79.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.08 -46.07 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.098 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.91 -28.46 64.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.976 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -80.69 -47.89 13.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.38 110.82 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 53.24 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 -174.38 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 t -82.24 -28.68 31.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 tp -125.94 147.5 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.07 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt -151.67 131.0 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.513 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.435 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HD13 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.4 t60 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.3 tp -125.11 123.42 39.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.18 177.39 22.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.791 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.25 27.72 4.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.334 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.52 -26.96 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.37 -12.73 7.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.633 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.87 -170.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 110.985 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 160.25 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG13 ' C ' ' A' ' 88' ' ' HIS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 ' N ' HD22 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.452 ' O ' HD12 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.485 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 125' ' ' SER . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -84.78 111.35 19.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.51 -29.89 68.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -58.61 -43.92 89.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.636 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.64 -44.09 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -37.84 85.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.04 -46.7 87.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.078 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.7 t -62.9 -45.97 90.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.58 -39.08 88.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.15 -44.04 97.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.62 -36.16 26.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p30 42.37 91.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.52 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -66.82 128.63 37.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.8 t -98.68 130.57 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -147.55 94.81 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -147.11 164.84 31.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.983 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 30.1 mm -80.19 124.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.82 158.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.58 30.95 0.59 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.33 158.83 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -94.28 109.48 21.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 138.54 50.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.04 179.62 4.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -122.01 125.1 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 62.2 p -118.19 -37.81 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -129.26 -151.71 0.49 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.65 152.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.907 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.885 0.374 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -105.84 -66.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.92 -39.41 79.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.02 -44.49 18.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.53 105.19 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.88 138.82 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.815 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -109.81 101.97 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.25 138.29 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.575 0.703 . . . . 0.0 111.907 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.92 34.25 5.77 Favored Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.564 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.86 -33.21 27.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER 175.96 39.25 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.705 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.83 142.43 26.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.427 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 1.1 m-20 -74.92 120.07 19.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.094 0.473 . . . . 0.0 111.103 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.3 -42.85 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.23 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -57.55 -40.27 78.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.184 0.516 . . . . 0.0 110.649 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 36.1 mm-40 -68.41 -38.41 81.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.769 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.07 -40.46 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.978 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -37.24 72.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -72.02 -46.81 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.13 102.58 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 80.93 4.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -135.62 164.72 27.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 p -75.46 -25.67 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.85 150.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.125 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.43 -63.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt -138.18 132.62 32.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 92' ' ' LEU . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.524 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.442 ' HA ' HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.778 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.426 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.578 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 91' ' ' ILE . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.25 136.97 54.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.33 161.41 34.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.666 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 61.36 152.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.47 104.71 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 -84.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -150.11 -172.89 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -106.91 160.61 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.646 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.564 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.785 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.785 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.646 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 145' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -79.73 112.89 17.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -34.8 72.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -44.58 92.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.685 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -58.91 -43.92 91.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -60.88 -41.1 95.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.062 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.06 -40.93 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.8 t -64.1 -46.02 86.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.69 -36.0 82.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.17 -36.55 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -90.31 -37.1 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.1 p30 44.25 -171.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.551 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.36 154.0 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.07 137.59 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.4 32.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -89.22 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.41 162.07 13.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.92 -52.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.82 149.45 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -84.37 128.39 34.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.9 -25.31 9.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.63 -175.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.5 155.14 17.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -154.23 152.14 29.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -87.69 58.19 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.742 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.2 163.0 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.971 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.828 0.347 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.64 74.11 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.87 -45.95 66.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t -75.87 -40.75 53.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -138.68 90.68 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -90.77 133.78 34.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 101.8 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.16 138.49 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.706 0.765 . . . . 0.0 111.822 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.05 36.63 21.1 Favored Glycine 0 C--N 1.315 -0.599 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -89.13 -32.05 17.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.44 35.66 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.571 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.06 142.43 27.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 2.9 m-20 -88.09 137.43 32.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 111.068 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 52' ' ' ILE . 1.7 mp -64.34 -43.61 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.784 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.01 -38.84 73.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.334 0.588 . . . . 0.0 110.547 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.0 mm-40 -68.48 -41.15 80.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.636 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.67 -46.56 91.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.043 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -71.07 -29.2 65.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -77.42 -46.85 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.93 109.9 2.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.52 77.68 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -168.63 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -84.44 -32.59 23.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 tp -122.24 153.45 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.16 -65.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.189 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -145.46 134.36 22.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.428 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.571 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.425 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.664 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.6 t60 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 tp -125.15 124.59 42.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 -155.8 26.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.54 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.074 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.65 31.24 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -116.19 -175.94 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' HD23 ' A' ' 124' ' ' LEU . 1.4 mp -120.46 155.83 32.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 125' ' ' SER . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' N ' HG21 ' A' ' 140' ' ' ILE . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.454 ' HB3' HG21 ' A' ' 40' ' ' THR . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' HD22 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -81.28 114.46 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -31.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -44.54 89.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -58.27 -44.11 88.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.93 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -64.18 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.18 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -60.45 -45.72 92.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.05 -42.4 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.015 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -40.27 78.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.69 -46.2 89.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.46 -31.93 26.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 42.44 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.486 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 152.6 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.96 130.8 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.071 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.12 -171.94 1.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 146.39 28.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.41 133.66 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 175.09 9.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.62 -47.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.739 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.08 138.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.62 159.77 12.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -166.24 138.85 3.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -160.03 169.3 23.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.84 78.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.173 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 76.3 p -146.25 -47.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.53 59.05 4.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.08 107.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.85 -74.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -60.7 -45.76 92.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t -77.7 -25.1 49.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -53.47 159.44 1.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.046 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.71 121.0 15.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -83.6 135.23 34.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.37 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.624 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -163.57 103.01 0.21 Allowed Glycine 0 C--N 1.314 -0.655 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.676 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.2 -30.98 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 178.02 39.7 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.646 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CH2' ' A' ' 66' ' ' TRP . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -138.54 142.0 39.29 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 6.2 m-20 -74.87 119.8 19.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 111.178 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -64.49 -43.75 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.027 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.2 p -59.61 -40.87 88.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 110.589 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 32.5 mm-40 -68.44 -36.86 79.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.754 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.27 -42.33 95.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.37 -32.02 70.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -35.99 47.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.38 120.16 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -28.47 22.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -57.78 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.939 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.2 p -86.95 -43.56 12.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 tp -83.38 146.68 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -117.76 -68.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.796 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt -144.54 138.92 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 tt -125.32 122.82 37.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.05 26.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 63.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 52.16 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.026 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.11 -51.11 3.73 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -155.61 149.24 25.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.16 160.34 15.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.516 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.508 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 40' ' ' THR . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -82.67 124.88 30.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.222 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -56.9 -42.42 79.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.23 -42.54 91.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.723 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -33.98 77.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.055 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.68 -43.99 95.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -59.36 -46.14 89.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.989 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -35.93 77.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.93 -35.81 64.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -91.96 -34.43 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.55 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.02 124.22 41.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.14 122.38 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -116.93 132.79 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -104.24 116.93 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.7 pt -77.04 133.67 30.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.943 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.804 0.335 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.35 99.77 6.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.64 -51.6 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.51 139.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -91.08 111.81 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.3 152.92 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -111.57 168.33 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.25 149.17 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 46.5 p -119.74 69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.33 78.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.74 131.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.895 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.866 0.365 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -61.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.66 -43.29 80.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -71.34 -35.89 71.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 109.57 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 124.96 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.69 116.44 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 136.69 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 37.95 6.42 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.31 -38.44 91.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.333 . . . . 0.0 110.931 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 177.0 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.644 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG22 ' CE2' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.644 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.23 141.79 32.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.487 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -80.06 142.32 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.312 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -64.16 -45.22 97.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.551 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -38.7 79.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.338 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.1 mm-40 -68.55 -37.01 79.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.454 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.16 -39.99 65.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.93 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -32.57 69.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -49.24 62.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.6 107.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -87.75 -31.83 19.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -132.58 170.84 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m 60.79 178.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.51 155.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -94.62 -74.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.245 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -128.5 134.76 48.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' A' ' 92' ' ' LEU . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.627 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.556 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.475 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.667 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.525 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' HB3' HG12 ' A' ' 65' ' ' VAL . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.7 tm? -125.38 128.63 48.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 -57.07 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.629 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.34 101.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.34 174.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.807 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.05 175.66 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 63.48 -179.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.95 160.22 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.462 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.414 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 145' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.67 118.37 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.28 -27.87 66.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -46.13 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 24.2 t80 -61.15 -43.49 98.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -38.15 69.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -47.04 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.2 t -62.99 -44.2 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.72 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.415 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -57.92 -35.84 71.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.778 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.97 -42.41 98.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -84.61 -31.22 24.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.05 -91.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.692 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tttm -87.36 125.95 34.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.6 m -81.71 130.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.46 -66.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -160.59 -174.62 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.12 136.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.982 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.705 0.288 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.6 95.49 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -100.48 31.01 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.17 128.19 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -63.83 82.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.47 121.72 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -97.91 167.12 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.61 102.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 1.5 p -114.49 139.38 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -159.99 48.03 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.58 30.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.822 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.709 0.29 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -121.17 -46.09 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -46.95 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -75.61 -26.02 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.65 30.42 0.79 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.319 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -91.34 124.83 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.02 103.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.756 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.89 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 111.779 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.76 103.67 0.01 OUTLIER Glycine 0 C--N 1.314 -0.667 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.275 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -76.76 -31.53 57.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 178.52 38.9 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' CG2' ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.13 144.82 31.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 5.8 m-20 -74.95 136.45 41.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 111.269 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -45.23 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.084 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -39.28 74.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.0 110.694 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.6 mm100 -68.47 -38.13 80.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.597 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.1 -43.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.127 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.06 -31.6 68.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -47.67 36.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.986 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.64 111.99 9.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -30.54 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -123.87 173.57 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m 59.23 167.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG12 ' CG2' ' A' ' 65' ' ' VAL . 9.8 tp -73.92 155.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -70.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt -137.64 130.97 30.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.357 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.546 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CE2' HG21 ' A' ' 43' ' ' ILE . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.5 tp -125.22 124.15 41.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.92 -129.58 2.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.505 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 63.34 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -137.29 28.89 2.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.36 -23.45 31.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.654 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -73.59 -170.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.56 151.22 31.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.94 109.14 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.05 -35.15 72.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.984 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.28 -45.97 91.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.66 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -58.55 -44.03 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -34.61 76.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -63.67 -40.77 97.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -61.84 -45.7 92.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -36.01 81.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.35 -44.93 96.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 159' ' ' LYS . 13.9 pt20 -84.99 -30.24 24.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.85 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.604 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.1 tttp -104.06 154.74 19.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.874 0.368 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.7 m -95.08 128.75 46.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.0 167.59 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -135.29 108.06 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.0 122.39 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.88 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 tp -156.81 122.88 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.28 108.24 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.9 155.64 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -79.55 114.28 18.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -120.43 -169.33 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -140.72 168.47 19.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.9 118.59 37.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.074 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 38.1 p -129.42 163.49 25.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.67 79.02 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.16 139.91 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.3 -63.08 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -70.23 -33.75 72.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -65.69 -34.6 78.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -82.86 161.59 21.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.19 149.25 35.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -69.15 115.38 8.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.84 138.28 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.625 0.726 . . . . 0.0 111.795 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 116.59 0.5 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.551 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -73.05 -29.61 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.51 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 76' ' ' TYR . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.665 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.33 150.21 28.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.1 m-20 -74.84 122.86 24.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.097 0.475 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 52' ' ' ILE . 47.0 mt -64.58 -42.62 95.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.118 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -61.3 -40.31 93.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.344 0.592 . . . . 0.0 110.716 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.42 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 2.0 mm-40 -68.49 -36.79 79.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.743 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.43 -38.0 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -69.72 -29.21 66.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -28.54 17.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 121.11 12.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 31.98 4.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.07 117.9 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.1 -171.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.39 151.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -82.43 -75.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER -126.59 137.28 53.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.394 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' N ' HD12 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 HG13 ' CE1' ' A' ' 68' ' ' PHE . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' HG ' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 tp -125.02 122.8 38.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.58 -170.68 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.746 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.08 -27.76 16.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -83.45 54.89 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.228 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.18 -169.0 0.06 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.857 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.8 172.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.88 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.17 160.25 31.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 122' ' ' GLN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.846 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.846 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.441 ' N ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.476 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.5 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.79 108.85 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.69 -32.89 73.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -44.04 89.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 35.3 t80 -58.14 -44.05 87.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.848 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -60.71 -45.05 95.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.48 -45.19 92.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.7 t -60.86 -46.02 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -35.96 80.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.91 -39.92 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.41 -37.16 16.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.3 p30 44.56 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -120.68 147.15 45.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -103.01 130.88 52.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -87.31 114.96 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.39 109.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.96 115.79 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.046 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tp 60.1 161.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.46 140.88 58.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.52 137.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -47.5 -61.2 2.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.15 179.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -128.19 161.26 29.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.787 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.29 174.56 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.3 t 44.77 37.31 2.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -134.95 82.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.17 65.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.882 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -155.35 -50.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -43.66 66.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -67.75 -29.16 68.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.12 112.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.79 130.72 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -67.39 131.99 46.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.99 138.34 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.651 0.739 . . . . 0.0 111.62 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.07 80.34 1.21 Allowed Glycine 0 C--N 1.313 -0.744 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.344 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.08 -36.99 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 111.147 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 177.34 40.08 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG23 ' CE1' ' A' ' 76' ' ' TYR . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.519 HG23 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.581 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.605 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.36 142.95 31.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -74.98 120.91 21.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -64.29 -40.25 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.898 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -40.15 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.61 -39.8 80.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.757 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.9 t -71.84 -42.41 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -25.93 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -55.39 3.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.81 119.34 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.953 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 29.68 7.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.756 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -156.67 153.25 28.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.71 168.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.94 152.05 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -67.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -151.48 135.07 16.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.386 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 92' ' ' LEU . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.605 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.651 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' HG2' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HB3' HG12 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -125.21 122.88 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.19 -175.05 15.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.738 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -170.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.89 27.67 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.54 -163.36 7.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.54 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m120 61.09 166.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.373 . . . . 0.0 111.011 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.52 160.16 31.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 90' ' ' GLN . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.519 ' OG ' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -75.93 123.04 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.02 -25.98 62.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -56.88 -36.52 70.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -66.99 -39.76 87.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.077 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -64.95 -50.18 67.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 154' ' ' CYS . 2.6 pt20 -60.6 -36.63 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.414 ' N ' ' HG3' ' A' ' 153' ' ' GLN . 9.9 t -66.39 -44.57 82.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -35.92 82.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -41.29 83.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.821 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 4.1 tt0 -84.69 -30.83 24.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.85 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.672 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.1 tttp -106.31 154.3 20.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.26 129.91 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -123.74 78.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -98.86 138.02 36.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 pt -96.02 134.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.889 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.98 145.67 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -116.4 86.62 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.87 146.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.22 170.77 15.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.69 163.03 40.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.111 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.4 165.63 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.77 73.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 71.0 p -118.67 31.39 6.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.18 73.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.64 117.53 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.872 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.798 0.333 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.2 m -152.13 -52.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.95 -45.21 61.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -75.96 -20.9 57.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.14 -69.58 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.08 120.93 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.742 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.44 101.94 10.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -84.39 138.37 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.88 88.79 1.4 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.445 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.73 -39.02 87.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 175.73 39.37 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.589 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -156.26 141.87 17.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -81.28 132.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.079 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 mp -64.42 -43.27 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.861 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 m -59.72 -41.13 90.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.252 0.548 . . . . 0.0 110.626 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.85 -41.24 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.06 -42.01 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -26.44 63.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 115.0 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.987 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.18 29.11 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -110.56 166.56 10.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -63.47 -24.88 68.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.1 tp -133.73 153.41 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.314 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.67 -74.43 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -135.03 132.74 38.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 92' ' ' LEU . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.589 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 88' ' ' HIS . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.591 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.426 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tp -125.28 123.63 39.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.61 -133.85 2.22 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.59 -69.76 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -157.08 -47.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.67 35.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.401 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -128.59 168.54 15.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.76 0.314 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.05 136.63 51.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 125' ' ' SER . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.449 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 110' ' ' TRP . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 40' ' ' THR . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.435 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -80.61 121.32 25.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.65 -38.95 89.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.966 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -43.61 87.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD2' HD22 ' A' ' 155' ' ' LEU . 31.8 t80 -59.07 -44.12 91.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -61.09 -34.02 74.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -47.1 75.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -68.12 -42.71 79.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.415 HD22 ' CD2' ' A' ' 151' ' ' PHE . 3.6 mm? -63.38 -35.89 81.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.59 -44.23 93.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 7.0 mt-30 -84.99 -29.04 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.53 -91.11 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.65 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 9.8 mtpp -63.58 160.32 16.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.74 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.72 175.24 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 34.02 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.48 110.1 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.89 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 136.46 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 179.44 6.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.9 121.73 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.028 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 157.47 13.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -163.62 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.02 163.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.72 154.46 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.08 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.3 t 44.87 33.75 1.06 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.348 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.42 76.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.84 146.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.837 0.351 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.19 -62.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -32.21 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t -57.88 -35.28 70.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.53 137.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.43 136.56 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.22 104.78 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.04 138.41 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.646 0.736 . . . . 0.0 111.79 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.68 26.49 56.37 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.02 -43.38 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.32 33.95 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.517 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.08 141.81 23.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -78.55 133.97 37.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.985 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.4 85.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.522 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m -56.56 -40.85 75.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.825 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -38.35 80.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.4 t -65.3 -45.01 94.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -32.64 69.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.045 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.21 -45.3 18.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -74.58 114.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 31.38 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -80.2 -62.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.55 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.995 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 tp -137.38 152.87 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.023 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -98.33 -66.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.969 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -142.32 137.53 30.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 92' ' ' LEU . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.516 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.3 t-20 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.739 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tp -125.27 122.9 38.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.57 -131.62 2.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.657 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.31 -76.47 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.763 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -146.1 -46.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.681 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.79 173.05 43.36 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.408 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 61.38 -179.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -106.99 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.526 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.499 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 145' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.73 126.04 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.06 -26.95 60.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.0 -43.43 81.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.49 -44.13 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -36.55 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -69.04 -38.66 79.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.66 -45.48 89.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -35.98 81.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.69 -35.52 79.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -91.59 -37.07 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.57 -172.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.693 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.38 149.98 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.349 . . . . 0.0 110.93 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.09 138.2 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.7 -28.52 11.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.024 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 61.4 39.47 15.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -94.45 119.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.04 -179.1 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.02 169.19 18.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.19 153.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . 0.445 ' O3P' HG23 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.19 178.42 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.06 -178.7 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.88 172.46 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.87 137.55 5.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.5 t -165.71 132.25 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 27.3 t80 60.67 102.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.61 147.39 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.836 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 m -133.21 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.42 -47.05 65.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -72.31 -32.57 66.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.32 99.94 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.72 120.99 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.96 129.4 36.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.95 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.694 0.759 . . . . 0.0 111.751 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.71 97.99 0.11 Allowed Glycine 0 C--N 1.313 -0.717 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.437 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.13 -34.32 77.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 0.0 110.963 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 174.44 40.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 76' ' ' TYR . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.28 144.09 26.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 12.0 m-20 -78.32 129.14 34.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 111.139 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -64.39 -45.21 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.203 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -56.84 -40.22 75.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.261 0.553 . . . . 0.0 110.695 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 7.9 mm-40 -68.41 -36.99 79.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.1 -41.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.096 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -31.08 67.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.19 -49.61 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.89 122.87 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.65 41.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 169.89 8.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -48.33 81.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.41 159.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -126.38 -46.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.27 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt -139.26 128.46 23.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.628 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.525 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 21.8 tp -125.35 122.97 38.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.87 -135.21 3.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.572 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 61.98 34.01 16.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.945 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.96 30.51 20.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.96 165.74 11.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 62.72 166.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mp -110.64 159.98 17.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' GLN . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.814 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 125' ' ' SER . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.404 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.478 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 145' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.27 133.35 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -26.73 65.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -44.43 89.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -59.56 -44.1 93.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.978 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -36.23 83.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -38.52 90.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.85 -46.13 79.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -35.95 82.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.775 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.84 -40.29 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.9 mt-30 -87.33 -30.92 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.33 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.602 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 157' ' ' GLN . 36.2 mttm -64.27 121.66 14.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.8 m -103.01 134.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -146.02 98.38 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.86 165.68 10.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.89 121.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.921 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 63.27 142.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -137.35 -54.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.9 124.36 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.029 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 156.29 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -145.99 -59.22 0.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.44 176.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 101.76 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.111 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.3 p -117.01 104.25 11.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.15 47.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.7 110.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.121 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.5 p -60.41 -41.92 94.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.21 -44.83 82.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.813 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -62.66 -31.03 71.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.34 112.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -77.19 147.42 36.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.29 115.44 13.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 29' ' ' GLY . 18.5 mm -83.28 138.3 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.722 0.772 . . . . 0.0 111.634 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 28' ' ' ILE . . . 88.7 73.22 1.28 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.353 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.9 -39.79 63.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.118 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 177.26 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.63 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.4 160.81 31.94 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.414 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 4.9 m-20 -93.45 104.15 16.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.093 0.473 . . . . 0.0 110.799 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.48 -44.3 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.07 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 m -58.75 -41.07 85.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.271 0.557 . . . . 0.0 110.766 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.414 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 8.1 mm100 -68.44 -39.72 81.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.656 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 t -72.66 -38.08 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.029 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -58.7 -32.35 69.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.66 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -69.11 -53.04 22.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.787 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -69.78 135.56 49.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -73.72 -42.84 60.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.029 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -159.65 112.36 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.455 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 3.2 m -176.75 39.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.75 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 61' ' ' SER . 2.2 tt 52.71 159.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.771 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -85.51 -80.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.796 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? -155.35 156.53 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 92' ' ' LEU . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.544 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.8 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB3' HG11 ' A' ' 65' ' ' VAL . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -111.57 127.79 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.05 -133.93 1.71 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.697 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.92 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -177.57 65.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.95 -26.3 21.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -75.3 -177.18 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.997 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 156.09 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.714 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.427 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 125' ' ' SER . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -85.84 130.98 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.53 -20.53 61.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.21 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -58.53 -44.66 89.65 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.673 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -59.03 -43.95 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -62.2 -38.99 91.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -42.4 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.7 t -68.09 -46.22 71.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.033 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -37.68 77.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.48 -42.38 95.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.8 tt0 -84.1 -33.59 24.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.766 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.71 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.656 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.9 tttp -68.21 160.67 28.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -82.36 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.18 -29.15 68.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 63.43 87.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.77 122.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.885 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.765 0.317 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.61 164.23 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.25 80.56 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.63 149.91 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.29 138.13 45.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -140.74 128.55 21.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.37 -172.59 2.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.96 87.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.0 t -151.05 119.33 6.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 38.3 t80 60.47 106.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.79 123.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.89 179.9 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -116.52 -50.61 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -70.62 -39.43 73.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.07 -40.65 23.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -98.21 72.22 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -83.05 121.01 26.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -78.18 139.65 38.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 29' ' ' GLY . 18.6 mm -82.11 138.21 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.61 0.719 . . . . 0.0 111.75 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 28' ' ' ILE . . . 109.49 35.33 2.28 Favored Glycine 0 C--N 1.312 -0.777 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.366 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -41.55 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.981 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 177.77 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.495 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.95 141.75 21.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -84.7 133.52 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.13 0.49 . . . . 0.0 111.184 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.11 -41.49 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.812 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -37.42 69.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.913 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.49 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.41 -37.0 79.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.052 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 46.3 t -72.98 -50.06 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.265 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.58 -29.9 69.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.94 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -81.61 -54.04 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -63.71 128.62 36.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.21 32.64 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -69.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -175.32 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 tp -122.78 151.88 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -112.26 -69.98 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt -141.28 131.58 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.4 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.549 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 151' ' ' PHE . 1.1 tt -125.08 122.96 38.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.39 -125.77 1.44 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.597 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.87 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.796 0.332 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -151.5 -63.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.21 27.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -131.88 -177.28 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.757 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 153.32 36.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.666 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 120' ' ' SER . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.481 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 125' ' ' SER . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.39 109.13 17.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -57.67 -28.64 63.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.96 92.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.98 0.419 . . . . 0.0 110.681 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.414 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 36.9 t80 -58.34 -44.13 88.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.983 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -63.47 -37.76 88.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -64.74 -42.33 95.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.08 -45.93 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -68.19 -35.83 78.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.1 -40.52 96.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -86.19 -31.85 21.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.711 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 23.4 mmtt -117.24 117.72 30.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 129.68 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.33 173.52 11.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.13 -56.0 2.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.82 128.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.901 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.86 0.362 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 tp 62.34 118.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.87 38.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.9 p -74.65 151.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 143.16 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -150.92 121.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.59 171.16 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.8 153.99 17.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.3 p -126.33 114.78 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.08 47.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.51 110.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.859 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.13 -53.62 35.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -59.84 -43.17 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -72.53 -33.11 66.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.71 91.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.31 138.52 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.9 132.1 48.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -82.07 138.43 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 111.714 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.73 105.2 1.0 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.2 -33.9 63.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 177.25 40.16 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.622 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.565 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.72 141.83 23.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -84.37 135.46 34.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.07 -42.73 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.79 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 m -56.57 -37.31 70.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.308 0.575 . . . . 0.0 110.603 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -68.54 -38.56 80.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.416 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.1 t -72.99 -42.03 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.051 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mp -71.07 -35.89 72.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.849 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -46.34 39.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.38 116.0 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 30.21 3.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.38 173.04 6.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 t -72.05 -24.94 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 9.1 tp -120.64 150.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -121.41 -70.24 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -138.56 129.83 27.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.381 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.622 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -125.05 123.56 40.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.11 1.29 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 57.21 -171.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.718 0.294 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.61 46.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.13 38.07 1.43 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.467 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 124' ' ' LEU . 6.0 mp -132.18 160.06 37.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.4 ' N ' HD12 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.48 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.48 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.573 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -92.96 115.96 28.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -63.96 -18.92 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.27 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -59.89 -46.05 90.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.947 0.403 . . . . 0.0 110.812 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 93' ' ' LEU . 39.1 t80 -58.47 -44.32 89.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.812 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -65.09 -33.92 77.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -65.83 -42.57 90.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.95 -44.15 77.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.005 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -48.4 81.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -34.76 77.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.57 -21.49 59.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -125.41 105.97 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.936 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -74.07 147.5 42.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.79 138.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.5 106.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -88.32 -176.34 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.7 pt -101.86 134.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.766 0.317 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 mt -152.87 122.79 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.21 91.7 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.48 158.75 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.084 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 107.21 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.73 -0.57 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.595 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 60.46 177.22 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.69 80.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 4.9 t -105.4 119.61 39.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.93 77.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.25 162.92 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.732 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -159.73 -52.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -35.63 71.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -80.84 -25.8 37.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -97.55 29.56 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.23 127.01 31.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.55 101.9 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.786 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -82.59 138.33 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.686 0.755 . . . . 0.0 111.68 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.92 117.32 4.13 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.446 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.01 -24.11 22.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.726 0.298 . . . . 0.0 111.194 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.38 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.668 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.25 143.48 27.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.499 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -74.78 131.52 40.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.287 0.565 . . . . 0.0 111.235 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.21 -41.5 92.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.287 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.91 -42.2 79.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.68 -42.51 77.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.782 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.41 -38.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.75 -30.32 67.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -50.48 6.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.922 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.28 120.67 13.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 31.47 3.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -152.08 151.01 30.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t 61.99 -82.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 tp -179.63 151.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.18 -67.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt -151.63 137.44 18.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HA ' HG12 ' A' ' 43' ' ' ILE . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 88' ' ' HIS . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.2 tp -125.12 126.61 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.33 2.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -178.66 43.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.96 -28.57 10.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.404 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -72.08 -178.5 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.74 148.63 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.56 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.56 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.831 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.831 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.462 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.82 114.66 15.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.36 -37.41 83.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -60.13 -46.0 91.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -60.19 -44.16 95.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.956 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -65.17 -39.94 93.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.005 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -60.67 -40.43 92.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -64.16 -45.99 86.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.034 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.19 -39.03 78.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -44.65 95.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 23.2 mm-40 -84.44 -31.03 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.2 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.2 mmpt? -64.81 138.4 58.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.855 0.359 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.61 130.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.28 159.12 16.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.24 76.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.28 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.96 150.11 47.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -78.24 -69.12 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.6 152.93 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.73 128.35 33.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.54 -37.73 3.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 60.6 172.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.09 65.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.5 t -127.3 55.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -89.34 55.63 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 10.7 p 43.05 50.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.636 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.863 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.5 p -67.15 -36.45 81.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -60.22 -47.01 87.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -60.5 -36.05 77.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.81 35.08 4.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -86.13 138.5 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -64.85 121.23 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.9 138.23 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 121.676 0.751 . . . . 0.0 111.861 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.28 102.45 0.28 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.427 -1.261 . . . . 0.0 112.38 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -85.11 -29.11 25.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.33 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.91 141.84 20.19 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -87.94 138.79 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 111.379 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.5 mp -64.28 -45.09 97.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.748 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -38.35 73.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.288 0.566 . . . . 0.0 110.351 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 16.4 mm-40 -68.57 -36.82 79.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.273 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 46.7 t -68.4 -49.96 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.75 -28.01 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -38.98 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.07 114.91 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -101.73 -26.45 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 64.5 p -68.93 132.51 46.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 61' ' ' SER . 7.8 tp 51.69 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.958 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 13.4 mptt -108.51 -72.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt -135.85 113.9 11.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.541 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG2' HG21 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 151' ' ' PHE . 24.3 tp -122.7 124.44 43.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.9 -119.54 0.93 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 67.78 -68.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.51 -46.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.79 49.22 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.53 -175.53 5.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.81 147.98 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.67 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.555 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.823 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 40' ' ' THR . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.4 ' CD1' HD12 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.437 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -78.19 128.96 34.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.03 -29.63 62.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -45.39 92.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.772 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 34.9 t80 -58.54 -44.05 89.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.975 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -62.31 -33.87 75.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.073 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -66.76 -47.0 73.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.85 -43.78 95.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.48 -35.92 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.41 -42.44 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 1.8 mt-30 -84.75 -31.08 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.29 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -69.38 145.29 53.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.53 137.43 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -50.06 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 tt -79.59 138.02 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.827 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.09 69.9 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.84 79.24 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 25.4 t -78.23 137.63 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.74 143.33 42.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -147.02 168.29 21.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -123.91 165.15 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.83 71.27 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.9 p -113.64 -36.86 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.1 85.86 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.96 148.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -81.87 -45.41 15.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.2 -45.09 94.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -28.06 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 63.68 145.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.35 129.32 37.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.64 134.67 34.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.94 138.46 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.596 0.712 . . . . 0.0 111.831 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.22 44.17 0.06 OUTLIER Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.5 38.65 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 146' ' ' PHE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.547 HG22 ' CB ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.591 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.21 141.87 35.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.0 m-20 -81.4 113.99 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 111.157 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.514 HG23 HD12 ' A' ' 52' ' ' ILE . 20.7 mt -64.35 -37.05 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.449 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -56.61 -42.0 78.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 0.0 110.905 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 10.0 mt-30 -68.53 -36.81 79.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.629 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.3 t -59.3 -49.61 82.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mt -59.57 -32.91 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.969 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.52 -40.44 92.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.59 127.84 44.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.2 30.77 2.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -176.63 -165.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 62.58 156.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 HD11 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -71.97 124.91 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -46.67 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -155.14 145.68 22.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG13 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.52 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 91' ' ' ILE . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.5 tp -117.36 128.55 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.74 164.34 12.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.65 113.19 11.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t0 61.54 112.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.9 33.31 0.65 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.68 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 60.01 -170.6 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.43 160.45 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.684 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.544 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.532 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.788 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 125' ' ' SER . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.53 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.494 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.547 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.415 ' CG1' ' CD2' ' A' ' 124' ' ' LEU . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.07 107.83 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.82 -26.38 68.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.32 -43.92 88.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 110.714 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -58.94 -44.12 91.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -36.46 81.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -61.09 -46.06 92.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -36.14 83.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -60.32 -36.13 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -92.06 -37.05 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.6 p30 44.3 -171.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.654 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 131.27 50.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.915 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -99.54 132.84 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.93 -54.96 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -136.61 -50.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.0 132.11 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.341 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.04 122.02 26.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.25 106.55 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.64 147.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.37 114.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.725 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.72 152.06 31.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.52 164.8 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.46 79.43 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 66.1 p -110.5 -43.11 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.784 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -140.19 67.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.787 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.81 -28.72 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.853 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -138.18 -52.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -72.12 -37.8 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p -80.99 -31.54 34.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -177.05 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -79.93 130.26 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -87.89 142.28 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 136.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.262 0.553 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.23 43.99 0.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.158 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.21 -41.65 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.312 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER -178.37 37.03 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.509 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.476 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 142.84 33.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 3.5 m-20 -74.95 133.79 41.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 111.122 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.31 -43.36 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.027 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -38.96 73.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.3 0.571 . . . . 0.0 110.526 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.416 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.9 mm100 -68.67 -36.88 79.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.484 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.67 -46.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -65.44 -39.45 92.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -38.35 90.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 124.7 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -94.79 87.15 4.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 61.0 33.03 19.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 t -118.42 175.85 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.95 143.8 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.053 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -95.72 -70.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt -155.03 145.98 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.083 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 76' ' ' TYR . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' ILE . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.676 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.2 m120 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.1 tp -125.08 122.74 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.4 123.56 2.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.441 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -177.95 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -175.42 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.838 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.94 47.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.562 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -168.79 -174.49 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -106.87 159.23 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.718 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' GLN . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.4 mm-40 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 147' ' ' ILE . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.503 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.509 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 145' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.447 HG12 HD22 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -92.09 100.95 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.42 -25.94 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -44.66 88.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.09 -44.33 87.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -33.85 76.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.0 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -65.95 -45.99 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 111.055 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -36.53 79.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -34.48 73.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.788 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.68 -27.28 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.41 100.24 6.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.65 159.19 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.53 133.35 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.2 110.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -111.38 65.27 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.35 129.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.977 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.736 0.303 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.88 129.91 53.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 116.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.39 159.09 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.04 134.04 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.95 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -144.41 134.77 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -147.46 -178.5 6.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.19 85.57 0.67 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.99 160.18 43.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.93 97.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 11.0 p -172.4 137.45 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.89 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.794 0.33 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m 71.08 -63.42 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -59.89 -35.95 75.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -81.04 -37.23 29.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.4 146.55 47.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -100.99 154.83 18.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 120.7 17.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.79 138.37 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.686 0.755 . . . . 0.0 111.93 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.16 63.2 0.73 Allowed Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.152 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -23.82 47.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.52 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.0 35.93 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.518 HG23 ' CB ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.624 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.01 153.93 46.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -91.21 141.11 29.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 111.074 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.23 -44.9 95.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.268 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -43.13 95.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.928 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.9 79.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.668 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -70.44 -44.78 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.04 -30.12 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -66.65 -43.32 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.84 114.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -79.63 -31.22 41.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.72 177.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -80.7 137.46 36.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 62' ' ' ILE . 32.2 mm 66.28 152.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.254 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.37 -54.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.589 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -122.42 120.73 34.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.855 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.776 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CD2' ' CE2' ' A' ' 68' ' ' PHE . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' CD2' ' CD1' ' A' ' 76' ' ' TYR . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.434 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.776 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.19 122.95 38.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.68 -176.79 38.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.57 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.17 89.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.92 -166.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.1 56.17 5.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -131.97 -178.96 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -135.0 157.25 47.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.781 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.514 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.789 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.487 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.493 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.487 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.518 ' CB ' HG23 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 145' ' ' ILE . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.16 130.62 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.64 -30.24 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.003 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.89 -46.09 90.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.034 0.445 . . . . 0.0 110.706 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.56 -44.19 89.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.68 -38.69 92.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.73 87.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.1 t -67.89 -42.4 81.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.161 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -36.03 82.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.02 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.39 -47.94 68.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -78.11 -36.96 47.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.33 33.72 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.458 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 132.9 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 127.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -151.72 159.33 44.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.33 169.58 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.8 mm -98.92 126.54 52.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.897 0.379 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.17 126.33 47.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.08 85.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.61 145.25 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.22 122.81 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.829 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -123.02 168.87 11.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.98 0.419 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -174.8 169.46 3.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.34 112.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.2 p -140.08 178.81 7.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.24 77.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 m -108.49 -37.62 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.725 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.724 HG21 ' H ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 5.5 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.591 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.013 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.796 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 43' ' ' ILE . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 84' ' ' LEU . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.935 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.935 ' CD1' HD12 ' A' ' 81' ' ' ILE . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.661 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 67' ' ' THR . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG2' HG12 ' A' ' 65' ' ' VAL . 32.3 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 33' ' ' VAL . 21.5 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.849 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.826 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.566 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.866 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.866 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.619 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.849 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 147' ' ' ILE . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.582 ' HA ' HD13 ' A' ' 147' ' ' ILE . 6.6 mm-40 -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.826 ' CD1' HD21 ' A' ' 101' ' ' LEU . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD13 ' N ' ' A' ' 142' ' ' SER . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.724 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 124' ' ' LEU . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.673 ' CG1' HD21 ' A' ' 124' ' ' LEU . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.688 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pp0? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 16' ' ' GLN . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.974 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD12 ' A' ' 43' ' ' ILE . 1.3 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.789 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.974 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.79 0.329 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.789 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 1.7 p-10 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 84' ' ' LEU . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 81' ' ' ILE . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.612 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.668 ' CD2' HD22 ' A' ' 84' ' ' LEU . 61.3 t-80 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' C ' HG13 ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 33' ' ' VAL . 26.3 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.623 HD21 ' CD1' ' A' ' 130' ' ' ILE . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HB2' ' A' ' 87' ' ' LYS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.535 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.425 ' HB3' HD23 ' A' ' 111' ' ' LEU . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.727 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.2 m-80 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.658 ' O ' HD23 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 mm-40 -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.87 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 145' ' ' ILE . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.645 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 142' ' ' SER . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.52 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 38' ' ' CYS . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 130' ' ' ILE . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tm0? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' HD12 ' A' ' 20' ' ' ILE . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 16' ' ' GLN . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.82 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.751 HG12 HD23 ' A' ' 78' ' ' LEU . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.575 0.226 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.755 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.8 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 43' ' ' ILE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 84' ' ' LEU . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 81' ' ' ILE . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.593 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 65' ' ' VAL . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.905 0.383 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB2' HD23 ' A' ' 92' ' ' LEU . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.605 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.653 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.463 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.831 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m-80 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.707 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 138' ' ' SER . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.555 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' GLU . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 143' ' ' LEU . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.74 ' C ' HD22 ' A' ' 143' ' ' LEU . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.82 HD13 ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 130' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 124' ' ' LEU . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 68' ' ' PHE . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.88 HG23 HG12 ' A' ' 45' ' ' ILE . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.88 HG12 HG23 ' A' ' 37' ' ' ILE . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.575 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.0 ttpt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.733 0.301 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 78' ' ' LEU . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 83' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG23 ' A' ' 132' ' ' VAL . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.661 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.1 t-80 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.665 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.586 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 99' ' ' LEU . 26.9 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.593 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.525 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.708 ' HB3' HD23 ' A' ' 100' ' ' LEU . 26.2 m-80 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.864 HD21 HG12 ' A' ' 147' ' ' ILE . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.548 ' HG3' HG22 ' A' ' 144' ' ' VAL . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.661 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.412 ' HA ' HD12 ' A' ' 140' ' ' ILE . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.526 ' H ' HG12 ' A' ' 136' ' ' VAL . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.56 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 36' ' ' VAL . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.864 HG12 HD21 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.771 HG21 ' HE2' ' A' ' 68' ' ' PHE . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.888 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.888 HG12 HG23 ' A' ' 37' ' ' ILE . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.64 HD11 HG23 ' A' ' 36' ' ' VAL . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.771 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.492 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.582 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.551 ' H ' HG22 ' A' ' 81' ' ' ILE . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 81' ' ' ILE . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.616 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.486 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 33' ' ' VAL . 4.0 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.704 0.288 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 130' ' ' ILE . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.886 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m120 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.886 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.748 ' HB3' HD13 ' A' ' 100' ' ' LEU . 77.4 m-20 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD13 HD23 ' A' ' 124' ' ' LEU . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.538 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.676 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 101' ' ' LEU . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 138' ' ' SER . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.424 ' H ' HG12 ' A' ' 136' ' ' VAL . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.72 ' N ' HD23 ' A' ' 141' ' ' LEU . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 38' ' ' CYS . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 129' ' ' GLU . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 91' ' ' ILE . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.646 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.642 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 43' ' ' ILE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.795 HD13 HD22 ' A' ' 84' ' ' LEU . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 81' ' ' ILE . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.646 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.2 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.7 tm? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.46 HD22 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 67' ' ' THR . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.599 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.0 m120 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 111' ' ' LEU . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 100' ' ' LEU . 12.6 m-80 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 145' ' ' ILE . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.604 ' OD2' HD23 ' A' ' 111' ' ' LEU . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.941 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 145' ' ' ILE . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.68 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 138' ' ' SER . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.52 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.68 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.573 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.941 HG22 ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 130' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' A' ' 22' ' ' LYS . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HD2' ' CD1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.028 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.801 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.028 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.657 0.265 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.997 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 36' ' ' VAL . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 83' ' ' ARG . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.647 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.997 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.603 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 33' ' ' VAL . 29.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.524 -0.035 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.437 HD22 HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 89' ' ' PHE . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.603 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.603 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.713 ' HB3' HD23 ' A' ' 100' ' ' LEU . 2.0 m-80 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.643 ' O ' HD12 ' A' ' 145' ' ' ILE . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.499 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 138' ' ' SER . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 142' ' ' SER . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.801 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 130' ' ' ILE . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' GLU . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.543 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 120.759 0.314 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.629 ' HH2' HG21 ' A' ' 33' ' ' VAL . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' N ' HD11 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.763 HD12 HD11 ' A' ' 84' ' ' LEU . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 81' ' ' ILE . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 101' ' ' LEU . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.638 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.6 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 99' ' ' LEU . 1.6 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.852 0.358 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.836 HD11 ' HA ' ' A' ' 121' ' ' ASN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.732 ' N ' HD13 ' A' ' 100' ' ' LEU . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.61 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.8 m120 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.836 ' HA ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.586 ' O ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 145' ' ' ILE . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 147' ' ' ILE . 6.3 mm-40 -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.519 HG22 ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 138' ' ' SER . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.44 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.908 HG21 HD11 ' A' ' 124' ' ' LEU . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.589 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.947 0.403 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.808 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.871 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 45' ' ' ILE . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.723 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.61 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.723 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.989 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.808 ' CE2' HG11 ' A' ' 36' ' ' VAL . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.789 HD23 HD13 ' A' ' 84' ' ' LEU . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD13 HD23 ' A' ' 78' ' ' LEU . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.989 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.69 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.88 HD13 HG22 ' A' ' 33' ' ' VAL . 4.5 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' A' ' 93' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.715 HD22 ' HB3' ' A' ' 121' ' ' ASN . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m120 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.715 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.2 m-80 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.713 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 101' ' ' LEU . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' OD2' HD13 ' A' ' 111' ' ' LEU . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.787 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.561 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG23 HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.75 HD22 ' CD2' ' A' ' 143' ' ' LEU . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.75 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.681 HG13 HD11 ' A' ' 130' ' ' ILE . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 99' ' ' LEU . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.708 ' SG ' HG22 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 36' ' ' VAL . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' HD12 ' A' ' 78' ' ' LEU . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HG3' ' A' ' 70' ' ' ARG . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 81' ' ' ILE . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 33' ' ' VAL . 1.6 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.332 . . . . 0.0 110.916 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.745 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.889 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.889 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.745 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.691 ' OD1' HD11 ' A' ' 92' ' ' LEU . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 123' ' ' LEU . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.547 ' HA ' HD13 ' A' ' 147' ' ' ILE . 5.2 mm-40 -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HB3' HD13 ' A' ' 145' ' ' ILE . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CD1' HD11 ' A' ' 145' ' ' ILE . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.604 ' C ' HD22 ' A' ' 143' ' ' LEU . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.708 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.412 ' C ' ' HG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.984 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.7 ' HA ' HD13 ' A' ' 143' ' ' LEU . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 129' ' ' GLU . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.547 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.982 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.628 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.862 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.7 t30 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.982 HD22 HD13 ' A' ' 43' ' ' ILE . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG23 ' A' ' 132' ' ' VAL . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.601 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.745 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 87' ' ' LYS . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.744 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.653 ' HB3' HD22 ' A' ' 100' ' ' LEU . 47.4 m-80 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.559 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.931 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 145' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.661 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.817 HG23 HD21 ' A' ' 84' ' ' LEU . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 138' ' ' SER . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.509 ' H ' HG12 ' A' ' 136' ' ' VAL . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.661 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.657 HD22 HD21 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.576 ' C ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.931 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 125' ' ' SER . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.908 0.385 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.65 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.569 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG13 ' C ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.974 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' HD11 ' A' ' 78' ' ' LEU . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' CG ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.841 HD12 HD11 ' A' ' 84' ' ' LEU . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 81' ' ' ILE . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 67' ' ' THR . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.974 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.871 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.731 HD12 ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.659 HD13 ' CG1' ' A' ' 33' ' ' VAL . 21.8 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.814 HD21 HG12 ' A' ' 33' ' ' VAL . 1.2 mp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 92' ' ' LEU . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.69 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.717 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.634 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.2 m-80 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 145' ' ' ILE . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.517 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.603 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.69 ' HG3' HG22 ' A' ' 144' ' ' VAL . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.698 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.465 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.698 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.643 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.498 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 130' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.799 0.333 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 68' ' ' PHE . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.767 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.634 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.7 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.767 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HA2' ' A' ' 69' ' ' GLY . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.7 ' HG3' HG23 ' A' ' 67' ' ' THR . 27.4 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' HG13 ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.832 0.349 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 91' ' ' ILE . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.586 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.798 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 67' ' ' THR . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.615 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m120 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.798 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.912 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.3 m-80 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 100' ' ' LEU . 7.9 mm100 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.832 HD23 ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.645 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.645 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.521 ' H ' HG21 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' CYS . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.832 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.745 HG23 HG12 ' A' ' 45' ' ' ILE . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 141' ' ' LEU . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 143' ' ' LEU . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.745 HG12 HG23 ' A' ' 37' ' ' ILE . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.675 0.274 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.673 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.717 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 43' ' ' ILE . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 HG23 ' A' ' 132' ' ' VAL . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.832 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.914 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-80 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 100' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 147' ' ' ILE . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.627 ' HA ' HD13 ' A' ' 147' ' ' ILE . 3.7 mm100 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 145' ' ' ILE . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.598 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD13 ' N ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD13 ' A' ' 141' ' ' LEU . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 43' ' ' ILE . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 39' ' ' THR . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.639 HG21 HD11 ' A' ' 124' ' ' LEU . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.644 HG13 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.725 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' HD22 ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.531 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD13 ' A' ' 48' ' ' LEU . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 143' ' ' LEU . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.776 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.776 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 84' ' ' LEU . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.864 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.864 HD12 HD13 ' A' ' 81' ' ' ILE . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.725 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 91' ' ' ILE . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.786 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.584 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.619 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.887 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.709 ' O ' HD13 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.618 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.696 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.466 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.715 ' N ' HD23 ' A' ' 141' ' ' LEU . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.669 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.772 HG12 HD12 ' A' ' 124' ' ' LEU . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.541 HG21 ' H ' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 78' ' ' LEU . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.97 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 HD13 ' A' ' 84' ' ' LEU . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 84' ' ' LEU . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 81' ' ' ILE . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD12 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.612 ' C ' HG13 ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.769 0.318 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.72 ' HB3' HD23 ' A' ' 100' ' ' LEU . 15.4 m-80 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.898 HD21 HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.535 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 136' ' ' VAL . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.535 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 142' ' ' SER . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.541 ' H ' HG21 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 124' ' ' LEU . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.898 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 99' ' ' LEU . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 68' ' ' PHE . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 45' ' ' ILE . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.788 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.659 HG22 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.566 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 83' ' ' ARG . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 67' ' ' THR . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.559 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 130' ' ' ILE . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.809 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 m120 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.809 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 5.0 p-10 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.7 m-80 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.412 ' C ' HD23 ' A' ' 100' ' ' LEU . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.736 HD22 HG12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.646 ' C ' HD22 ' A' ' 143' ' ' LEU . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.021 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.761 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.021 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.717 0.294 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.822 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' HA2' ' A' ' 69' ' ' GLY . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.957 HD13 HD12 ' A' ' 84' ' ' LEU . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.957 HD12 HD13 ' A' ' 81' ' ' ILE . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.014 0.435 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.611 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.783 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.0 m-80 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 100' ' ' LEU . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 145' ' ' ILE . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.7 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.9 mm-40 -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.855 HD11 HD11 ' A' ' 101' ' ' LEU . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.761 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.715 HG21 HD11 ' A' ' 124' ' ' LEU . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.766 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG21 ' HE2' ' A' ' 68' ' ' PHE . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.562 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.602 HG21 ' H ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.931 HD13 HD22 ' A' ' 78' ' ' LEU . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HG23 ' A' ' 37' ' ' ILE . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.688 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.931 HD22 HD13 ' A' ' 43' ' ' ILE . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' HD12 ' A' ' 84' ' ' LEU . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CG1' ' A' ' 81' ' ' ILE . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.5 m-20 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.674 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.853 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.814 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.6 mm? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 116' ' ' VAL . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.0 m120 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.57 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.7 m-80 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 5.1 mm100 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 123' ' ' LEU . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD2' HD23 ' A' ' 111' ' ' LEU . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 145' ' ' ILE . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 142' ' ' SER . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 43' ' ' ILE . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 39' ' ' THR . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 130' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.6 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 16' ' ' GLN . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 48' ' ' LEU . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.802 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.783 HG21 ' OG ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.824 HD13 HD22 ' A' ' 78' ' ' LEU . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 36' ' ' VAL . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.9 ttpt . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.771 0.32 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG21 HD23 ' A' ' 92' ' ' LEU . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.688 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.737 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 5.0 t30 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 71' ' ' ASN . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CD1' HD23 ' A' ' 78' ' ' LEU . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.824 HD22 HD13 ' A' ' 43' ' ' ILE . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 88' ' ' HIS . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.787 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.609 ' CE1' HD22 ' A' ' 84' ' ' LEU . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.2 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 33' ' ' VAL . 3.2 mm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.844 0.354 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 92' ' ' LEU . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 67' ' ' THR . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.6 m120 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.426 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 123' ' ' LEU . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.418 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.714 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HD2' ' A' ' 83' ' ' ARG . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 137' ' ' GLU . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 142' ' ' SER . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.507 HD11 HD12 ' A' ' 43' ' ' ILE . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.579 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -104.57 75.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -70.09 -47.01 63.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -76.03 -46.77 27.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 64.92 -75.07 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.54 121.87 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.01 110.98 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.42 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.634 0.731 . . . . 0.0 111.647 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 48.77 18.61 Favored Glycine 0 C--N 1.313 -0.726 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.124 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -56.21 -46.81 79.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.681 0.277 . . . . 0.0 111.352 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.19 35.23 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.725 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.724 HG21 ' H ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 5.5 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.591 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.013 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -146.03 141.89 28.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.761 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.95 140.7 32.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.057 0.456 . . . . 0.0 111.187 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' SG ' ' A' ' 154' ' ' CYS . 8.5 mt -64.16 -45.67 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.88 -39.33 74.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.0 110.555 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 44.5 mm-40 -68.47 -36.92 79.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.518 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.9 t -66.29 -45.62 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.909 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tp -71.05 -30.39 66.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -80.45 -43.03 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.021 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.96 137.05 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.25 30.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.15 35.87 2.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 p 60.83 26.05 15.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.024 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.794 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.3 tp -179.28 134.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.738 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -100.96 -65.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt -147.33 133.03 18.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.794 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.796 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 43' ' ' ILE . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 84' ' ' LEU . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.935 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.935 ' CD1' HD12 ' A' ' 81' ' ' ILE . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.661 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 67' ' ' THR . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG2' HG12 ' A' ' 65' ' ' VAL . 32.3 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 33' ' ' VAL . 21.5 tp -125.08 124.66 42.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.35 -136.55 2.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.543 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.28 -178.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -31.56 69.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 43.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -139.14 170.69 15.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -112.97 157.22 21.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.849 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.826 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.566 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.866 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.866 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.619 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.849 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 147' ' ' ILE . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.582 ' HA ' HD13 ' A' ' 147' ' ' ILE . 6.6 mm-40 -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.826 ' CD1' HD21 ' A' ' 101' ' ' LEU . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD13 ' N ' ' A' ' 142' ' ' SER . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.724 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 124' ' ' LEU . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.673 ' CG1' HD21 ' A' ' 124' ' ' LEU . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -87.19 108.74 19.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.03 -27.5 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.228 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -45.95 92.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -58.69 -44.17 90.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -36.21 76.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.91 -43.22 91.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.425 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.1 t -64.7 -46.0 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.23 -35.88 80.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.98 -41.75 97.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -84.49 -33.08 23.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.78 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.635 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 157' ' ' GLN . 29.5 mttt -88.06 122.81 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 160' ' ' VAL . 14.1 p -93.35 125.25 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.034 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.61 102.17 14.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.68 -56.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.19 129.19 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.893 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.38 114.62 5.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -171.3 -60.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.476 HG12 ' N ' ' B' ' 169' ' ' TPO . 34.2 t -106.03 158.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.476 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.4 140.49 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -136.72 167.76 20.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.163 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.44 167.29 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.57 126.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 72.1 p -84.09 145.54 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -105.69 48.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 176' ' ' VAL . 11.2 m -140.7 97.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.917 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.2 m -129.42 -68.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.688 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pp0? -60.67 -43.85 97.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 16' ' ' GLN . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -81.01 -26.81 36.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 65.82 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.58 129.37 39.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -90.07 106.27 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.45 138.36 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.683 0.754 . . . . 0.0 111.773 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.13 28.96 57.47 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.82 -35.52 78.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.709 0.29 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 177.8 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.974 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD12 ' A' ' 43' ' ' ILE . 1.3 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.789 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.974 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.77 141.85 23.08 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.755 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.7 m-20 -84.97 139.12 32.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.207 0.527 . . . . 0.0 111.302 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.605 HD13 ' SG ' ' A' ' 154' ' ' CYS . 15.8 mt -64.4 -45.2 96.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.436 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.75 -40.86 76.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.875 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 14.1 mt-30 -68.47 -36.89 79.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 51' ' ' ASP . 53.9 t -70.08 -46.07 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.098 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.91 -28.46 64.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.976 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -80.69 -47.89 13.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.38 110.82 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 53.24 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 -174.38 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 t -82.24 -28.68 31.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 65' ' ' VAL . 8.4 tp -125.94 147.5 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.682 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt -151.67 131.0 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG22 HD11 ' A' ' 62' ' ' ILE . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.789 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 1.7 p-10 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 84' ' ' LEU . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 81' ' ' ILE . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.612 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.668 ' CD2' HD22 ' A' ' 84' ' ' LEU . 61.3 t-80 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' C ' HG13 ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 33' ' ' VAL . 26.3 tp -125.11 123.42 39.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.18 177.39 22.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.791 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.25 27.72 4.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.334 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.52 -26.96 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.37 -12.73 7.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.633 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.87 -170.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 110.985 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.14 160.25 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.623 HD21 ' CD1' ' A' ' 130' ' ' ILE . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HB2' ' A' ' 87' ' ' LYS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.535 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' HB3' HD23 ' A' ' 111' ' ' LEU . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.727 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.2 m-80 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.658 ' O ' HD23 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.5 mm-40 -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.87 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 145' ' ' ILE . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.645 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 142' ' ' SER . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.52 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 38' ' ' CYS . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 130' ' ' ILE . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -84.78 111.35 19.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.51 -29.89 68.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -58.61 -43.92 89.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.636 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.64 -44.09 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -37.84 85.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.04 -46.7 87.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.078 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.605 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.7 t -62.9 -45.97 90.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.069 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.58 -39.08 88.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.15 -44.04 97.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.62 -36.16 26.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p30 42.37 91.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.52 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -66.82 128.63 37.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.8 t -98.68 130.57 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -147.55 94.81 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -147.11 164.84 31.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.983 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 30.1 mm -80.19 124.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.82 158.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.58 30.95 0.59 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 169' ' ' TPO . 23.9 t -74.33 158.83 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.49 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -94.28 109.48 21.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.537 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -115.08 138.54 50.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.04 179.62 4.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -122.01 125.1 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 62.2 p -118.19 -37.81 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' PHE . . . . . 0.455 ' HB3' ' H ' ' B' ' 176' ' ' VAL . 5.4 m-85 -129.26 -151.71 0.49 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' B' ' 175' ' ' PHE . 21.3 t -86.65 152.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.907 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.885 0.374 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -105.84 -66.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tm0? -68.92 -39.41 79.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' HD12 ' A' ' 20' ' ' ILE . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 16' ' ' GLN . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.02 -44.49 18.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.53 105.19 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.88 138.82 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.815 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -109.81 101.97 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.25 138.29 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.575 0.703 . . . . 0.0 111.907 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.92 34.25 5.77 Favored Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.564 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.86 -33.21 27.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER 175.96 39.25 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.82 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.751 HG12 HD23 ' A' ' 78' ' ' LEU . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.83 142.43 26.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -74.92 120.07 19.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.094 0.473 . . . . 0.0 111.103 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.515 HD13 ' SG ' ' A' ' 154' ' ' CYS . 57.9 mt -64.3 -42.85 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.23 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -57.55 -40.27 78.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.184 0.516 . . . . 0.0 110.649 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 36.1 mm-40 -68.41 -38.41 81.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.769 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.721 HG13 ' HG3' ' A' ' 63' ' ' LYS . 40.6 t -73.07 -40.46 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.978 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.611 HD21 ' OD2' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -71.08 -37.24 72.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -72.02 -46.81 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.13 102.58 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 80.93 4.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -135.62 164.72 27.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 p -75.46 -25.67 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.924 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.9 tp -126.85 150.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -138.43 -63.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt -138.18 132.62 32.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HD11 ' A' ' 62' ' ' ILE . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.755 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.8 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 43' ' ' ILE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 84' ' ' LEU . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 81' ' ' ILE . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.593 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 65' ' ' VAL . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.25 136.97 54.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.33 161.41 34.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.666 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 61.36 152.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.611 ' OD2' HD21 ' A' ' 56' ' ' LEU . 10.3 t70 -74.47 104.71 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 -84.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -150.11 -172.89 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -106.91 160.61 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB2' HD23 ' A' ' 92' ' ' LEU . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.605 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.653 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.463 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.831 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.4 m-80 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.707 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 138' ' ' SER . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.555 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' GLU . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 143' ' ' LEU . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.74 ' C ' HD22 ' A' ' 143' ' ' LEU . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.82 HD13 ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 130' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 124' ' ' LEU . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -79.73 112.89 17.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -34.8 72.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -44.58 92.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.685 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -58.91 -43.92 91.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -60.88 -41.1 95.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.062 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.06 -40.93 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.515 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -64.1 -46.02 86.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.69 -36.0 82.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.17 -36.55 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -90.31 -37.1 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.25 -171.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.551 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.36 154.0 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.07 137.59 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.4 32.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -89.22 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.41 162.07 13.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.92 -52.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.82 149.45 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -84.37 128.39 34.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.9 -25.31 9.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.63 -175.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.5 155.14 17.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -154.23 152.14 29.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -87.69 58.19 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.742 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.2 163.0 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.971 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.828 0.347 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.64 74.11 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.87 -45.95 66.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t -75.87 -40.75 53.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -138.68 90.68 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -90.77 133.78 34.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 101.8 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.16 138.49 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.706 0.765 . . . . 0.0 111.822 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.05 36.63 21.1 Favored Glycine 0 C--N 1.315 -0.599 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -89.13 -32.05 17.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.44 35.66 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 68' ' ' PHE . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.88 HG23 HG12 ' A' ' 45' ' ' ILE . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.88 HG12 HG23 ' A' ' 37' ' ' ILE . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.575 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -147.06 142.43 27.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.9 m-20 -88.09 137.43 32.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 111.068 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 52' ' ' ILE . 1.7 mp -64.34 -43.61 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.784 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.01 -38.84 73.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.334 0.588 . . . . 0.0 110.547 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.48 -41.15 80.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.636 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 63' ' ' LYS . 56.1 t -64.67 -46.56 91.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.043 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -71.07 -29.2 65.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -77.42 -46.85 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.93 109.9 2.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.52 77.68 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -168.63 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -84.44 -32.59 23.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 92' ' ' LEU . 8.7 tp -122.24 153.45 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.799 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -115.16 -65.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.189 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.0 ttpt -145.46 134.36 22.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.428 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 78' ' ' LEU . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 83' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG23 ' A' ' 132' ' ' VAL . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.661 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.1 t-80 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.665 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.586 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 99' ' ' LEU . 26.9 tp -125.15 124.59 42.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 -155.8 26.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.54 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.074 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.65 31.24 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -116.19 -175.94 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp -120.46 155.83 32.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.593 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.554 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.623 HG22 ' HB2' ' B' ' 171' ' ' ALA . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.525 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.708 ' HB3' HD23 ' A' ' 100' ' ' LEU . 26.2 m-80 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.864 HD21 HG12 ' A' ' 147' ' ' ILE . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' HG3' HG22 ' A' ' 144' ' ' VAL . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.661 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.412 ' HA ' HD12 ' A' ' 140' ' ' ILE . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.526 ' H ' HG12 ' A' ' 136' ' ' VAL . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.56 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 36' ' ' VAL . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.864 HG12 HD21 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -81.28 114.46 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -31.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -44.54 89.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 33' ' ' VAL . 32.8 t80 -58.27 -44.11 88.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.93 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -64.18 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.18 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -60.45 -45.72 92.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.05 -42.4 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.015 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -40.27 78.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.69 -46.2 89.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.46 -31.93 26.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 42.44 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.486 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 152.6 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.96 130.8 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.071 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.12 -171.94 1.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 146.39 28.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.41 133.66 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 175.09 9.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.62 -47.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.739 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.08 138.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.62 159.77 12.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -166.24 138.85 3.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -160.03 169.3 23.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.84 78.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.173 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 76.3 p -146.25 -47.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.53 59.05 4.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.08 107.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.85 -74.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -60.7 -45.76 92.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t -77.7 -25.1 49.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -53.47 159.44 1.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.046 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.71 121.0 15.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -83.6 135.23 34.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.37 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.624 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -163.57 103.01 0.21 Allowed Glycine 0 C--N 1.314 -0.655 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.676 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.2 -30.98 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 178.02 39.7 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.771 HG21 ' HE2' ' A' ' 68' ' ' PHE . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.888 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.888 HG12 HG23 ' A' ' 37' ' ' ILE . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD11 HG23 ' A' ' 36' ' ' VAL . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -138.54 142.0 39.29 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.9 ' O ' HG23 ' A' ' 55' ' ' VAL . 6.2 m-20 -74.87 119.8 19.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 111.178 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.578 HD13 ' SG ' ' A' ' 154' ' ' CYS . 64.1 mt -64.49 -43.75 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.027 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.2 p -59.61 -40.87 88.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 110.589 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 32.5 mm-40 -68.44 -36.86 79.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.754 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.5 t -64.27 -42.33 95.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.37 -32.02 70.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -35.99 47.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.38 120.16 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -28.47 22.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -57.78 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.939 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.2 p -86.95 -43.56 12.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.4 tp -83.38 146.68 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.578 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.0 mmtt -117.76 -68.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.796 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt -144.54 138.92 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.771 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.492 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.527 HD22 HD12 ' B' ' 166' ' ' LEU . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.582 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.551 ' H ' HG22 ' A' ' 81' ' ' ILE . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 81' ' ' ILE . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.616 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.486 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 33' ' ' VAL . 4.0 tt -125.32 122.82 37.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.05 26.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 63.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.488 ' CG ' HD23 ' A' ' 155' ' ' LEU . 2.6 m-20 52.16 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.026 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.11 -51.11 3.73 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 123' ' ' LEU . 18.7 p30 -155.61 149.24 25.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.16 160.34 15.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 130' ' ' ILE . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.657 HG22 ' HB2' ' B' ' 171' ' ' ALA . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.886 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m120 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.886 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.748 ' HB3' HD13 ' A' ' 100' ' ' LEU . 77.4 m-20 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD13 HD23 ' A' ' 124' ' ' LEU . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.538 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.676 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 101' ' ' LEU . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 138' ' ' SER . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.424 ' H ' HG12 ' A' ' 136' ' ' VAL . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.72 ' N ' HD23 ' A' ' 141' ' ' LEU . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 38' ' ' CYS . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 129' ' ' GLU . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 91' ' ' ILE . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -82.67 124.88 30.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.222 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -56.9 -42.42 79.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.23 -42.54 91.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.723 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -33.98 77.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.055 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.68 -43.99 95.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 52' ' ' ILE . 13.0 t -59.36 -46.14 89.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.488 HD23 ' CG ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -69.0 -35.93 77.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.942 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.93 -35.81 64.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -91.96 -34.43 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.55 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.02 124.22 41.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.14 122.38 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -116.93 132.79 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -104.24 116.93 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.7 pt -77.04 133.67 30.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.943 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.804 0.335 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.527 HD12 HD22 ' A' ' 80' ' ' ASN . 9.7 mt -123.35 99.77 6.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.64 -51.6 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.51 139.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -91.08 111.81 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -114.3 152.92 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -111.57 168.33 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.25 149.17 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 46.5 p -119.74 69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.33 78.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.74 131.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.895 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.866 0.365 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -61.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.66 -43.29 80.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -71.34 -35.89 71.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 109.57 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 124.96 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.69 116.44 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 136.69 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 37.95 6.42 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.31 -38.44 91.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.333 . . . . 0.0 110.931 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.0 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.23 141.79 32.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -80.06 142.32 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.312 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -64.16 -45.22 97.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.551 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -38.7 79.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.338 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.1 mm-40 -68.55 -37.01 79.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.454 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.825 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.8 t -72.16 -39.99 65.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.93 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -32.57 69.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -49.24 62.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.6 107.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -87.75 -31.83 19.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -132.58 170.84 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m 60.79 178.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.602 HD13 HD12 ' A' ' 92' ' ' LEU . 10.5 tp -75.51 155.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HD3' HG13 ' A' ' 55' ' ' VAL . 1.6 mttp -94.62 -74.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.245 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -128.5 134.76 48.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.646 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.642 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 43' ' ' ILE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.795 HD13 HD22 ' A' ' 84' ' ' LEU . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 81' ' ' ILE . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.646 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.2 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD13 ' A' ' 62' ' ' ILE . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.7 tm? -125.38 128.63 48.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.514 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 154.85 -57.07 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.629 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.34 101.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.34 174.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.807 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.05 175.66 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.0 m120 63.48 -179.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -106.95 160.22 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.843 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.46 HD22 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 67' ' ' THR . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.599 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.766 HG21 ' O ' ' B' ' 168' ' ' VAL . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.0 m120 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 111' ' ' LEU . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 100' ' ' LEU . 12.6 m-80 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 145' ' ' ILE . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.604 ' OD2' HD23 ' A' ' 111' ' ' LEU . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.941 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 145' ' ' ILE . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.68 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 138' ' ' SER . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.52 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.68 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.573 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.941 HG22 ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 130' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.443 HG21 ' HE2' ' A' ' 152' ' ' LYS . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.67 118.37 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.28 -27.87 66.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -46.13 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 24.2 t80 -61.15 -43.49 98.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.443 ' HE2' HG21 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -55.66 -38.15 69.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.976 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -47.04 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.2 t -62.99 -44.2 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.72 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.415 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -57.92 -35.84 71.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.778 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.97 -42.41 98.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -84.61 -31.22 24.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.05 -91.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.692 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tttm -87.36 125.95 34.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.6 m -81.71 130.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.46 -66.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -160.59 -174.62 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.12 136.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.172 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.982 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.705 0.288 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.6 95.49 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -100.48 31.01 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.766 ' O ' HG21 ' A' ' 106' ' ' THR . 22.8 t -117.17 128.19 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -63.83 82.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.756 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -103.47 121.72 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -97.91 167.12 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.61 102.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 1.5 p -114.49 139.38 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -159.99 48.03 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.58 30.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.822 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.709 0.29 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -121.17 -46.09 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -46.95 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' A' ' 22' ' ' LYS . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HD2' ' CD1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -75.61 -26.02 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.65 30.42 0.79 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.319 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -91.34 124.83 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.02 103.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.756 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.89 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 111.779 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 64.76 103.67 0.01 OUTLIER Glycine 0 C--N 1.314 -0.667 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.275 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -76.76 -31.53 57.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 178.52 38.9 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.028 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.801 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.028 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.13 144.82 31.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.8 m-20 -74.95 136.45 41.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 111.269 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.662 HD13 ' SG ' ' A' ' 154' ' ' CYS . 78.6 mt -64.53 -45.23 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.084 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -39.28 74.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.0 110.694 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.6 mm100 -68.47 -38.13 80.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.597 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.7 t -73.1 -43.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.06 -31.6 68.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -47.67 36.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.986 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.64 111.99 9.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -30.54 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -123.87 173.57 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m 59.23 167.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 65' ' ' VAL . 9.8 tp -73.92 155.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -70.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt -137.64 130.97 30.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.357 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.997 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 36' ' ' VAL . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 83' ' ' ARG . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.647 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.997 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.603 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 33' ' ' VAL . 29.5 tp -125.22 124.15 41.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.92 -129.58 2.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.505 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 63.34 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -137.29 28.89 2.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.36 -23.45 31.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.654 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -73.59 -170.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.4 mm? -113.56 151.22 31.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.958 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.437 HD22 HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 89' ' ' PHE . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.603 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.806 HG22 ' HB2' ' B' ' 171' ' ' ALA . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.603 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.713 ' HB3' HD23 ' A' ' 100' ' ' LEU . 2.0 m-80 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.643 ' O ' HD12 ' A' ' 145' ' ' ILE . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.499 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 138' ' ' SER . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 142' ' ' SER . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.801 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 130' ' ' ILE . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' GLU . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.94 109.14 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.05 -35.15 72.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.984 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.28 -45.97 91.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.66 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -58.55 -44.03 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -34.61 76.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -63.67 -40.77 97.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.662 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -61.84 -45.7 92.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -36.01 81.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.35 -44.93 96.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 159' ' ' LYS . 13.9 pt20 -84.99 -30.24 24.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.85 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.604 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.1 tttp -104.06 154.74 19.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.874 0.368 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.7 m -95.08 128.75 46.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.0 167.59 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -135.29 108.06 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -96.0 122.39 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.88 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 tp -156.81 122.88 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.28 108.24 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.6 t -77.9 155.64 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -79.55 114.28 18.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.806 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -120.43 -169.33 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -140.72 168.47 19.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.9 118.59 37.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.074 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 38.1 p -129.42 163.49 25.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.67 79.02 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.16 139.91 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.3 -63.08 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -70.23 -33.75 72.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -65.69 -34.6 78.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -82.86 161.59 21.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.19 149.25 35.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -69.15 115.38 8.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.84 138.28 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.625 0.726 . . . . 0.0 111.795 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 82.39 116.59 0.5 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.551 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -73.05 -29.61 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.51 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.543 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.33 150.21 28.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.1 m-20 -74.84 122.86 24.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.097 0.475 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 47.0 mt -64.58 -42.62 95.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.118 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -61.3 -40.31 93.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.344 0.592 . . . . 0.0 110.716 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 2.0 mm-40 -68.49 -36.79 79.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.743 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.0 t -70.43 -38.0 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -69.72 -29.21 66.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -28.54 17.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 121.11 12.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 31.98 4.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.07 117.9 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.1 -171.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 93' ' ' LEU . 10.1 tp -68.39 151.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -82.43 -75.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER -126.59 137.28 53.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.394 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.629 ' HH2' HG21 ' A' ' 33' ' ' VAL . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' N ' HD11 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.763 HD12 HD11 ' A' ' 84' ' ' LEU . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 81' ' ' ILE . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 101' ' ' LEU . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.638 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.6 tp -125.02 122.8 38.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.58 -170.68 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.746 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.08 -27.76 16.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -83.45 54.89 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.228 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.18 -169.0 0.06 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.857 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.8 172.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.88 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 99' ' ' LEU . 1.6 mm? -127.17 160.25 31.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.836 HD11 ' HA ' ' A' ' 121' ' ' ASN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.732 ' N ' HD13 ' A' ' 100' ' ' LEU . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.61 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' B' ' 171' ' ' ALA . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.8 m120 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.836 ' HA ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.586 ' O ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 145' ' ' ILE . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 147' ' ' ILE . 6.3 mm-40 -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.519 HG22 ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 138' ' ' SER . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.44 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.908 HG21 HD11 ' A' ' 124' ' ' LEU . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.589 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.79 108.85 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.69 -32.89 73.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -44.04 89.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 35.3 t80 -58.14 -44.05 87.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.848 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -60.71 -45.05 95.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.48 -45.19 92.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.7 t -60.86 -46.02 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.6 OUTLIER -67.28 -35.96 80.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.91 -39.92 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.41 -37.16 16.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.56 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -120.68 147.15 45.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -103.01 130.88 52.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -87.31 114.96 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.39 109.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.96 115.79 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.046 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tp 60.1 161.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.46 140.88 58.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.52 137.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.602 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -47.5 -61.2 2.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.558 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . 61.15 179.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -128.19 161.26 29.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.787 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.471 ' O ' HG22 ' B' ' 174' ' ' THR . . . -125.29 174.56 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.471 HG22 ' O ' ' B' ' 173' ' ' ALA . 15.3 t 44.77 37.31 2.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -134.95 82.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' VAL . . . . . 0.576 HG13 ' O ' ' B' ' 176' ' ' VAL . 9.5 p -156.17 65.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.882 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -155.35 -50.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -43.66 66.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -67.75 -29.16 68.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.12 112.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.79 130.72 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -67.39 131.99 46.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.99 138.34 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.651 0.739 . . . . 0.0 111.62 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.07 80.34 1.21 Allowed Glycine 0 C--N 1.313 -0.744 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.344 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.08 -36.99 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 111.147 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 177.34 40.08 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.808 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.871 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 45' ' ' ILE . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.723 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.61 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -143.36 142.95 31.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -74.98 120.91 21.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.717 HD13 ' SG ' ' A' ' 154' ' ' CYS . 35.1 mt -64.29 -40.25 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.898 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -40.15 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.61 -39.8 80.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.757 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 63' ' ' LYS . 39.9 t -71.84 -42.41 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.066 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -25.93 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -55.39 3.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.81 119.34 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.953 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 29.68 7.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.756 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -156.67 153.25 28.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.71 168.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.94 152.05 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.782 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -83.11 -67.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -151.48 135.07 16.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.386 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.723 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.989 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.808 ' CE2' HG11 ' A' ' 36' ' ' VAL . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.789 HD23 HD13 ' A' ' 84' ' ' LEU . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD13 HD23 ' A' ' 78' ' ' LEU . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.989 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.69 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.88 HD13 HG22 ' A' ' 33' ' ' VAL . 4.5 tt -125.21 122.88 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.19 -175.05 15.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.738 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -170.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.89 27.67 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.54 -163.36 7.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.54 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m120 61.09 166.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.373 . . . . 0.0 111.011 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' A' ' 93' ' ' LEU . 5.2 mp -126.52 160.16 31.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.715 HD22 ' HB3' ' A' ' 121' ' ' ASN . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m120 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.715 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.2 m-80 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.713 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 101' ' ' LEU . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' OD2' HD13 ' A' ' 111' ' ' LEU . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.787 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.561 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG23 HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.75 HD22 ' CD2' ' A' ' 143' ' ' LEU . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.75 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.681 HG13 HD11 ' A' ' 130' ' ' ILE . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 99' ' ' LEU . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -75.93 123.04 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.02 -25.98 62.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -56.88 -36.52 70.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -66.99 -39.76 87.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.077 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -64.95 -50.18 67.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' CYS . 2.6 pt20 -60.6 -36.63 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.717 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.9 t -66.39 -44.57 82.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -35.92 82.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -41.29 83.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.821 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 4.1 tt0 -84.69 -30.83 24.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.85 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.672 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.1 tttp -106.31 154.3 20.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.26 129.91 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -123.74 78.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -98.86 138.02 36.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 pt -96.02 134.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.889 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.98 145.67 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -116.4 86.62 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.87 146.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.22 170.77 15.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.69 163.03 40.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.111 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.4 165.63 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.77 73.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 71.0 p -118.67 31.39 6.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.18 73.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.64 117.53 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.872 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.798 0.333 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.2 m -152.13 -52.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.95 -45.21 61.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -75.96 -20.9 57.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.14 -69.58 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.08 120.93 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.742 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.44 101.94 10.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -84.39 138.37 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.88 88.79 1.4 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.445 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.73 -39.02 87.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 175.73 39.37 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.708 ' SG ' HG22 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 36' ' ' VAL . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -156.26 141.87 17.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -81.28 132.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.079 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 52' ' ' ILE . 1.6 mp -64.42 -43.27 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.861 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 m -59.72 -41.13 90.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.252 0.548 . . . . 0.0 110.626 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.0 t -68.85 -41.24 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.004 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.06 -42.01 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -26.44 63.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 115.0 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.987 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.18 29.11 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -110.56 166.56 10.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -63.47 -24.88 68.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 65' ' ' VAL . 8.1 tp -133.73 153.41 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.314 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -112.67 -74.43 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -135.03 132.74 38.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' HD12 ' A' ' 78' ' ' LEU . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HG3' ' A' ' 70' ' ' ARG . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 81' ' ' ILE . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 33' ' ' VAL . 1.6 tp -125.28 123.63 39.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.61 -133.85 2.22 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.59 -69.76 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -157.08 -47.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.67 35.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.401 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -128.59 168.54 15.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.76 0.314 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -112.05 136.63 51.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.745 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.592 HG22 ' HB2' ' B' ' 171' ' ' ALA . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.889 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.889 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.745 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.691 ' OD1' HD11 ' A' ' 92' ' ' LEU . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 123' ' ' LEU . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.547 ' HA ' HD13 ' A' ' 147' ' ' ILE . 5.2 mm-40 -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HB3' HD13 ' A' ' 145' ' ' ILE . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CD1' HD11 ' A' ' 145' ' ' ILE . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.604 ' C ' HD22 ' A' ' 143' ' ' LEU . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.708 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.412 ' C ' ' HG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.61 121.32 25.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.65 -38.95 89.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.966 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -43.61 87.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.608 ' CZ ' HD21 ' A' ' 155' ' ' LEU . 31.8 t80 -59.07 -44.12 91.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -61.09 -34.02 74.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -47.1 75.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -68.12 -42.71 79.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.608 HD21 ' CZ ' ' A' ' 151' ' ' PHE . 3.6 mm? -63.38 -35.89 81.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.59 -44.23 93.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 7.0 mt-30 -84.99 -29.04 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.53 -91.11 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.65 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 9.8 mtpp -63.58 160.32 16.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.74 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.72 175.24 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 34.02 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.48 110.1 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.89 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 136.46 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 179.44 6.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.475 ' O ' HG13 ' B' ' 168' ' ' VAL . 12.2 p -62.9 121.73 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 157.47 13.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -163.62 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.02 163.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 174' ' ' THR . . . -153.72 154.46 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.466 HG22 ' O ' ' B' ' 173' ' ' ALA . 15.3 t 44.87 33.75 1.06 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.348 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.42 76.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.84 146.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.837 0.351 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.19 -62.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -32.21 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t -57.88 -35.28 70.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.53 137.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.43 136.56 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.22 104.78 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.04 138.41 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.646 0.736 . . . . 0.0 111.79 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.68 26.49 56.37 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.02 -43.38 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.32 33.95 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.984 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.7 ' HA ' HD13 ' A' ' 143' ' ' LEU . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 129' ' ' GLU . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.547 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.982 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.628 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.08 141.81 23.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -78.55 133.97 37.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.985 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.4 85.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.522 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m -56.56 -40.85 75.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.825 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -38.35 80.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' HG3' ' A' ' 63' ' ' LYS . 43.4 t -65.3 -45.01 94.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.155 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -32.64 69.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.045 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.21 -45.3 18.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -74.58 114.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 31.38 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -80.2 -62.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.55 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.995 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 tp -137.38 152.87 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.023 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.771 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.9 mmtm -98.33 -66.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.969 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -142.32 137.53 30.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.862 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 5.7 t30 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.982 HD22 HD13 ' A' ' 43' ' ' ILE . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG23 ' A' ' 132' ' ' VAL . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.601 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.745 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.0 tp -125.27 122.9 38.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.57 -131.62 2.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.657 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.31 -76.47 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.763 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -146.1 -46.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.681 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.79 173.05 43.36 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.408 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 61.38 -179.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.99 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 87' ' ' LYS . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.744 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.653 ' HB3' HD22 ' A' ' 100' ' ' LEU . 47.4 m-80 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.559 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.931 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 145' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.661 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.817 HG23 HD21 ' A' ' 84' ' ' LEU . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 138' ' ' SER . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.509 ' H ' HG12 ' A' ' 136' ' ' VAL . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.661 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.657 HD22 HD21 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.576 ' C ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.931 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 125' ' ' SER . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.73 126.04 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.06 -26.95 60.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.0 -43.43 81.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.49 -44.13 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -36.55 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -69.04 -38.66 79.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.66 -45.48 89.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -35.98 81.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.69 -35.52 79.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -91.59 -37.07 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.57 -172.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.693 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.38 149.98 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.349 . . . . 0.0 110.93 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 162' ' ' ARG . 12.5 p -67.09 138.2 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.7 -28.52 11.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.024 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.413 ' HG2' HG22 ' A' ' 160' ' ' VAL . 4.3 mmt85 61.4 39.47 15.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -94.45 119.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.04 -179.1 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.02 169.19 18.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.19 153.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.466 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' GLU . . . . . 0.433 ' N ' HG23 ' B' ' 169' ' ' TPO . 22.5 mt-10 -96.19 178.42 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.06 -178.7 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.88 172.46 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.87 137.55 5.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.5 t -165.71 132.25 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 27.3 t80 60.67 102.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.61 147.39 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.836 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 m -133.21 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.42 -47.05 65.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -72.31 -32.57 66.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.32 99.94 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.72 120.99 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.96 129.4 36.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.95 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.694 0.759 . . . . 0.0 111.751 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.71 97.99 0.11 Allowed Glycine 0 C--N 1.313 -0.717 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.437 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.13 -34.32 77.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 0.0 110.963 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 174.44 40.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.65 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.569 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.28 144.09 26.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.0 m-20 -78.32 129.14 34.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 111.139 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 154' ' ' CYS . 62.3 mt -64.39 -45.21 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.203 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -56.84 -40.22 75.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.261 0.553 . . . . 0.0 110.695 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.9 mm-40 -68.41 -36.99 79.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.9 t -71.1 -41.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -31.08 67.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.19 -49.61 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.89 122.87 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.65 41.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 169.89 8.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -48.33 81.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 63' ' ' LYS . 33.0 mm -125.41 159.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.72 ' HE3' HG13 ' A' ' 55' ' ' VAL . 2.7 mppt? -126.38 -46.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.27 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt -139.26 128.46 23.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG13 ' C ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.974 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' HD11 ' A' ' 78' ' ' LEU . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' CG ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.841 HD12 HD11 ' A' ' 84' ' ' LEU . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 81' ' ' ILE . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 67' ' ' THR . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.974 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.871 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.731 HD12 ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.659 HD13 ' CG1' ' A' ' 33' ' ' VAL . 21.8 tp -125.35 122.97 38.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.87 -135.21 3.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.572 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 61.98 34.01 16.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.945 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.96 30.51 20.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.96 165.74 11.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 62.72 166.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.814 HD21 HG12 ' A' ' 33' ' ' VAL . 1.2 mp -110.64 159.98 17.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 92' ' ' LEU . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.69 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.666 HG22 ' HB2' ' B' ' 171' ' ' ALA . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.717 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.634 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.2 m-80 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 145' ' ' ILE . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.517 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.603 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.69 ' HG3' HG22 ' A' ' 144' ' ' VAL . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.698 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.465 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.698 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.498 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 130' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.27 133.35 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -26.73 65.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -44.43 89.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -59.56 -44.1 93.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.978 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -36.23 83.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -38.52 90.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.7 t -65.85 -46.13 79.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -35.95 82.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.775 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.84 -40.29 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.9 mt-30 -87.33 -30.92 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.33 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.602 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 157' ' ' GLN . 36.2 mttm -64.27 121.66 14.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.8 m -103.01 134.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -146.02 98.38 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.86 165.68 10.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.89 121.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.921 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 63.27 142.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -137.35 -54.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.423 ' O ' HG13 ' B' ' 168' ' ' VAL . 11.1 p -69.9 124.36 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.029 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 156.29 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -145.99 -59.22 0.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.44 176.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 101.76 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.111 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.3 p -117.01 104.25 11.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.15 47.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.7 110.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.121 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.5 p -60.41 -41.92 94.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.21 -44.83 82.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.813 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -62.66 -31.03 71.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.34 112.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -77.19 147.42 36.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.29 115.44 13.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.28 138.3 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.722 0.772 . . . . 0.0 111.634 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.7 73.22 1.28 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.353 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.9 -39.79 63.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.118 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 177.26 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 68' ' ' PHE . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.767 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.634 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -129.4 160.81 31.94 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.9 m-20 -93.45 104.15 16.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.093 0.473 . . . . 0.0 110.799 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.619 HD13 ' SG ' ' A' ' 154' ' ' CYS . 66.9 mt -64.48 -44.3 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.07 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 m -58.75 -41.07 85.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.271 0.557 . . . . 0.0 110.766 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 8.1 mm100 -68.44 -39.72 81.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.656 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ASP . 30.7 t -72.66 -38.08 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.029 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -58.7 -32.35 69.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.66 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -69.11 -53.04 22.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.787 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -69.78 135.56 49.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -73.72 -42.84 60.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.029 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -159.65 112.36 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.716 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.2 m -176.75 39.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.75 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 61' ' ' SER . 2.2 tt 52.71 159.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.771 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.784 ' CB ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -85.51 -80.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.796 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? -155.35 156.53 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.7 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.767 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HA2' ' A' ' 69' ' ' GLY . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.7 ' HG3' HG23 ' A' ' 67' ' ' THR . 27.4 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' HG13 ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' CB ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -111.57 127.79 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.05 -133.93 1.71 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.697 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.92 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -177.57 65.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.95 -26.3 21.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -75.3 -177.18 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.997 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -134.36 156.09 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.714 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 91' ' ' ILE . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.586 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.798 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 67' ' ' THR . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.615 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.712 HG22 ' HB2' ' B' ' 171' ' ' ALA . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m120 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.798 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.912 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.3 m-80 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 100' ' ' LEU . 7.9 mm100 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.832 HD23 ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.645 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.645 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.521 ' H ' HG21 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' CYS . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.832 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -85.84 130.98 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.53 -20.53 61.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.21 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -58.53 -44.66 89.65 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.673 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.6 t80 -59.03 -43.95 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -62.2 -38.99 91.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -42.4 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.619 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.7 t -68.09 -46.22 71.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -37.68 77.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.48 -42.38 95.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.8 tt0 -84.1 -33.59 24.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.766 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.71 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.656 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.9 tttp -68.21 160.67 28.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -82.36 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.18 -29.15 68.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 63.43 87.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.77 122.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.885 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.765 0.317 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.507 HD12 ' N ' ' B' ' 166' ' ' LEU . 6.9 mp -87.61 164.23 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.25 80.56 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.63 149.91 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.29 138.13 45.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -140.74 128.55 21.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.37 -172.59 2.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.96 87.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.0 t -151.05 119.33 6.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 38.3 t80 60.47 106.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.79 123.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.89 179.9 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -116.52 -50.61 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -70.62 -39.43 73.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.07 -40.65 23.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -98.21 72.22 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -83.05 121.01 26.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -78.18 139.65 38.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.11 138.21 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.61 0.719 . . . . 0.0 111.75 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.49 35.33 2.28 Favored Glycine 0 C--N 1.312 -0.777 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.366 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -41.55 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.981 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 177.77 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.745 HG23 HG12 ' A' ' 45' ' ' ILE . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 141' ' ' LEU . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 143' ' ' LEU . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.745 HG12 HG23 ' A' ' 37' ' ' ILE . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -151.95 141.75 21.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -84.7 133.52 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.13 0.49 . . . . 0.0 111.184 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.1 mp -64.11 -41.49 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.812 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -37.42 69.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.913 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.41 -37.0 79.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.052 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 63' ' ' LYS . 46.3 t -72.98 -50.06 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.265 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 52' ' ' ILE . 86.2 mt -60.58 -29.9 69.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.94 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -81.61 -54.04 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -63.71 128.62 36.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.21 32.64 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -69.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -175.32 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 65' ' ' VAL . 8.7 tp -122.78 151.88 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -112.26 -69.98 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt -141.28 131.58 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.673 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.717 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 43' ' ' ILE . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 HG23 ' A' ' 132' ' ' VAL . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.1 tt -125.08 122.96 38.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.39 -125.77 1.44 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.597 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.87 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.796 0.332 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -151.5 -63.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -159.21 27.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -131.88 -177.28 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.757 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.832 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.08 153.32 36.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.914 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-80 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 100' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 147' ' ' ILE . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.627 ' HA ' HD13 ' A' ' 147' ' ' ILE . 3.7 mm100 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 145' ' ' ILE . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.598 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD13 ' N ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD13 ' A' ' 141' ' ' LEU . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 43' ' ' ILE . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 39' ' ' THR . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.639 HG21 HD11 ' A' ' 124' ' ' LEU . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.644 HG13 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.39 109.13 17.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -57.67 -28.64 63.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.96 92.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.98 0.419 . . . . 0.0 110.681 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 93' ' ' LEU . 36.9 t80 -58.34 -44.13 88.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.983 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -63.47 -37.76 88.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -64.74 -42.33 95.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.08 -45.93 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.523 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -68.19 -35.83 78.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.1 -40.52 96.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -86.19 -31.85 21.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.711 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 23.4 mmtt -117.24 117.72 30.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 129.68 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.33 173.52 11.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.13 -56.0 2.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.82 128.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.901 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.86 0.362 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 tp 62.34 118.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.87 38.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.9 p -74.65 151.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 143.16 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -150.92 121.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.59 171.16 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.8 153.99 17.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.3 p -126.33 114.78 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.08 47.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.51 110.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.859 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.13 -53.62 35.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -59.84 -43.17 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -72.53 -33.11 66.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.71 91.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.31 138.52 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.9 132.1 48.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -82.07 138.43 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 111.714 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.73 105.2 1.0 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.2 -33.9 63.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 177.25 40.16 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.725 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' HD22 ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.531 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD13 ' A' ' 48' ' ' LEU . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 143' ' ' LEU . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.776 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -150.72 141.83 23.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.7 m-20 -84.37 135.46 34.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 52' ' ' ILE . 1.8 mp -64.07 -42.73 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.79 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 m -56.57 -37.31 70.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.308 0.575 . . . . 0.0 110.603 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 5.3 mm100 -68.54 -38.56 80.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.416 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG13 ' HG2' ' A' ' 63' ' ' LYS . 55.1 t -72.99 -42.03 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 52' ' ' ILE . 2.7 mp -71.07 -35.89 72.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -46.34 39.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.38 116.0 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 30.21 3.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.38 173.04 6.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 t -72.05 -24.94 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.812 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.1 tp -120.64 150.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.829 ' HG2' HG13 ' A' ' 55' ' ' VAL . 5.0 mptt -121.41 -70.24 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -138.56 129.83 27.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.381 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.812 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.776 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 84' ' ' LEU . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.864 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.576 ' O ' HG22 ' B' ' 169' ' ' TPO . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.864 HD12 HD13 ' A' ' 81' ' ' ILE . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.725 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.05 123.56 40.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.11 1.29 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 57.21 -171.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.718 0.294 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.61 46.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' CA ' HD22 ' A' ' 155' ' ' LEU . . . 112.13 38.07 1.43 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.467 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.406 ' C ' HD12 ' A' ' 99' ' ' LEU . 58.9 m-80 -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.0 mp -132.18 160.06 37.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 91' ' ' ILE . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.786 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.584 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.619 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.887 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.709 ' O ' HD13 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.618 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.696 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.466 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.715 ' N ' HD23 ' A' ' 141' ' ' LEU . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.669 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.772 HG12 HD12 ' A' ' 124' ' ' LEU . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -92.96 115.96 28.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -63.96 -18.92 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.27 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -59.89 -46.05 90.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.947 0.403 . . . . 0.0 110.812 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 93' ' ' LEU . 39.1 t80 -58.47 -44.32 89.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.812 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -65.09 -33.92 77.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -65.83 -42.57 90.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.95 -44.15 77.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.005 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.565 HD22 ' CA ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -59.5 -48.4 81.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -34.76 77.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.57 -21.49 59.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -125.41 105.97 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.936 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -74.07 147.5 42.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.79 138.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.5 106.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -88.32 -176.34 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.7 pt -101.86 134.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.766 0.317 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 mt -152.87 122.79 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.21 91.7 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.4 t -105.48 158.75 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.084 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.576 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 107.21 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.419 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -107.73 -0.57 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 60.46 177.22 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.69 80.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 4.9 t -105.4 119.61 39.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.93 77.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.25 162.92 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.732 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -159.73 -52.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -35.63 71.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -80.84 -25.8 37.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -97.55 29.56 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.23 127.01 31.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.55 101.9 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.786 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -82.59 138.33 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.686 0.755 . . . . 0.0 111.68 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 107.92 117.32 4.13 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.446 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.01 -24.11 22.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.726 0.298 . . . . 0.0 111.194 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 175.38 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.541 HG21 ' H ' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 78' ' ' LEU . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.97 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.25 143.48 27.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -74.78 131.52 40.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.287 0.565 . . . . 0.0 111.235 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.712 HD13 ' SG ' ' A' ' 154' ' ' CYS . 83.8 mt -64.21 -41.5 92.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.287 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.91 -42.2 79.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.68 -42.51 77.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.782 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.747 HG13 ' HG3' ' A' ' 63' ' ' LYS . 40.1 t -64.41 -38.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 52' ' ' ILE . 11.5 mt -69.75 -30.32 67.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -50.48 6.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.922 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.28 120.67 13.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 31.47 3.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -152.08 151.01 30.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t 61.99 -82.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 93' ' ' LEU . 9.7 tp -179.63 151.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -75.18 -67.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt -151.63 137.44 18.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 HD13 ' A' ' 84' ' ' LEU . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 84' ' ' LEU . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.406 ' O ' HG22 ' B' ' 169' ' ' TPO . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 81' ' ' ILE . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD12 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.612 ' C ' HG13 ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp -125.12 126.61 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 63' ' ' LYS . . . 173.8 -133.33 2.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -178.66 43.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.96 -28.57 10.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.404 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.55 ' O ' HD12 ' A' ' 93' ' ' LEU . 65.7 m-20 -72.08 -178.5 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -131.74 148.63 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.72 ' HB3' HD23 ' A' ' 100' ' ' LEU . 15.4 m-80 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.898 HD21 HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.535 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 136' ' ' VAL . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.535 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 142' ' ' SER . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.541 ' H ' HG21 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 124' ' ' LEU . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.898 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.82 114.66 15.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.36 -37.41 83.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -60.13 -46.0 91.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -60.19 -44.16 95.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.956 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -65.17 -39.94 93.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.005 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -60.67 -40.43 92.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.712 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.5 t -64.16 -45.99 86.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.19 -39.03 78.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -44.65 95.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 23.2 mm-40 -84.44 -31.03 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.2 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.2 mmpt? -64.81 138.4 58.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.855 0.359 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.61 130.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.28 159.12 16.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.24 76.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.28 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.583 HD23 ' H ' ' B' ' 167' ' ' GLU . 0.4 OUTLIER -136.96 150.11 47.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.583 ' H ' HD23 ' B' ' 166' ' ' LEU . 36.2 mt-10 -78.24 -69.12 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.6 152.93 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.406 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.73 128.35 33.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.54 -37.73 3.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 60.6 172.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.09 65.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.5 t -127.3 55.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -89.34 55.63 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' VAL . . . . . 0.586 HG22 ' O ' ' B' ' 176' ' ' VAL . 10.7 p 43.05 50.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.636 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.863 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.5 p -67.15 -36.45 81.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -60.22 -47.01 87.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -60.5 -36.05 77.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.81 35.08 4.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -86.13 138.5 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -64.85 121.23 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.9 138.23 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 121.676 0.751 . . . . 0.0 111.861 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 148.28 102.45 0.28 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.427 -1.261 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -85.11 -29.11 25.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.33 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 99' ' ' LEU . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 68' ' ' PHE . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 45' ' ' ILE . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.91 141.84 20.19 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.94 138.79 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 111.379 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.5 mp -64.28 -45.09 97.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.748 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -38.35 73.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.288 0.566 . . . . 0.0 110.351 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 16.4 mm-40 -68.57 -36.82 79.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.273 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.7 t -68.4 -49.96 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.75 -28.01 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -38.98 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.07 114.91 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -101.73 -26.45 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 62' ' ' ILE . 64.5 p -68.93 132.51 46.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 92' ' ' LEU . 7.8 tp 51.69 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.958 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.755 ' HG2' HG13 ' A' ' 55' ' ' VAL . 13.4 mptt -108.51 -72.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt -135.85 113.9 11.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.659 HG22 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.566 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 83' ' ' ARG . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 67' ' ' THR . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.96 HD12 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp -122.7 124.44 43.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.9 -119.54 0.93 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 67.78 -68.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.51 -46.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.79 49.22 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.53 -175.53 5.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.559 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -114.81 147.98 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 130' ' ' ILE . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.809 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.533 HG22 ' HB2' ' B' ' 171' ' ' ALA . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 m120 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.809 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 5.0 p-10 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.7 m-80 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.412 ' C ' HD23 ' A' ' 100' ' ' LEU . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.736 HD22 HG12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.646 ' C ' HD22 ' A' ' 143' ' ' LEU . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -78.19 128.96 34.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.03 -29.63 62.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -45.39 92.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.772 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.54 -44.05 89.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.975 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -62.31 -33.87 75.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.073 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -66.76 -47.0 73.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.85 -43.78 95.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 155' ' ' LEU . 3.1 mm? -59.48 -35.92 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.41 -42.44 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 1.8 mt-30 -84.75 -31.08 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.29 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -69.38 145.29 53.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.53 137.43 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -50.06 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 tt -79.59 138.02 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.827 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.09 69.9 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.84 79.24 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 25.4 t -78.23 137.63 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.74 143.33 42.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.533 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -147.02 168.29 21.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -123.91 165.15 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.83 71.27 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.9 p -113.64 -36.86 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.1 85.86 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.96 148.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -81.87 -45.41 15.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.2 -45.09 94.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -28.06 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 63.68 145.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.35 129.32 37.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.64 134.67 34.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.94 138.46 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.596 0.712 . . . . 0.0 111.831 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.22 44.17 0.06 OUTLIER Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.5 38.65 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.021 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.761 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.021 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.21 141.87 35.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 m-20 -81.4 113.99 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 111.157 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.7 mt -64.35 -37.05 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.449 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -56.61 -42.0 78.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 0.0 110.905 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 10.0 mt-30 -68.53 -36.81 79.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.629 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 51' ' ' ASP . 51.3 t -59.3 -49.61 82.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mt -59.57 -32.91 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.969 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.52 -40.44 92.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.59 127.84 44.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.2 30.77 2.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -176.63 -165.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 62.58 156.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -71.97 124.91 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -46.67 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -155.14 145.68 22.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 62' ' ' ILE . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.822 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' HA2' ' A' ' 69' ' ' GLY . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.957 HD13 HD12 ' A' ' 84' ' ' LEU . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.957 HD12 HD13 ' A' ' 81' ' ' ILE . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp -117.36 128.55 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.74 164.34 12.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.65 113.19 11.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t0 61.54 112.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.9 33.31 0.65 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.68 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 60.01 -170.6 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.43 160.45 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.611 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.58 HG22 ' HB2' ' B' ' 171' ' ' ALA . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.783 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.0 m-80 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 100' ' ' LEU . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 145' ' ' ILE . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.7 ' HA ' HD13 ' A' ' 147' ' ' ILE . 1.9 mm-40 -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.855 HD11 HD11 ' A' ' 101' ' ' LEU . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.761 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.715 HG21 HD11 ' A' ' 124' ' ' LEU . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.766 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.07 107.83 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.82 -26.38 68.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.32 -43.92 88.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 110.714 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -58.94 -44.12 91.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -36.46 81.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -61.09 -46.06 92.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -63.99 -36.14 83.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -60.32 -36.13 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -92.06 -37.05 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 44.3 -171.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.654 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 131.27 50.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.915 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 164' ' ' ARG . 11.2 p -99.54 132.84 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.93 -54.96 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -136.61 -50.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.0 132.11 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.59 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.341 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.04 122.02 26.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.25 106.55 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.64 147.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.61 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.37 114.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.725 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -113.72 152.06 31.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.52 164.8 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.46 79.43 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 66.1 p -110.5 -43.11 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.784 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -140.19 67.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.787 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.81 -28.72 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.853 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -138.18 -52.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -72.12 -37.8 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p -80.99 -31.54 34.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -177.05 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -79.93 130.26 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -87.89 142.28 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 136.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.262 0.553 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.23 43.99 0.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.158 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.21 -41.65 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.312 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 -178.37 37.03 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG21 ' HE2' ' A' ' 68' ' ' PHE . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.562 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.602 HG21 ' H ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.931 HD13 HD22 ' A' ' 78' ' ' LEU . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HG23 ' A' ' 37' ' ' ILE . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 142.84 33.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.5 m-20 -74.95 133.79 41.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 111.122 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' SG ' ' A' ' 154' ' ' CYS . 78.6 mt -64.31 -43.36 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.027 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -38.96 73.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.3 0.571 . . . . 0.0 110.526 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.9 mm100 -68.67 -36.88 79.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.484 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.8 t -69.67 -46.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.632 ' HG ' HG12 ' A' ' 160' ' ' VAL . 4.2 tp -65.44 -39.45 92.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -38.35 90.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 124.7 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -94.79 87.15 4.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 61.0 33.03 19.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 t -118.42 175.85 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.95 143.8 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.053 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.626 ' HE3' HG13 ' A' ' 55' ' ' VAL . 4.5 mttp -95.72 -70.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt -155.03 145.98 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.083 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.931 HD22 HD13 ' A' ' 43' ' ' ILE . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' HD12 ' A' ' 84' ' ' LEU . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CG1' ' A' ' 81' ' ' ILE . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.5 m-20 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.674 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.853 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp -125.08 122.74 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.4 123.56 2.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.441 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -177.95 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -175.42 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.838 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.94 47.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.562 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -168.79 -174.49 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.814 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.6 mm? -106.87 159.23 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.718 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.973 HG22 ' HB2' ' B' ' 171' ' ' ALA . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 116' ' ' VAL . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.0 m120 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.57 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.7 m-80 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 5.1 mm100 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 123' ' ' LEU . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD2' HD23 ' A' ' 111' ' ' LEU . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 145' ' ' ILE . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 142' ' ' SER . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 43' ' ' ILE . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 39' ' ' THR . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 130' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -92.09 100.95 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.42 -25.94 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -44.66 88.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.09 -44.33 87.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -33.85 76.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.0 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.639 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -65.95 -45.99 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 111.055 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.75 -36.53 79.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -34.48 73.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.788 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.68 -27.28 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.41 100.24 6.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.65 159.19 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 56' ' ' LEU . 27.1 m -78.53 133.35 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.2 110.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -111.38 65.27 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.35 129.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.977 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.736 0.303 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.472 ' O ' HD12 ' B' ' 166' ' ' LEU . 3.7 pp -105.88 129.91 53.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 116.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.7 t -76.39 159.09 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.483 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.04 134.04 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.95 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.973 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -144.41 134.77 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -147.46 -178.5 6.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.19 85.57 0.67 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.99 160.18 43.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.93 97.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 11.0 p -172.4 137.45 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.89 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.794 0.33 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m 71.08 -63.42 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.6 tt0 -59.89 -35.95 75.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 16' ' ' GLN . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -81.04 -37.23 29.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.4 146.55 47.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -100.99 154.83 18.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 120.7 17.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.79 138.37 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.686 0.755 . . . . 0.0 111.93 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.16 63.2 0.73 Allowed Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.152 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -23.82 47.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.52 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.0 35.93 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 48' ' ' LEU . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.802 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.783 HG21 ' OG ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.824 HD13 HD22 ' A' ' 78' ' ' LEU . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 36' ' ' VAL . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -140.01 153.93 46.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -91.21 141.11 29.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 111.074 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.23 -44.9 95.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.268 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -43.13 95.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.928 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.9 79.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.668 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.3 t -70.44 -44.78 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.04 -30.12 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -66.65 -43.32 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.84 114.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -79.63 -31.22 41.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.72 177.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -80.7 137.46 36.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.631 HD12 ' CB ' ' A' ' 92' ' ' LEU . 32.2 mm 66.28 152.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.254 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -143.37 -54.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.589 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.9 ttpt -122.42 120.73 34.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.855 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG21 HD23 ' A' ' 92' ' ' LEU . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.688 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.737 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 5.0 t30 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 71' ' ' ASN . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CD1' HD23 ' A' ' 78' ' ' LEU . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.824 HD22 HD13 ' A' ' 43' ' ' ILE . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 88' ' ' HIS . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.787 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.609 ' CE1' HD22 ' A' ' 84' ' ' LEU . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -125.19 122.95 38.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.638 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 161.68 -176.79 38.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.57 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.17 89.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.92 -166.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.1 56.17 5.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.785 ' O ' HD22 ' A' ' 99' ' ' LEU . 15.4 m120 -131.97 -178.96 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 98' ' ' ASN . 3.2 mm? -135.0 157.25 47.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.781 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 92' ' ' LEU . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 67' ' ' THR . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.728 HG22 ' HB2' ' B' ' 171' ' ' ALA . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.6 m120 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.426 ' HB3' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 123' ' ' LEU . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.418 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.714 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HD2' ' A' ' 83' ' ' ARG . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 137' ' ' GLU . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 142' ' ' SER . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.507 HD11 HD12 ' A' ' 43' ' ' ILE . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.16 130.62 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.64 -30.24 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.003 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.89 -46.09 90.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.034 0.445 . . . . 0.0 110.706 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.56 -44.19 89.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 147' ' ' ILE . 62.7 mttm -63.68 -38.69 92.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.73 87.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.1 t -67.89 -42.4 81.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.161 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -65.81 -36.03 82.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.02 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.39 -47.94 68.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -78.11 -36.96 47.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.33 33.72 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.458 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 132.9 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 127.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -151.72 159.33 44.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.33 169.58 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.8 mm -98.92 126.54 52.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.897 0.379 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.17 126.33 47.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.08 85.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.61 145.25 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' TPO . . . . . 0.603 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.22 122.81 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.829 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.728 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -123.02 168.87 11.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.98 0.419 . . . . 0.0 111.081 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -174.8 169.46 3.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.34 112.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.2 p -140.08 178.81 7.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.24 77.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 m -108.49 -37.62 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.725 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.724 HG21 ' H ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 1.3 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.591 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.013 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.774 0.321 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.796 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 43' ' ' ILE . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 84' ' ' LEU . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.935 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.935 ' CD1' HD12 ' A' ' 81' ' ' ILE . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.661 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 67' ' ' THR . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 33' ' ' VAL . 21.5 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.849 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.826 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.566 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.866 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.866 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.8 p30 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.619 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.849 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 147' ' ' ILE . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.582 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.826 ' CD1' HD21 ' A' ' 101' ' ' LEU . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD13 ' N ' ' A' ' 142' ' ' SER . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.724 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 124' ' ' LEU . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.673 ' CG1' HD21 ' A' ' 124' ' ' LEU . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.688 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pp0? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 16' ' ' GLN . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.974 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' NE2' HD12 ' A' ' 141' ' ' LEU . 8.4 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.789 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.974 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.79 0.329 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.789 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.8 p30 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 84' ' ' LEU . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 81' ' ' ILE . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.612 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.592 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.4 t60 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' C ' HG13 ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 33' ' ' VAL . 26.3 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.623 HD21 ' CD1' ' A' ' 130' ' ' ILE . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HB2' ' A' ' 87' ' ' LYS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.425 ' HB3' HD23 ' A' ' 111' ' ' LEU . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.727 ' HB3' HD13 ' A' ' 100' ' ' LEU . 12.0 m120 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.658 ' O ' HD23 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.87 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 145' ' ' ILE . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 142' ' ' SER . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.52 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 38' ' ' CYS . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 130' ' ' ILE . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tm0? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.774 0.321 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' HD12 ' A' ' 20' ' ' ILE . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 16' ' ' GLN . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.82 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.751 HG12 HD23 ' A' ' 78' ' ' LEU . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.575 0.226 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.755 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.8 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 43' ' ' ILE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 84' ' ' LEU . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 81' ' ' ILE . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.593 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 65' ' ' VAL . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.905 0.383 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB2' HD23 ' A' ' 92' ' ' LEU . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.605 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.653 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.463 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.831 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.2 m120 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.707 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 138' ' ' SER . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.555 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' GLU . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 143' ' ' LEU . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.74 ' C ' HD22 ' A' ' 143' ' ' LEU . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.82 HD13 ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 130' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 124' ' ' LEU . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 68' ' ' PHE . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.88 HG23 HG12 ' A' ' 45' ' ' ILE . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.88 HG12 HG23 ' A' ' 37' ' ' ILE . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.575 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.0 ttpt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.733 0.301 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 78' ' ' LEU . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 83' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG23 ' A' ' 132' ' ' VAL . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.6 t60 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.665 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.586 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 99' ' ' LEU . 26.9 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.593 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.525 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.708 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.3 m120 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.864 HD21 HG12 ' A' ' 147' ' ' ILE . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.548 ' HG3' HG22 ' A' ' 144' ' ' VAL . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.647 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.412 ' HA ' HD12 ' A' ' 140' ' ' ILE . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.526 ' H ' HG12 ' A' ' 136' ' ' VAL . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.56 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 36' ' ' VAL . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.864 HG12 HD21 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.771 HG21 ' HE2' ' A' ' 68' ' ' PHE . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.888 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 43' ' ' ILE . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.888 HG12 HG23 ' A' ' 37' ' ' ILE . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.64 HD11 HG23 ' A' ' 36' ' ' VAL . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt . . . . . 0 CA--C 1.523 -0.079 0 CA-C-O 120.81 0.338 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.771 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.492 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.582 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.551 ' H ' HG22 ' A' ' 81' ' ' ILE . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 81' ' ' ILE . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.616 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD21 HD22 ' A' ' 121' ' ' ASN . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 33' ' ' VAL . 4.0 tt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.704 0.288 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 130' ' ' ILE . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.886 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.886 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.748 ' HB3' HD13 ' A' ' 100' ' ' LEU . 27.5 m120 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD13 HD23 ' A' ' 124' ' ' LEU . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.538 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.676 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 101' ' ' LEU . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 138' ' ' SER . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.424 ' H ' HG12 ' A' ' 136' ' ' VAL . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.72 ' N ' HD23 ' A' ' 141' ' ' LEU . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 38' ' ' CYS . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 129' ' ' GLU . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 91' ' ' ILE . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' C ' HD13 ' A' ' 43' ' ' ILE . 8.8 mt-30 -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.646 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.642 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 43' ' ' ILE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.795 HD13 HD22 ' A' ' 84' ' ' LEU . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 81' ' ' ILE . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.646 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD11 ' ND2' ' A' ' 121' ' ' ASN . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.588 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.7 tm? . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.46 HD22 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 67' ' ' THR . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.599 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 111' ' ' LEU . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 100' ' ' LEU . 8.8 m120 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 145' ' ' ILE . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.604 ' OD2' HD23 ' A' ' 111' ' ' LEU . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.941 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 145' ' ' ILE . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.68 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 138' ' ' SER . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.52 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.68 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.573 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.941 HG22 ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 130' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' A' ' 22' ' ' LYS . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HD2' ' CD1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.028 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.801 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.028 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.657 0.265 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.997 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 36' ' ' VAL . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 83' ' ' ARG . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.647 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.997 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.603 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 33' ' ' VAL . 29.5 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.524 -0.035 0 CA-C-O 120.888 0.375 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.437 HD22 HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 89' ' ' PHE . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.603 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.603 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.713 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.643 ' O ' HD12 ' A' ' 145' ' ' ILE . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.499 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 138' ' ' SER . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 142' ' ' SER . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.801 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 130' ' ' ILE . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' GLU . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.717 0.294 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 . . . . . 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.543 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-O 120.759 0.314 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.629 ' HH2' HG21 ' A' ' 33' ' ' VAL . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' N ' HD11 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.763 HD12 HD11 ' A' ' 84' ' ' LEU . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 81' ' ' ILE . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 101' ' ' LEU . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.638 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.6 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 99' ' ' LEU . 1.6 mm? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.852 0.358 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.836 HD11 ' HA ' ' A' ' 121' ' ' ASN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.732 ' N ' HD13 ' A' ' 100' ' ' LEU . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.61 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 9.0 m-80 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.836 ' HA ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.586 ' O ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 145' ' ' ILE . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.519 HG22 ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 138' ' ' SER . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.44 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.908 HG21 HD11 ' A' ' 124' ' ' LEU . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.589 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.947 0.403 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.808 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.871 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 45' ' ' ILE . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.723 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.61 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.714 0.293 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.723 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.989 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.808 ' CE2' HG11 ' A' ' 36' ' ' VAL . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.789 HD23 HD13 ' A' ' 84' ' ' LEU . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD13 HD23 ' A' ' 78' ' ' LEU . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.989 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.69 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.88 HD13 HG22 ' A' ' 33' ' ' VAL . 4.5 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' A' ' 93' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.716 0.293 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.715 HD22 ' HB3' ' A' ' 121' ' ' ASN . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.715 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.2 m120 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.713 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 101' ' ' LEU . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' OD2' HD13 ' A' ' 111' ' ' LEU . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.787 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.561 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG23 HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.75 HD22 ' CD2' ' A' ' 143' ' ' LEU . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.75 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.681 HG13 HD11 ' A' ' 130' ' ' ILE . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 99' ' ' LEU . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.708 ' SG ' HG22 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.7 mt-30 -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 36' ' ' VAL . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' HD12 ' A' ' 78' ' ' LEU . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HG3' ' A' ' 70' ' ' ARG . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 81' ' ' ILE . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 33' ' ' VAL . 1.6 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.798 0.332 . . . . 0.0 110.916 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.745 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.889 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.889 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.745 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.691 ' OD1' HD11 ' A' ' 92' ' ' LEU . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 123' ' ' LEU . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.547 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HB3' HD13 ' A' ' 145' ' ' ILE . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CD1' HD11 ' A' ' 145' ' ' ILE . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.604 ' C ' HD22 ' A' ' 143' ' ' LEU . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.708 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.412 ' C ' ' HG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.984 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.7 ' HA ' HD13 ' A' ' 143' ' ' LEU . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 129' ' ' GLU . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.547 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.982 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.628 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.862 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.3 t-20 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.982 HD22 HD13 ' A' ' 43' ' ' ILE . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG23 ' A' ' 132' ' ' VAL . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.601 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.745 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.686 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 87' ' ' LYS . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.744 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.686 ' ND2' HD11 ' A' ' 92' ' ' LEU . 28.4 m120 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.559 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.931 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 145' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.661 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.817 HG23 HD21 ' A' ' 84' ' ' LEU . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 138' ' ' SER . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.509 ' H ' HG12 ' A' ' 136' ' ' VAL . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.661 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.657 HD22 HD21 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.576 ' C ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.931 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 125' ' ' SER . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.908 0.385 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.65 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.569 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG13 ' C ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.974 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' HD11 ' A' ' 78' ' ' LEU . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.841 HD12 HD11 ' A' ' 84' ' ' LEU . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 81' ' ' ILE . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 67' ' ' THR . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.974 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.871 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.731 HD12 ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.659 HD13 ' CG1' ' A' ' 33' ' ' VAL . 21.8 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.814 HD21 HG12 ' A' ' 33' ' ' VAL . 1.2 mp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.82 0.343 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 92' ' ' LEU . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.69 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.717 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.634 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.2 m120 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 145' ' ' ILE . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.517 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.603 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.69 ' HG3' HG22 ' A' ' 144' ' ' VAL . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.698 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.465 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.698 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.643 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.498 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 130' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.799 0.333 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 68' ' ' PHE . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.767 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.634 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.7 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.767 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HA2' ' A' ' 69' ' ' GLY . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.7 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.8 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' HG13 ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.832 0.349 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 91' ' ' ILE . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.586 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.798 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 67' ' ' THR . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.615 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.798 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.912 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.7 m120 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.5 mm-40 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.832 HD23 ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.645 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.645 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.521 ' H ' HG21 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' CYS . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.832 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.745 HG23 HG12 ' A' ' 45' ' ' ILE . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 141' ' ' LEU . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 143' ' ' LEU . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.745 HG12 HG23 ' A' ' 37' ' ' ILE . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.675 0.274 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.673 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.717 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 43' ' ' ILE . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 HG23 ' A' ' 132' ' ' VAL . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 121' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.832 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.914 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.6 m120 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 100' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 147' ' ' ILE . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.627 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 145' ' ' ILE . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.598 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD13 ' N ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD13 ' A' ' 141' ' ' LEU . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 43' ' ' ILE . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 39' ' ' THR . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.639 HG21 HD11 ' A' ' 124' ' ' LEU . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.644 HG13 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.725 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' HD22 ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.531 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD13 ' A' ' 48' ' ' LEU . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 143' ' ' LEU . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.776 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.821 0.343 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.776 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 84' ' ' LEU . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.864 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.864 HD12 HD13 ' A' ' 81' ' ' ILE . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.725 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 91' ' ' ILE . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.786 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.584 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.619 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.887 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.485 HD22 HD21 ' A' ' 92' ' ' LEU . 31.2 m120 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.709 ' O ' HD13 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.618 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.696 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.466 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.715 ' N ' HD23 ' A' ' 141' ' ' LEU . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.669 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.772 HG12 HD12 ' A' ' 124' ' ' LEU . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.541 HG21 ' H ' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 78' ' ' LEU . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.97 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 HD13 ' A' ' 84' ' ' LEU . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 84' ' ' LEU . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 81' ' ' ILE . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD12 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.612 ' C ' HG13 ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.769 0.318 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.72 ' HB3' HD23 ' A' ' 100' ' ' LEU . 9.9 m120 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.898 HD21 HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.535 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 136' ' ' VAL . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.535 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 142' ' ' SER . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.541 ' H ' HG21 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 124' ' ' LEU . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.898 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 99' ' ' LEU . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 68' ' ' PHE . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 45' ' ' ILE . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.788 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.659 HG22 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.566 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 83' ' ' ARG . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 67' ' ' THR . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.538 HD21 HD22 ' A' ' 121' ' ' ASN . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.559 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 130' ' ' ILE . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.809 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.809 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.9 m120 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.412 ' C ' HD23 ' A' ' 100' ' ' LEU . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.736 HD22 HG12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.646 ' C ' HD22 ' A' ' 143' ' ' LEU . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.021 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.761 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.021 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.717 0.294 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.822 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' HA2' ' A' ' 69' ' ' GLY . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.957 HD13 HD12 ' A' ' 84' ' ' LEU . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.957 HD12 HD13 ' A' ' 81' ' ' ILE . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.014 0.435 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.611 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.783 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.4 m120 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 100' ' ' LEU . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 145' ' ' ILE . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.7 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.855 HD11 HD11 ' A' ' 101' ' ' LEU . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.761 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.715 HG21 HD11 ' A' ' 124' ' ' LEU . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.766 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG21 ' HE2' ' A' ' 68' ' ' PHE . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.562 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.602 HG21 ' H ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.931 HD13 HD22 ' A' ' 78' ' ' LEU . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HG23 ' A' ' 37' ' ' ILE . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.688 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.931 HD22 HD13 ' A' ' 43' ' ' ILE . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' HD12 ' A' ' 84' ' ' LEU . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CG1' ' A' ' 81' ' ' ILE . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.2 m120 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.674 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.853 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.814 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.6 mm? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 116' ' ' VAL . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.57 ' HB3' HD23 ' A' ' 100' ' ' LEU . 10.6 m120 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.4 mm-40 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 123' ' ' LEU . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD2' HD23 ' A' ' 111' ' ' LEU . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 145' ' ' ILE . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 142' ' ' SER . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 43' ' ' ILE . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 39' ' ' THR . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 130' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.6 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 16' ' ' GLN . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 48' ' ' LEU . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.802 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.783 HG21 ' OG ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.824 HD13 HD22 ' A' ' 78' ' ' LEU . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 36' ' ' VAL . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.9 ttpt . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 120.771 0.32 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG21 HD23 ' A' ' 92' ' ' LEU . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.688 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.737 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 1.1 t-20 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CD1' HD23 ' A' ' 78' ' ' LEU . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.824 HD22 HD13 ' A' ' 43' ' ' ILE . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 88' ' ' HIS . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.787 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.609 ' CE1' HD22 ' A' ' 84' ' ' LEU . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.2 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 33' ' ' VAL . 3.2 mm? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.844 0.354 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 92' ' ' LEU . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 67' ' ' THR . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.8 m-80 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.584 HD22 HD13 ' A' ' 92' ' ' LEU . 2.4 m120 -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 123' ' ' LEU . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.418 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.714 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HD2' ' A' ' 83' ' ' ARG . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 137' ' ' GLU . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 142' ' ' SER . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.507 HD11 HD12 ' A' ' 43' ' ' ILE . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.579 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -104.57 75.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -70.09 -47.01 63.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -69.43 -37.03 77.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.63 84.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -60.28 -41.53 93.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.0 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.1 mm -69.1 -35.21 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.38 -35.22 69.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.369 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.66 -47.55 79.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.177 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -76.03 -46.77 27.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.769 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 64.92 -75.07 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -100.54 121.87 42.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.01 110.98 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.42 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-O 121.634 0.731 . . . . 0.0 111.647 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 48.77 18.61 Favored Glycine 0 C--N 1.313 -0.726 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.124 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -56.21 -46.81 79.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.681 0.277 . . . . 0.0 111.352 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.19 35.23 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -77.8 131.7 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.508 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.6 t -89.28 -61.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.835 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -150.21 158.01 43.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -120.14 138.16 53.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.153 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.6 t -104.07 122.78 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.046 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -121.42 117.63 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.365 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.725 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.1 t -79.96 111.82 16.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.648 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -19.75 31.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.724 HG21 ' H ' ' A' ' 142' ' ' SER . 32.7 p -84.36 -2.99 58.01 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.608 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.9 74.97 0.5 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.358 0.503 . . . . 0.0 114.358 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 1.3 mt-30 -148.53 -43.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.293 . . . . 0.0 111.217 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.591 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.5 mp -114.65 141.15 26.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.0 Cg_endo -72.87 141.89 34.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.159 1.906 . . . . 0.0 112.067 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -56.04 129.81 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.785 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -129.21 164.03 24.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.928 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.2 119.64 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 111.713 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.2 mp -81.89 133.79 35.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.013 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.92 155.71 47.84 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -146.03 141.89 28.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.407 -1.724 . . . . 0.0 110.471 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.761 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.95 140.7 32.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.057 0.456 . . . . 0.0 111.187 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' SG ' ' A' ' 154' ' ' CYS . 8.5 mt -64.16 -45.67 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.88 -39.33 74.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.333 0.587 . . . . 0.0 110.555 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 44.5 mm-40 -68.47 -36.92 79.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.518 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.9 t -66.29 -45.62 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.909 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tp -71.05 -30.39 66.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -80.45 -43.03 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.021 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -62.96 137.05 58.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.25 30.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.15 35.87 2.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 p 60.83 26.05 15.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.024 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.794 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.3 tp -179.28 134.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.738 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -100.96 -65.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.2 ttpt -147.33 133.03 18.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.794 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.2 t -129.16 139.0 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 121.214 0.531 . . . . 0.0 111.866 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.796 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.3 m-90 -103.3 139.25 38.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.115 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.27 130.21 55.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -115.92 145.68 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.456 -178.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -169.21 36.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.714 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 40.1 mtp180 -83.57 3.09 34.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.8 t-20 -84.86 132.78 45.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.501 0.191 . . . . 0.0 110.82 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.1 Cg_exo -66.09 -12.49 35.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.444 2.096 . . . . 0.0 111.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.79 17.72 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.954 0.883 . . . . 0.0 108.762 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -45.59 138.06 4.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.705 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.9 m-20 -56.37 -18.68 11.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.831 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -129.58 125.81 37.06 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.031 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 43' ' ' ILE . 1.8 t-160 -104.76 123.62 47.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.637 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 84' ' ' LEU . 19.8 mt -90.34 -167.65 1.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.44 17.29 56.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.75 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.51 78.75 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 111.62 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.935 HD12 ' CD1' ' A' ' 84' ' ' LEU . 33.2 mt -105.96 124.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 m -54.56 -37.15 65.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.412 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.54 -44.4 74.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.935 ' CD1' HD12 ' A' ' 81' ' ' ILE . 44.6 mt -72.83 152.08 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -95.73 165.57 12.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.749 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.661 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -42.59 -53.72 4.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.431 0.634 . . . . 0.0 109.804 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 67' ' ' THR . 24.8 mttt -118.69 82.54 1.87 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.0 t60 -61.74 -46.23 90.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.686 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -146.16 159.44 43.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.73 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.98 141.83 44.45 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.398 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 52.9 mt -114.84 129.86 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -110.46 149.67 29.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.05 0.452 . . . . 0.0 111.724 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 33' ' ' VAL . 21.5 tp -125.08 124.66 42.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.449 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.35 -136.55 2.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.543 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.28 -178.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -31.56 69.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.35 43.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -139.14 170.69 15.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -112.97 157.22 21.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.849 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -133.3 147.28 51.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.826 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.35 129.06 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.184 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.11 115.57 25.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 111.872 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.98 138.98 39.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.963 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.1 pt -147.07 39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.566 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.57 159.81 14.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.048 0.451 . . . . 0.0 111.751 -179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.501 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 86.2 m -69.11 -37.59 78.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.699 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.32 -19.97 17.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.542 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.88 161.78 11.24 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.685 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 16.5 m -117.67 138.09 52.22 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.182 0.593 . . . . 0.0 109.465 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.866 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.12 148.35 37.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.4 18.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.266 177.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 46.9 m-20 44.1 43.04 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.437 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.84 -10.01 74.19 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.502 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -105.58 118.55 36.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.107 0.453 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.866 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -73.12 130.94 41.39 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.314 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -103.27 164.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.393 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.6 tp10 -69.97 126.2 28.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.574 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 18.2 tttp -51.92 161.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.67 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.8 p30 34.99 34.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.33 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.2 138.26 49.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.044 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.619 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -79.59 131.76 36.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.985 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.849 ' O ' HD23 ' A' ' 100' ' ' LEU . 29.6 mm-40 -129.35 147.4 51.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.4 tt -72.84 136.01 45.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.673 HD21 ' CG1' ' A' ' 147' ' ' ILE . 14.7 tp -66.17 153.7 41.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.654 0.74 . . . . 0.0 111.678 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.96 152.73 43.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.066 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.582 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.86 125.31 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.65 23.08 35.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.1 t0 -53.88 169.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 7.3 tt0 -145.24 135.52 24.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.826 ' CD1' HD21 ' A' ' 101' ' ' LEU . 5.8 mt -112.21 128.39 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.665 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.671 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.16 140.11 38.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.844 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.1 m -140.31 158.57 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.91 44.2 10.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.957 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 58.5 t -83.52 140.52 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 112.544 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.57 -39.41 0.85 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 47.1 t -126.55 120.77 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 114.546 -0.827 . . . . 0.0 108.913 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -50.32 -28.58 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.831 0.348 . . . . 0.0 111.389 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.3 m -93.39 6.56 47.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -128.97 28.5 5.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.671 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.04 139.4 28.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.229 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD13 ' N ' ' A' ' 142' ' ' SER . 0.4 OUTLIER -115.69 134.55 54.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.538 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.724 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.57 134.7 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.159 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.3 mm? -129.72 139.55 51.31 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.431 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.3 t -110.87 137.67 42.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 124' ' ' LEU . 1.2 mm -106.27 129.36 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.029 0.442 . . . . 0.0 111.41 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.71 139.54 45.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.22 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.673 ' CG1' HD21 ' A' ' 124' ' ' LEU . 3.2 mp -107.66 134.15 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 112.019 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -87.19 108.74 19.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.587 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -58.03 -27.5 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.228 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -45.95 92.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -58.69 -44.17 90.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -36.21 76.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.91 -43.22 91.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.425 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.1 t -64.7 -46.0 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.041 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.23 -35.88 80.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -63.98 -41.75 97.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.851 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -84.49 -33.08 23.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.739 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.78 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.635 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 157' ' ' GLN . 29.5 mttt -88.06 122.81 32.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.893 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 160' ' ' VAL . 14.1 p -93.35 125.25 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.034 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.61 102.17 14.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.68 -56.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.19 129.19 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.893 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.38 114.62 5.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -171.3 -60.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.783 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.476 HG12 ' N ' ' B' ' 169' ' ' TPO . 34.2 t -106.03 158.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.046 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.476 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.4 140.49 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -136.72 167.76 20.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.163 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.44 167.29 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -174.57 126.2 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 72.1 p -84.09 145.54 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -105.69 48.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 176' ' ' VAL . 11.2 m -140.7 97.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.917 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.2 m -129.42 -68.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.688 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.5 pp0? -60.67 -43.85 97.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -39.67 82.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -39.23 82.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 16' ' ' GLN . 8.2 mt -60.29 -42.09 94.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mm -73.01 -35.06 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -57.16 -33.9 67.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -67.07 -23.74 65.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.988 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.83 -47.96 79.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.144 0.497 . . . . 0.0 111.141 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -81.01 -26.81 36.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.98 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 65.82 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.58 129.37 39.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -90.07 106.27 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.45 138.36 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.683 0.754 . . . . 0.0 111.773 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.13 28.96 57.47 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -67.82 -35.52 78.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.709 0.29 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 177.8 38.67 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -73.39 135.5 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 112.492 -177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.974 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.55 -58.56 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.602 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.3 p -148.25 165.44 30.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.129 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -129.81 138.13 50.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.518 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -107.67 122.8 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.624 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -125.37 122.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.688 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.693 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.8 t -82.21 115.9 21.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.225 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.99 -26.14 29.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.685 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 142' ' ' SER . 82.2 p -79.95 -2.34 43.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 64.92 78.19 0.22 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.375 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' NE2' HD12 ' A' ' 141' ' ' LEU . 8.4 mt-30 -147.81 -46.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.848 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mp -112.8 140.83 24.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.139 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.75 138.84 29.7 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.196 1.931 . . . . 0.0 112.103 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -54.22 132.84 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.745 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -119.17 164.19 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.317 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.94 119.62 32.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.972 0.415 . . . . 0.0 111.761 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.789 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mp -93.34 125.46 37.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.974 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.56 156.43 48.11 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 113.593 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.77 141.85 23.08 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.451 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.755 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.7 m-20 -84.97 139.12 32.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.207 0.527 . . . . 0.0 111.302 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.605 HD13 ' SG ' ' A' ' 154' ' ' CYS . 15.8 mt -64.4 -45.2 96.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.436 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.75 -40.86 76.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.875 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 14.1 mt-30 -68.47 -36.89 79.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 51' ' ' ASP . 53.9 t -70.08 -46.07 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.098 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.91 -28.46 64.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.976 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -80.69 -47.89 13.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -63.38 110.82 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.18 53.24 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 -174.38 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 t -82.24 -28.68 31.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 65' ' ' VAL . 8.4 tp -125.94 147.5 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.682 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -108.84 -62.42 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.884 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.0 ttpt -151.67 131.0 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.276 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.671 HG22 HD11 ' A' ' 62' ' ' ILE . 12.5 t -128.15 139.04 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.12 0.486 . . . . 0.0 111.935 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.58 139.37 37.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.183 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -111.6 132.21 54.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.11 177.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.789 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.23 145.52 46.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.011 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.09 -169.5 37.48 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.196 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 11.1 mtm105 -81.76 1.56 34.01 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.2 t-20 -84.84 134.46 41.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.094 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.15 -13.03 38.02 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.665 2.243 . . . . 0.0 111.759 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.77 -44.38 15.64 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.875 0.845 . . . . 0.0 108.966 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.22 138.1 3.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.995 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.65 -18.52 12.46 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.113 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' ILE . 4.5 t80 -129.42 116.41 18.97 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.289 . . . . 0.0 110.938 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -101.94 107.96 19.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -80.37 -68.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.15 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.133 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 3.8 p30 178.01 50.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.995 HD13 HD12 ' A' ' 84' ' ' LEU . 4.5 mp -75.34 127.14 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.14 -41.75 75.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.343 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -43.19 88.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 81' ' ' ILE . 43.1 mt -73.42 152.19 40.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 95.1 p -99.66 167.45 10.57 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.612 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -43.89 -54.23 5.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.33 0.586 . . . . 0.0 109.662 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.74 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.1 mtmp? -116.84 83.4 1.96 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.592 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.4 t60 -59.02 -45.02 91.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.922 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.1 p90 -149.07 160.02 43.71 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.939 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.9 tt0 -136.07 142.84 44.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.145 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' C ' HG13 ' A' ' 65' ' ' VAL . 57.8 mt -118.42 129.54 74.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.814 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.732 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -112.09 149.97 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.112 0.482 . . . . 0.0 112.068 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD22 HG11 ' A' ' 33' ' ' VAL . 26.3 tp -125.11 123.42 39.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.021 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.18 177.39 22.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.791 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.25 27.72 4.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.334 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.52 -26.96 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.849 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.37 -12.73 7.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.633 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.87 -170.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 110.985 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.14 160.25 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.0 mt -131.68 145.28 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.526 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.623 HD21 ' CD1' ' A' ' 130' ' ' ILE . 2.4 tp -112.49 124.47 52.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.2 t30 -116.12 115.49 26.14 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.777 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -79.53 138.36 37.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HB2' ' A' ' 87' ' ' LYS . 6.6 pt -139.56 24.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.3 t -90.27 156.38 18.33 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.434 0.635 . . . . 0.0 112.224 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 96.3 m -69.88 -52.61 23.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.007 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.78 -3.23 43.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.46 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.13 158.61 28.25 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.0 m -117.66 137.77 52.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.865 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.76 148.87 35.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -123.79 113.67 18.87 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 44.8 42.22 5.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.439 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.42 -4.86 85.22 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.571 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' HB3' HD23 ' A' ' 111' ' ' LEU . 1.5 mp0 -105.76 118.74 37.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.12 0.486 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.865 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.3 tptm -75.21 113.12 12.2 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.243 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -88.3 162.75 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.0 mt-10 -69.97 128.07 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.398 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.2 tttt -53.22 161.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.37 35.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.269 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.17 145.12 40.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.314 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.727 ' HB3' HD13 ' A' ' 100' ' ' LEU . 12.0 m120 -86.73 124.99 33.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.813 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.658 ' O ' HD23 ' A' ' 100' ' ' LEU . 28.9 mm-40 -129.54 146.18 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 111.029 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tp -74.14 120.0 19.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.97 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.705 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.5 pt? -57.22 164.74 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 111.999 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -124.62 153.48 42.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.694 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.71 123.55 22.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.925 0.393 . . . . 0.0 110.401 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.37 22.65 45.42 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.976 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.7 t70 -56.12 175.07 0.11 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.87 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.2 mt-10 -145.08 135.62 24.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 145' ' ' ILE . 7.4 mt -107.54 127.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-O 120.965 0.412 . . . . 0.0 110.576 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 39.1 m -104.45 140.45 37.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.957 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.47 158.73 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.2 43.26 10.84 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.109 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.475 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.2 t -83.65 140.42 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.644 0.735 . . . . 0.0 112.102 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.76 -36.03 1.56 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 138' ' ' SER . 49.0 t -126.28 123.88 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.568 -0.816 . . . . 0.0 109.099 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.7 -33.81 24.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 t -93.48 6.59 47.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -122.73 25.12 8.85 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.7 mt -106.91 139.23 29.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.153 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 142' ' ' SER . 5.2 tt -124.3 134.07 53.29 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.52 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.6 t -109.93 150.16 28.86 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.622 0.725 . . . . 0.0 112.393 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 38' ' ' CYS . 78.8 mt -135.9 157.79 45.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.47 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -124.54 140.23 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 130' ' ' ILE . 33.8 mt -106.26 122.47 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 CA-C-O 120.925 0.393 . . . . 0.0 111.515 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 118.47 36.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.255 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -97.94 134.17 37.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -84.78 111.35 19.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.829 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.51 -29.89 68.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -58.61 -43.92 89.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.636 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.64 -44.09 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.892 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -37.84 85.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.034 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.04 -46.7 87.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.078 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.605 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.7 t -62.9 -45.97 90.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.069 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.58 -39.08 88.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.15 -44.04 97.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.62 -36.16 26.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p30 42.37 91.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.52 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -66.82 128.63 37.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.8 t -98.68 130.57 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -147.55 94.81 2.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -147.11 164.84 31.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.983 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 30.1 mm -80.19 124.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.731 0.3 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 60.82 158.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.58 30.95 0.59 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 169' ' ' TPO . 23.9 t -74.33 158.83 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.49 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -94.28 109.48 21.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.537 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -115.08 138.54 50.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.04 179.62 4.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -122.01 125.1 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.091 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 62.2 p -118.19 -37.81 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . 0.455 ' HB3' ' H ' ' B' ' 176' ' ' VAL . 5.4 m-85 -129.26 -151.71 0.49 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' B' ' 175' ' ' PHE . 21.3 t -86.65 152.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.907 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.885 0.374 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -105.84 -66.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.653 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.3 tm0? -68.92 -39.41 79.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' HD12 ' A' ' 20' ' ' ILE . 21.5 tpp180 -66.81 -35.84 81.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -57.02 -42.82 81.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.853 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 16' ' ' GLN . 4.0 mt -59.78 -32.36 70.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.7 mt -73.03 -35.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.41 -39.0 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.396 . . . . 0.0 110.446 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -23.96 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.716 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.73 -47.42 80.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -81.02 -44.49 18.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.53 105.19 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.88 138.82 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.815 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -109.81 101.97 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.8 mm -87.25 138.29 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.575 0.703 . . . . 0.0 111.907 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.92 34.25 5.77 Favored Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.564 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.86 -33.21 27.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER 175.96 39.25 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -73.32 134.6 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.516 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -90.58 -59.41 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.881 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.3 p -153.1 153.08 32.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.312 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.95 138.45 50.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 111.291 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -106.74 122.95 61.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.816 HG23 HG12 ' A' ' 45' ' ' ILE . 21.9 mt -123.82 123.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.82 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.5 t -79.92 127.01 31.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.903 0.383 . . . . 0.0 110.565 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -91.6 -31.17 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.633 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 142' ' ' SER . 41.1 p -79.95 -2.28 43.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 111.694 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.71 80.01 0.2 Allowed Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.381 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -147.32 -41.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.751 HG12 HD23 ' A' ' 78' ' ' LEU . 2.8 mp -118.06 140.5 27.97 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.4 Cg_endo -74.52 144.88 32.71 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.124 1.883 . . . . 0.0 112.016 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.816 HG12 HG23 ' A' ' 37' ' ' ILE . 46.1 mt -56.52 129.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.689 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -123.55 164.06 19.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.998 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.35 119.78 35.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 111.838 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.8 mt -94.18 137.4 33.41 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.11 158.21 43.86 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -147.83 142.43 26.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.699 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -74.92 120.07 19.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.094 0.473 . . . . 0.0 111.103 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.515 HD13 ' SG ' ' A' ' 154' ' ' CYS . 57.9 mt -64.3 -42.85 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.23 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -57.55 -40.27 78.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.184 0.516 . . . . 0.0 110.649 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 36.1 mm-40 -68.41 -38.41 81.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.769 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.721 HG13 ' HG3' ' A' ' 63' ' ' LYS . 40.6 t -73.07 -40.46 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.978 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.611 HD21 ' OD2' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -71.08 -37.24 72.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -72.02 -46.81 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.13 102.58 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.22 80.93 4.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -135.62 164.72 27.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.8 p -75.46 -25.67 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.924 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.9 tp -126.85 150.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -138.43 -63.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.2 ttpt -138.18 132.62 32.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HD11 ' A' ' 62' ' ' ILE . 17.0 t -128.94 139.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.388 0.613 . . . . 0.0 112.36 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.755 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.4 m-90 -102.3 136.57 41.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.766 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -114.84 129.16 56.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.84 145.31 38.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -178.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.8 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 171.01 -165.95 39.13 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.686 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.7 mtp85 -87.84 -10.48 50.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -84.92 142.07 38.56 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 111.629 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.0 Cg_exo -68.65 -5.87 16.41 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.999 2.466 . . . . 0.0 111.898 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.31 12.34 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 122.06 0.933 . . . . 0.0 108.934 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.62 140.07 3.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.468 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 10.4 m-20 -56.17 -18.95 11.53 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.053 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' HG21 ' A' ' 43' ' ' ILE . 9.2 t80 -129.47 123.91 32.72 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.588 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -100.39 121.88 42.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 43' ' ' ILE . 6.1 mt -98.83 168.24 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.37 -82.66 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.555 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -178.49 75.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.918 HD13 HD12 ' A' ' 84' ' ' LEU . 3.2 mp -103.49 113.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.66 -40.82 84.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.552 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -60.82 -30.03 69.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.192 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.918 HD12 HD13 ' A' ' 81' ' ' ILE . 65.4 mt -81.4 152.48 27.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.719 0.295 . . . . 0.0 110.645 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 84.0 p -95.5 169.13 10.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.023 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -41.56 -68.91 0.15 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.0 mttt -104.88 85.21 2.25 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.593 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 13.4 t60 -59.65 -46.15 89.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.474 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 15.3 p90 -146.0 156.82 43.75 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.349 -0.541 . . . . 0.0 112.075 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.03 142.31 44.42 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.713 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 65' ' ' VAL . 43.8 mt -115.29 125.64 72.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.675 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -116.33 139.1 50.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.815 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.25 136.97 54.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.346 179.227 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.33 161.41 34.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.666 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 61.36 152.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.611 ' OD2' HD21 ' A' ' 56' ' ' LEU . 10.3 t70 -74.47 104.71 5.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 -84.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -150.11 -172.89 4.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -106.91 160.61 15.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.996 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.831 HD23 ' HB3' ' A' ' 121' ' ' ASN . 5.9 mp -118.74 148.48 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.872 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -111.0 123.13 49.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB2' HD23 ' A' ' 92' ' ' LEU . 41.7 t30 -114.1 121.15 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.082 0.468 . . . . 0.0 112.162 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.2 p30 -83.1 126.84 33.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.708 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.9 pt -136.59 37.92 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.605 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.24 152.72 19.1 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.208 0.528 . . . . 0.0 112.314 -178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.9 m -69.15 -34.37 74.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.941 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -95.4 -20.2 19.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 155.42 9.77 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.854 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -117.72 137.81 52.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -118.49 148.23 42.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.14 113.44 18.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.455 177.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' N ' HD12 ' A' ' 111' ' ' LEU . 84.6 m-20 44.72 43.03 6.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.409 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.59 -11.38 66.38 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.524 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -104.38 118.45 36.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.054 0.427 . . . . 0.0 110.785 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 2.3 tptp -73.15 118.34 15.99 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.265 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.1 m -85.14 165.09 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.89 126.53 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.415 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.653 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -53.46 156.77 2.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.195 0.521 . . . . 0.0 111.031 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.463 ' H ' ' HG3' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 36.42 35.65 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.631 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.82 145.12 39.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.381 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.831 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.2 m120 -83.63 125.22 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -129.19 146.2 51.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.8 tt -78.85 117.05 19.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -53.61 163.24 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.328 0.585 . . . . 0.0 112.249 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.44 153.35 42.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.757 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 122.81 20.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.892 0.377 . . . . 0.0 110.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.78 21.07 60.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.845 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 14.3 t70 -56.99 173.96 0.19 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 8.8 tt0 -145.33 135.36 23.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.999 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -111.35 127.51 68.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.363 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 140' ' ' ILE . 49.8 m -104.36 140.93 37.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.028 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.707 HG23 HD21 ' A' ' 84' ' ' LEU . 35.6 m -140.2 158.31 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 112.117 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.63 42.24 17.99 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.705 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.5 t -84.49 140.39 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.704 0.764 . . . . 0.0 112.373 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.78 -37.58 1.26 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 138' ' ' SER . 57.2 t -126.47 118.55 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 114.522 -0.839 . . . . 0.0 108.944 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.72 -26.81 5.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 0.0 111.551 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.555 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.47 6.36 48.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -132.07 29.49 4.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' GLU . 6.2 mt -106.07 139.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.76 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 143' ' ' LEU . 1.6 tp -123.49 134.26 53.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.138 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.74 ' C ' HD22 ' A' ' 143' ' ' LEU . 34.1 t -112.54 149.32 32.87 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.811 0.815 . . . . 0.0 112.658 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.82 HD13 ' HA ' ' A' ' 38' ' ' CYS . 4.0 mm? -136.44 150.06 48.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.432 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 39.8 t -121.02 137.14 55.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 111.012 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.717 HD11 HD11 ' A' ' 130' ' ' ILE . 18.5 mt -106.33 127.16 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.26 115.1 28.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.466 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 124' ' ' LEU . 5.4 mm -89.16 133.22 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.702 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -79.73 112.89 17.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -34.8 72.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -44.58 92.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.685 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -58.91 -43.92 91.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -60.88 -41.1 95.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.062 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -59.06 -40.93 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.046 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.515 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -64.1 -46.02 86.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.69 -36.0 82.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.17 -36.55 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -90.31 -37.1 14.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.915 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.1 p30 44.25 -171.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.551 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.36 154.0 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.07 137.59 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.4 32.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 35.2 pt -89.22 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.41 162.07 13.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -147.92 -52.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.821 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.82 149.45 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -84.37 128.39 34.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.9 -25.31 9.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.63 -175.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.5 155.14 17.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -154.23 152.14 29.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -87.69 58.19 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.742 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 m -150.2 163.0 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.971 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.828 0.347 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.64 74.11 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.87 -45.95 66.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.036 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -35.98 81.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.16 -41.3 92.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -31.89 69.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.758 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.87 -35.38 49.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.31 -41.32 79.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.398 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -67.09 -23.89 65.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.727 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.78 -47.41 80.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.258 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.3 t -75.87 -40.75 53.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -138.68 90.68 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.99 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -90.77 133.78 34.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 101.8 13.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -89.16 138.49 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 121.706 0.765 . . . . 0.0 111.822 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.05 36.63 21.1 Favored Glycine 0 C--N 1.315 -0.599 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -89.13 -32.05 17.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 0.0 111.013 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.44 35.66 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.704 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.7 mm -83.07 96.53 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.841 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -47.52 -62.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.875 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.15 164.99 30.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.569 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -128.36 138.11 52.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.315 . . . . 0.0 111.354 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 68' ' ' PHE . 48.1 t -105.15 122.89 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.777 0.322 . . . . 0.0 110.841 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.88 HG23 HG12 ' A' ' 45' ' ' ILE . 20.2 mt -123.41 126.32 73.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.678 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 8.6 t -88.92 103.51 16.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.777 0.322 . . . . 0.0 110.388 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.2 p -79.18 -19.33 51.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.846 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 142' ' ' SER . 81.3 p -79.9 -2.39 43.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 111.594 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 72.24 0.73 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.186 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -145.84 -39.7 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.754 0.311 . . . . 0.0 111.336 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -124.1 142.07 38.85 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.7 Cg_endo -70.22 145.22 53.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.122 1.882 . . . . 0.0 112.069 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.88 HG12 HG23 ' A' ' 37' ' ' ILE . 33.5 mt -59.13 134.58 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.727 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 163.9 21.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.885 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -125.39 119.64 28.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.706 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.7 mp -91.27 126.73 36.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.704 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.67 155.54 50.27 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.575 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -147.06 142.43 27.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.129 -1.85 . . . . 0.0 110.834 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.67 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.9 m-20 -88.09 137.43 32.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.976 0.417 . . . . 0.0 111.068 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.56 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.7 mp -64.34 -43.61 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.784 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -57.01 -38.84 73.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.334 0.588 . . . . 0.0 110.547 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.0 mm-40 -68.48 -41.15 80.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.636 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 63' ' ' LYS . 56.1 t -64.67 -46.56 91.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.043 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -71.07 -29.2 65.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -77.42 -46.85 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.93 109.9 2.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.52 77.68 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.796 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -168.63 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -84.44 -32.59 23.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 92' ' ' LEU . 8.7 tp -122.24 153.45 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.799 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -115.16 -65.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.189 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.0 ttpt -145.46 134.36 22.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.428 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 90' ' ' GLN . 19.3 t -135.1 139.38 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 121.285 0.564 . . . . 0.0 112.035 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.706 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.7 m-90 -102.34 139.46 37.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.171 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.65 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.47 127.25 55.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 177.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -110.85 145.67 37.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.406 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.66 -179.13 38.13 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.005 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 78' ' ' LEU . 15.4 mtp180 -75.45 -2.32 28.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.2 t-20 -84.73 134.82 41.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.7 Cg_exo -68.99 -6.64 18.7 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.743 2.295 . . . . 0.0 111.859 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -43.7 15.78 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.015 0.912 . . . . 0.0 108.591 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.5 136.43 4.24 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.605 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.44 -18.94 12.86 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.142 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 49.9 t80 -129.71 119.58 23.72 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.7 126.51 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 70' ' ' ARG . 1.6 pp -124.91 -178.64 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.24 147.45 50.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -73.72 88.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.821 0.344 . . . . 0.0 111.087 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 83' ' ' ARG . 24.9 mm -106.81 119.89 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 p -54.67 -29.26 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -72.22 -25.32 61.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.807 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG23 ' A' ' 132' ' ' VAL . 41.0 mt -95.36 152.19 18.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.1 p -96.26 167.34 11.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.851 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.94 -53.3 6.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.386 0.612 . . . . 0.0 109.655 179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -118.02 83.07 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.587 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 15.6 t60 -59.73 -45.8 91.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.834 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.3 p90 -150.52 160.18 43.96 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.774 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -135.72 141.43 44.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.665 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.2 mt -116.59 125.44 73.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.938 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.586 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.35 152.2 24.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.171 0.51 . . . . 0.0 111.817 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 99' ' ' LEU . 26.9 tp -125.15 124.59 42.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 -155.8 26.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.54 92.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 -80.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.074 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.65 31.24 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -116.19 -175.94 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 33' ' ' VAL . 1.4 mp -120.46 155.83 32.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.864 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mp -133.05 147.26 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.37 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.669 HD11 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mp -112.59 125.49 54.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.164 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 57.7 t30 -118.12 115.79 25.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 112.067 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.6 p30 -78.42 142.42 37.58 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.593 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.8 pt -145.85 26.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.0 155.7 17.94 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.355 0.598 . . . . 0.0 112.425 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.623 HG22 ' HB2' ' B' ' 171' ' ' ALA . 98.7 m -69.94 -52.53 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.824 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -76.82 -3.67 39.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.487 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.78 156.69 29.33 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.435 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.525 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.61 138.0 52.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.6 148.71 33.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.48 18.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.377 177.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.1 m-20 44.86 43.2 6.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -12.68 63.78 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.568 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -104.61 118.5 36.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.93 0.395 . . . . 0.0 110.607 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.87 119.4 14.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.388 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.4 m -91.3 164.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.984 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 5.2 tp10 -69.89 128.54 36.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.563 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 25.6 tttt -54.96 162.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.19 34.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.143 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.04 40.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.009 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.708 ' HB3' HD23 ' A' ' 100' ' ' LEU . 16.3 m120 -89.69 132.63 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.073 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.7 mm-40 -129.28 151.14 50.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.395 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.71 136.06 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.486 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.864 HD21 HG12 ' A' ' 147' ' ' ILE . 33.0 tp -60.6 152.41 26.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.547 0.689 . . . . 0.0 111.486 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.4 152.82 44.31 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.554 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 119.83 16.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.709 0.29 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.21 25.08 59.59 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.153 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 22.3 t70 -50.33 166.37 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 111.33 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' HG3' HG22 ' A' ' 144' ' ' VAL . 26.7 tt0 -145.17 135.49 24.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.8 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.8 mt -112.13 128.08 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 27.7 m -104.53 140.36 38.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.647 HG23 HD21 ' A' ' 84' ' ' LEU . 32.0 m -140.36 158.68 25.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.51 43.6 10.2 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.196 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 72.3 t -83.76 140.46 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.69 0.757 . . . . 0.0 112.416 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.7 -39.26 1.09 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.34 120.25 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 114.532 -0.834 . . . . 0.0 108.855 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.412 ' HA ' HD12 ' A' ' 140' ' ' ILE . 4.2 tt0 -50.28 -28.41 7.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.448 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.526 ' H ' HG12 ' A' ' 136' ' ' VAL . 91.1 p -93.55 6.42 48.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.7 t70 -126.92 26.22 6.18 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.8 mt -107.13 138.77 31.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.982 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.55 53.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.126 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.56 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.0 t -113.35 150.46 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.656 0.741 . . . . 0.0 112.58 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.76 140.15 44.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.4 t -110.93 138.43 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.338 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.502 HD13 HG22 ' A' ' 36' ' ' VAL . 4.7 mm -106.22 121.18 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.013 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.53 124.19 50.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.778 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.864 HG12 HD21 ' A' ' 124' ' ' LEU . 3.8 mt -90.52 130.65 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.461 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -81.28 114.46 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.725 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -31.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -44.54 89.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.437 ' CE2' HG13 ' A' ' 33' ' ' VAL . 32.8 t80 -58.27 -44.11 88.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.93 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -64.18 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.18 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -60.45 -45.72 92.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.9 t -68.05 -42.4 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.015 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -40.27 78.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -59.69 -46.2 89.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -83.46 -31.93 26.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 42.44 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.486 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 152.6 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.96 130.8 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.071 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.12 -171.94 1.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 146.39 28.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.41 133.66 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 175.09 9.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.62 -47.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.739 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.08 138.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.028 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.62 159.77 12.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.623 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -166.24 138.85 3.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -160.03 169.3 23.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 59.84 78.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.173 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 76.3 p -146.25 -47.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.53 59.05 4.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.08 107.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.85 -74.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -60.7 -45.76 92.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -35.93 72.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -56.95 -42.93 80.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.752 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -33.66 69.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.713 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.7 mt -73.24 -35.37 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.771 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -57.61 -33.97 68.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -67.13 -24.04 65.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.922 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.87 -47.62 80.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.353 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.7 t -77.7 -25.1 49.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.225 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -53.47 159.44 1.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.046 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.71 121.0 15.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -83.6 135.23 34.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 mm -81.91 138.37 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-O 121.665 0.745 . . . . 0.0 111.624 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -163.57 103.01 0.21 Allowed Glycine 0 C--N 1.314 -0.655 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.676 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -89.2 -30.98 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER 178.02 39.7 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.639 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.19 143.81 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.632 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -108.93 -49.03 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.883 -178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -158.58 160.58 36.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.534 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.78 138.26 54.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.81 0.338 . . . . 0.0 111.466 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.771 HG21 ' HE2' ' A' ' 68' ' ' PHE . 41.4 t -110.89 122.6 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.746 0.308 . . . . 0.0 110.6 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.888 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -125.3 120.54 58.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HA ' HD23 ' A' ' 143' ' ' LEU . 51.2 t -81.65 116.16 21.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.049 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -23.34 26.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 0.0 111.685 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.33 76.82 0.32 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.406 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.615 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.1 mt-30 -145.96 -44.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.328 . . . . 0.0 110.943 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 43' ' ' ILE . 3.6 mp -117.95 141.74 29.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.003 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.89 143.43 36.79 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.209 1.939 . . . . 0.0 112.099 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.888 HG12 HG23 ' A' ' 37' ' ' ILE . 32.3 mt -55.6 139.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.842 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' CD1' ' A' ' 76' ' ' TYR . 42.8 mtt-85 -132.8 164.18 27.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.982 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.11 119.83 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.029 0.442 . . . . 0.0 111.866 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD11 HG23 ' A' ' 36' ' ' VAL . 8.0 mt -88.61 137.41 32.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.306 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.639 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.98 157.49 44.12 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 122.103 0.954 . . . . 0.0 113.32 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -138.54 142.0 39.29 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.662 -1.608 . . . . 0.0 110.769 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.9 ' O ' HG23 ' A' ' 55' ' ' VAL . 6.2 m-20 -74.87 119.8 19.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.076 0.465 . . . . 0.0 111.178 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.578 HD13 ' SG ' ' A' ' 154' ' ' CYS . 64.1 mt -64.49 -43.75 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.027 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.2 p -59.61 -40.87 88.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.344 0.592 . . . . 0.0 110.589 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 32.5 mm-40 -68.44 -36.86 79.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.754 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.5 t -64.27 -42.33 95.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.37 -32.02 70.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -35.99 47.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.801 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.38 120.16 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.91 -28.47 22.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -57.78 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.939 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.2 p -86.95 -43.56 12.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.4 tp -83.38 146.68 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.578 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.0 mmtt -117.76 -68.93 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.796 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 49' ' ' SER . 9.5 ttpt -144.54 138.92 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.6 t -131.61 139.47 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.065 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.2 m-90 -100.84 139.26 36.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.823 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.62 126.07 54.48 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.771 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -114.01 145.42 41.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.47 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.19 -167.17 38.03 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.685 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.1 mtm105 -85.11 -0.5 54.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.492 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.93 134.64 41.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.681 0.277 . . . . 0.0 111.11 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.56 -10.46 28.82 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.706 2.271 . . . . 0.0 111.791 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.57 -43.37 17.15 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.63 138.48 2.54 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.436 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -56.18 -19.11 12.21 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.923 179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 22.8 t80 -130.04 130.63 45.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.047 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -107.36 118.36 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.693 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -122.53 77.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.158 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.59 -125.26 10.8 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.799 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.527 HD22 HD12 ' B' ' 166' ' ' LEU . 11.0 p-10 -171.46 89.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.582 HD12 HD11 ' A' ' 84' ' ' LEU . 30.1 mt -105.08 134.27 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -55.51 -34.61 64.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.551 ' H ' HG22 ' A' ' 81' ' ' ILE . 8.0 mmp_? -66.97 -40.91 87.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 81' ' ' ILE . 17.1 mt -83.19 152.08 25.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.983 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.3 p -97.13 166.88 11.37 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.715 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.643 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 4.0 m-20 -43.14 -55.79 3.73 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 109.652 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -116.92 84.04 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -61.19 -46.37 90.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.842 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.2 p90 -146.26 159.32 43.49 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -135.87 141.69 44.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.322 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.616 ' C ' HG13 ' A' ' 65' ' ' VAL . 53.4 mt -118.43 127.69 75.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.812 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD21 HD22 ' A' ' 121' ' ' ASN . 0.5 OUTLIER -111.95 148.84 32.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 33' ' ' VAL . 4.0 tt -125.32 122.82 37.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.284 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.05 26.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 63.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.488 ' CG ' HD23 ' A' ' 155' ' ' LEU . 2.6 m-20 52.16 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.026 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.11 -51.11 3.73 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.451 ' HB2' HD21 ' A' ' 123' ' ' LEU . 18.7 p30 -155.61 149.24 25.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.16 160.34 15.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.668 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.748 HD13 ' HB3' ' A' ' 121' ' ' ASN . 12.4 mt -126.92 144.71 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.665 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 130' ' ' ILE . 7.3 mp -112.57 124.59 52.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.755 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.8 t30 -116.29 115.47 26.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.988 0.423 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.819 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.4 p30 -77.44 139.13 39.6 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.9 pt -146.28 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.593 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.39 154.64 17.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 120.945 0.402 . . . . 0.0 111.498 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.657 HG22 ' HB2' ' B' ' 171' ' ' ALA . 96.1 m -68.85 -32.91 72.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.962 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -96.42 -19.84 18.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.05 159.98 12.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.533 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.6 m -117.46 137.78 52.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.886 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.42 148.41 37.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.48 18.38 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.287 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.78 43.63 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.52 -12.17 65.96 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.511 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.64 118.52 36.9 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.964 0.412 . . . . 0.0 110.536 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.886 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.6 tptm -73.52 123.55 24.16 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.496 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.819 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.3 m -92.02 163.75 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.016 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.2 mt-10 -69.94 125.26 26.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.5 tttp -52.18 161.56 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 110.644 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.34 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.34 145.09 40.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.151 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.748 ' HB3' HD13 ' A' ' 100' ' ' LEU . 27.5 m120 -88.41 127.17 35.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.669 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.6 mm-40 -129.41 146.6 51.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD13 HD23 ' A' ' 124' ' ' LEU . 1.7 tm? -75.35 111.91 11.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.821 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -53.21 167.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.563 0.697 . . . . 0.0 112.106 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.538 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.54 153.81 41.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.1 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.676 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.91 114.55 9.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.97 24.6 73.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.725 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.3 t70 -57.39 177.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.5 tt0 -144.98 135.47 24.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 101' ' ' LEU . 12.9 mt -114.44 126.65 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.52 138.6 40.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.007 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.38 158.37 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.14 30.91 24.25 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.105 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.2 t -72.07 140.41 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.645 0.736 . . . . 0.0 112.514 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.99 -41.31 0.65 Allowed Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.121 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 138' ' ' SER . 45.9 t -126.39 134.47 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.235 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.51 -38.73 45.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.424 ' H ' HG12 ' A' ' 136' ' ' VAL . 58.1 m -93.38 6.51 47.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.4 m-20 -117.99 24.95 10.69 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.17 139.2 29.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.237 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 142' ' ' SER . 4.9 tt -124.15 134.24 53.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.332 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.72 ' N ' HD23 ' A' ' 141' ' ' LEU . 34.5 t -111.52 150.13 30.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.648 0.737 . . . . 0.0 112.631 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 38' ' ' CYS . 62.5 mt -135.96 146.36 47.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.031 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 129' ' ' GLU . 37.5 t -114.81 139.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 91' ' ' ILE . 2.0 mm -106.11 120.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.08 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.25 105.57 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.85 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.7 mp -84.95 123.25 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.204 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -82.67 124.88 30.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.0 -17.91 60.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.222 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -56.9 -42.42 79.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -59.23 -42.54 91.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.723 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -33.98 77.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.055 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.68 -43.99 95.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 52' ' ' ILE . 13.0 t -59.36 -46.14 89.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.989 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.488 HD23 ' CG ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -69.0 -35.93 77.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.942 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.93 -35.81 64.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -91.96 -34.43 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.55 82.98 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.02 124.22 41.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.14 122.38 49.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -116.93 132.79 56.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.928 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -104.24 116.93 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.7 pt -77.04 133.67 30.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.943 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.804 0.335 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.527 HD12 HD22 ' A' ' 80' ' ' ASN . 9.7 mt -123.35 99.77 6.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.64 -51.6 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.51 139.92 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -91.08 111.81 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.657 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -114.3 152.92 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -111.57 168.33 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.874 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -154.25 149.17 26.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 46.5 p -119.74 69.25 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.33 78.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.806 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.74 131.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.093 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.895 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.866 0.365 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.12 -61.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.835 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.66 -43.29 80.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -63.29 -39.79 95.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.89 -35.64 78.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tt -62.89 -36.66 84.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -71.13 -35.22 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -41.97 80.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.322 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -67.16 -23.75 65.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.43 79.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.267 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -71.34 -35.89 71.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.957 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 109.57 5.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 124.96 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.69 116.44 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 136.69 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 C-N-CA 123.047 0.539 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 37.95 6.42 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.471 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -64.31 -38.44 91.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.798 0.333 . . . . 0.0 110.931 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.0 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -77.2 134.07 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.462 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.6 -61.32 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.065 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 48' ' ' LEU . 7.9 p -145.67 161.61 39.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.496 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 138.11 54.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.111 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 17.7 t -107.57 122.85 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.817 HG23 HG12 ' A' ' 45' ' ' ILE . 17.4 mt -125.98 117.75 49.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.339 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.1 t -80.75 111.74 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -81.06 -24.53 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.62 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 75.7 p -79.97 -2.21 42.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.594 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.09 74.35 0.53 Allowed Glycine 0 CA--C 1.517 0.21 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.536 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' C ' HD13 ' A' ' 43' ' ' ILE . 8.8 mt-30 -146.47 -43.37 0.19 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 111.018 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.4 mm -113.95 141.62 26.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.749 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.714 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.1 Cg_endo -73.89 145.87 36.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.977 . . . . 0.0 112.144 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.817 HG12 HG23 ' A' ' 37' ' ' ILE . 45.4 mt -59.07 125.98 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.561 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 164.2 20.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.895 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.36 119.84 29.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.016 0.436 . . . . 0.0 111.936 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.2 mp -84.53 132.21 34.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.94 47.03 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.23 141.79 32.56 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 0.0 110.55 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -80.06 142.32 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.312 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -64.16 -45.22 97.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.551 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -38.7 79.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.338 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.1 mm-40 -68.55 -37.01 79.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.454 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.825 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.8 t -72.16 -39.99 65.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.93 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -32.57 69.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -49.24 62.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.6 107.08 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -87.75 -31.83 19.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -132.58 170.84 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m 60.79 178.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.602 HD13 HD12 ' A' ' 92' ' ' LEU . 10.5 tp -75.51 155.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.825 ' HD3' HG13 ' A' ' 55' ' ' VAL . 1.6 mttp -94.62 -74.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.245 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -128.5 134.76 48.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.646 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.7 t -132.76 139.3 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.175 0.512 . . . . 0.0 111.913 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.642 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.9 m-90 -104.9 139.35 39.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.259 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 128.27 56.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 0.0 110.053 177.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.0 m-85 -111.64 145.67 38.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.511 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.72 -169.05 35.66 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.917 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 7.0 mtp-105 -83.92 4.12 30.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.85 130.69 51.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.478 0.18 . . . . 0.0 110.727 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 20.7 Cg_exo -64.92 -12.48 34.62 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.361 2.04 . . . . 0.0 111.422 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.0 -43.11 16.75 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.909 0.862 . . . . 0.0 108.743 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -44.18 137.4 3.46 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.472 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.27 -19.04 12.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.911 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.807 ' CE2' HG21 ' A' ' 43' ' ' ILE . 8.4 t80 -129.78 125.81 36.67 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.789 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -101.39 114.81 29.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 110.922 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 mp -85.62 -176.0 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.14 43.91 2.82 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.73 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 41.91 84.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.904 0.383 . . . . 0.0 111.914 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.795 HD13 HD22 ' A' ' 84' ' ' LEU . 3.3 mp -111.25 123.83 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -42.34 70.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.45 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.43 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.2 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 81' ' ' ILE . 3.7 mp -96.36 153.5 17.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.055 0.455 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 p -94.59 169.13 10.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.872 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.6 m-20 -44.01 -56.53 3.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 1.8 ptpt -117.33 83.66 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.3 t60 -59.66 -46.85 87.79 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.905 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 25.4 p90 -146.12 159.72 42.9 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.229 -0.589 . . . . 0.0 112.091 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.646 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.0 140.71 44.11 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.51 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.9 mp -114.88 132.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.007 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD13 ' A' ' 62' ' ' ILE . 1.4 pt? -122.87 138.17 54.73 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 120.994 0.426 . . . . 0.0 111.834 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.588 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.7 tm? -125.38 128.63 48.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.533 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.514 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 154.85 -57.07 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.629 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.34 101.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 60.34 174.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.807 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.05 175.66 2.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 63.48 -179.48 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -106.95 160.22 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.843 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 11.0 mt -121.89 139.71 53.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.369 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.46 HD22 ' CG1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.71 122.05 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.204 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 55.4 t30 -113.82 115.51 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.941 0.4 . . . . 0.0 111.448 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -78.27 138.91 38.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.678 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 67' ' ' THR . 17.0 pt -146.81 38.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.599 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.21 152.8 19.85 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.954 0.407 . . . . 0.0 111.827 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.766 HG21 ' O ' ' B' ' 168' ' ' VAL . 97.1 m -68.82 -31.99 71.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.917 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -96.14 -19.98 18.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.3 158.56 11.47 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.653 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -117.42 137.98 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.97 148.4 40.14 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.831 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.39 113.56 18.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.892 177.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 46.84 36.08 3.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.1 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.94 -7.87 76.49 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.6 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.63 118.47 36.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.038 0.447 . . . . 0.0 110.666 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.4 130.84 41.66 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.254 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.831 HG11 HD12 ' A' ' 111' ' ' LEU . 10.6 m -104.33 165.74 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.235 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 47.7 tt0 -70.05 125.89 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 79.1 tttt -52.07 162.0 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.323 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.1 p30 35.64 34.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.23 136.8 51.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.107 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 100' ' ' LEU . 8.8 m120 -83.57 128.01 34.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.893 0.377 . . . . 0.0 110.803 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 52.8 mm-40 -129.41 149.59 51.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.801 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.71 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.974 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 145' ' ' ILE . 1.5 mm? -65.85 165.68 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.775 0.797 . . . . 0.0 112.052 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.466 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -125.36 153.26 43.63 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.3 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.28 118.01 13.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.214 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.55 26.58 64.76 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.062 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.604 ' OD2' HD23 ' A' ' 111' ' ' LEU . 6.1 t70 -60.47 177.68 0.26 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.941 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -145.14 135.47 24.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.04 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 145' ' ' ILE . 9.9 mt -111.87 128.24 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.327 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.68 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.22 140.75 37.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.7 m -140.28 158.15 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 79.37 43.64 10.3 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.058 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.7 t -82.75 140.34 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.682 0.753 . . . . 0.0 112.548 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -40.79 0.77 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 138' ' ' SER . 41.5 t -126.32 127.5 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.138 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -31.87 16.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.722 0.296 . . . . 0.0 111.608 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.52 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.0 t -93.54 6.33 48.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 133' ' ' GLY . 0.9 OUTLIER -122.97 24.26 9.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.68 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -106.86 139.01 29.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.327 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.29 53.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.573 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.6 t -111.75 150.36 30.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.687 0.756 . . . . 0.0 112.368 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.682 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.86 143.52 45.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.354 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.941 HG22 ' CG ' ' A' ' 129' ' ' GLU . 14.0 t -111.31 135.1 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.302 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 130' ' ' ILE . 8.8 mt -106.34 120.91 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.87 113.35 26.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.443 HG21 ' HE2' ' A' ' 152' ' ' LYS . 6.7 mt -85.04 134.09 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.598 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.67 118.37 24.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.614 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.28 -27.87 66.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -46.13 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.778 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 24.2 t80 -61.15 -43.49 98.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.443 ' HE2' HG21 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -55.66 -38.15 69.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.976 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -47.04 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.2 t -62.99 -44.2 96.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.72 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.415 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -57.92 -35.84 71.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.778 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.97 -42.41 98.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -84.61 -31.22 24.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.05 -91.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.692 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tttm -87.36 125.95 34.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.6 m -81.71 130.03 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.46 -66.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 mtm105 -160.59 -174.62 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.12 136.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.172 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.982 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.705 0.288 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.6 95.49 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -100.48 31.01 3.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.766 ' O ' HG21 ' A' ' 106' ' ' THR . 22.8 t -117.17 128.19 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -63.83 82.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.756 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -103.47 121.72 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -97.91 167.12 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.61 102.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 1.5 p -114.49 139.38 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -159.99 48.03 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 6.2 m -146.58 30.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.822 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.709 0.29 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -121.17 -46.09 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -46.95 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -37.96 83.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' A' ' 22' ' ' LYS . 34.3 t80 -65.87 -35.48 80.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -40.38 97.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 15.6 mm -72.14 -35.05 51.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -57.08 -36.17 70.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.974 0.416 . . . . 0.0 110.356 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HD2' ' CD1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -67.27 -23.86 65.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.58 -47.58 79.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.231 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -75.61 -26.02 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.65 30.42 0.79 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.319 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -91.34 124.83 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.02 103.76 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.756 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.89 138.32 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 111.779 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 64.76 103.67 0.01 OUTLIER Glycine 0 C--N 1.314 -0.667 0 CA-C-N 114.509 -1.223 . . . . 0.0 112.275 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -76.76 -31.53 57.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 178.52 38.9 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.707 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.52 134.99 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.606 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.028 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -90.55 -60.47 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.919 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 p -152.11 142.07 22.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.078 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -113.81 128.48 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 111.353 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG21 ' CE1' ' A' ' 76' ' ' TYR . 34.8 m -91.21 127.14 43.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 22.9 mt -125.13 112.86 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.607 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.97 112.08 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.742 0.306 . . . . 0.0 110.257 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.2 p -96.02 -19.68 19.28 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.801 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.6 p -79.86 -2.97 45.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.692 0.282 . . . . 0.0 111.336 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 73.77 76.25 0.7 Allowed Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.463 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -148.78 -42.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.776 0.322 . . . . 0.0 111.332 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.0 mt -131.12 141.9 43.59 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.435 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.4 Cg_endo -72.64 146.15 43.01 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.229 1.953 . . . . 0.0 111.908 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -53.58 149.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.179 0.514 . . . . 0.0 111.996 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -145.0 157.24 44.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.926 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.69 119.97 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.7 mt -96.27 137.39 35.41 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.028 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.01 158.74 43.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.13 144.82 31.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.669 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.8 m-20 -74.95 136.45 41.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 111.269 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.662 HD13 ' SG ' ' A' ' 154' ' ' CYS . 78.6 mt -64.53 -45.23 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.084 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.97 -39.28 74.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.0 110.694 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.6 mm100 -68.47 -38.13 80.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.597 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.7 t -73.1 -43.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.06 -31.6 68.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -47.67 36.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.986 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.64 111.99 9.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -30.54 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.909 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -123.87 173.57 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m 59.23 167.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 65' ' ' VAL . 9.8 tp -73.92 155.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -70.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.2 ttpt -137.64 130.97 30.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.357 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' C ' ' A' ' 91' ' ' ILE . 6.3 t -126.68 138.76 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.164 0.506 . . . . 0.0 111.815 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 15.7 m-90 -100.91 139.65 36.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.998 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.997 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.32 127.43 55.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -113.71 145.52 41.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.273 -178.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.29 -174.01 39.5 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.802 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 36.6 mtp180 -78.03 -1.38 31.96 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t-20 -84.72 132.92 44.94 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.625 0.25 . . . . 0.0 111.193 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.37 -8.31 22.63 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.639 2.226 . . . . 0.0 111.638 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.58 16.71 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.05 137.8 2.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.439 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.35 -19.08 12.98 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 36' ' ' VAL . 66.2 t80 -130.14 129.95 44.14 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.813 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.76 126.89 52.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 110.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -124.55 179.14 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.049 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.44 148.46 41.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.13 92.5 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 0.0 111.401 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 83' ' ' ARG . 23.8 mm -108.86 117.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -25.35 25.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -76.7 -42.64 40.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.935 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.0 mt -72.82 152.14 41.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.795 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.9 p -93.66 164.92 12.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.601 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.647 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -42.28 -54.0 3.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.527 0.68 . . . . 0.0 109.737 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -120.07 83.25 2.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -59.88 -44.58 94.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.046 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 13.5 p90 -145.3 163.01 35.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.301 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.997 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.51 136.23 41.06 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.603 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 49.5 mt -112.12 126.58 69.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.483 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -109.43 145.45 36.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.0 111.641 -179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 33' ' ' VAL . 29.5 tp -125.22 124.15 41.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.395 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.92 -129.58 2.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.505 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 63.34 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -137.29 28.89 2.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.799 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.36 -23.45 31.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.654 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -73.59 -170.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.4 mm? -113.56 151.22 31.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.958 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 7.8 mp -132.8 144.31 50.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.522 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.437 HD22 HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.77 120.06 40.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.959 179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.749 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.3 t30 -113.75 115.54 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.794 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.3 p30 -78.71 138.89 38.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.164 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 89' ' ' PHE . 15.5 pt -147.78 40.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.603 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -98.49 158.94 15.28 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.056 0.455 . . . . 0.0 111.607 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.806 HG22 ' HB2' ' B' ' 171' ' ' ALA . 84.9 m -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.429 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -19.95 17.41 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.603 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.59 161.78 11.56 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.338 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.65 137.9 52.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.067 -0.566 . . . . 0.0 109.57 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.24 148.59 35.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.0 113.35 18.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.098 177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.4 m-20 44.56 43.11 6.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.37 -7.03 82.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.535 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.02 118.59 37.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.105 0.479 . . . . 0.0 110.746 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.2 tptm -74.6 126.22 30.34 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.794 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.7 m -100.72 166.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.341 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.2 tp10 -69.87 126.96 31.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.4 tttt -54.16 163.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.6 OUTLIER 35.79 33.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.018 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.4 135.08 53.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.109 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.713 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -77.05 133.75 38.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.861 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 23.5 mm-40 -129.41 146.34 51.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.456 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.82 122.05 20.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.195 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.8 tt -55.83 153.92 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 111.574 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 1.2 t -124.81 152.99 43.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.333 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.89 123.54 22.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.17 23.84 48.82 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.281 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.643 ' O ' HD12 ' A' ' 145' ' ' ILE . 22.5 t70 -57.85 173.49 0.31 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.21 135.65 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.244 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.499 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.6 mt -110.79 126.44 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.57 137.06 42.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.015 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 88' ' ' HIS . 24.3 m -140.42 158.56 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.21 27.78 29.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.285 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.64 140.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.627 0.727 . . . . 0.0 112.349 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.5 -41.33 0.75 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 138' ' ' SER . 44.5 t -126.28 131.74 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.163 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -35.27 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.761 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.3 t -93.52 6.34 48.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.95 24.93 10.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -107.17 139.59 28.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.362 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 142' ' ' SER . 6.5 tt -120.0 134.41 55.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.262 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.801 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -113.91 126.51 55.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.177 0.513 . . . . 0.0 111.255 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 130' ' ' ILE . 18.1 mt -120.28 136.11 54.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.832 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' GLU . 23.5 t -110.69 137.75 41.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.282 . . . . 0.0 110.67 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 128' ' ' ASP . 1.0 OUTLIER -105.68 135.93 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.618 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.99 125.03 53.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.55 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -93.32 129.67 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.296 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.94 109.14 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.05 -35.15 72.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.984 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.28 -45.97 91.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.66 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -58.55 -44.03 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -34.61 76.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -63.67 -40.77 97.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.662 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -61.84 -45.7 92.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.968 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -36.01 81.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.35 -44.93 96.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 159' ' ' LYS . 13.9 pt20 -84.99 -30.24 24.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.85 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.604 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.1 tttp -104.06 154.74 19.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.874 0.368 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.7 m -95.08 128.75 46.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.0 167.59 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -135.29 108.06 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -96.0 122.39 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.88 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.352 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 tp -156.81 122.88 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.28 108.24 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.6 t -77.9 155.64 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.608 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -79.55 114.28 18.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.806 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -120.43 -169.33 1.79 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -140.72 168.47 19.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.9 118.59 37.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.074 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 38.1 p -129.42 163.49 25.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.965 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -128.67 79.02 1.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.16 139.91 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.3 -63.08 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -70.23 -33.75 72.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -62.92 -36.29 82.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.824 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -38.5 74.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 0.0 110.749 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.24 -31.79 69.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.667 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 mt -72.97 -35.41 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.59 -38.92 75.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.412 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.82 65.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.744 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.69 -47.45 79.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.23 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -65.69 -34.6 78.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -82.86 161.59 21.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.19 149.25 35.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -69.15 115.38 8.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.84 138.28 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.625 0.726 . . . . 0.0 111.795 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 82.39 116.59 0.5 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.551 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -73.05 -29.61 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 178.51 38.31 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -74.6 135.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.577 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.0 -60.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.686 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.15 158.0 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.147 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -122.09 138.28 54.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.9 m -104.57 122.75 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.711 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.778 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.39 119.83 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.791 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.543 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.0 t -82.64 114.18 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -22.72 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.968 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' H ' ' A' ' 142' ' ' SER . 82.1 p -79.85 -2.35 43.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.729 0.3 . . . . 0.0 111.542 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.72 75.26 0.4 Allowed Glycine 0 CA--C 1.517 0.162 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.36 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.14 -41.99 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.013 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mt -117.59 141.34 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.9 Cg_endo -73.29 141.93 32.89 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.203 1.935 . . . . 0.0 112.102 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.778 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -56.41 134.92 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -123.44 163.3 21.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.013 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.33 119.9 36.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 111.867 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -93.35 135.59 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.64 157.98 43.83 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.33 150.21 28.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.843 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.1 m-20 -74.84 122.86 24.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.097 0.475 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' CZ ' ' A' ' 151' ' ' PHE . 47.0 mt -64.58 -42.62 95.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.118 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.0 p -61.3 -40.31 93.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.344 0.592 . . . . 0.0 110.716 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 2.0 mm-40 -68.49 -36.79 79.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.743 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.0 t -70.43 -38.0 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -69.72 -29.21 66.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -28.54 17.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 121.11 12.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 31.98 4.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.07 117.9 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.1 -171.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.517 HD11 ' C ' ' A' ' 93' ' ' LEU . 10.1 tp -68.39 151.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -82.43 -75.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.1 OUTLIER -126.59 137.28 53.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.394 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.571 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -136.43 139.21 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.371 0.605 . . . . 0.0 112.071 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.629 ' HH2' HG21 ' A' ' 33' ' ' VAL . 18.6 m-90 -106.18 139.19 41.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.236 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.682 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.24 127.53 55.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -117.22 145.33 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.051 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.98 -169.54 37.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.424 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' N ' HD11 ' A' ' 78' ' ' LEU . 3.1 mtp85 -78.74 0.33 27.23 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 21.2 t-20 -84.81 132.31 46.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.612 0.244 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.63 -10.8 30.13 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.478 2.119 . . . . 0.0 111.851 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.14 -44.26 15.29 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.873 0.844 . . . . 0.0 108.92 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -38.38 138.43 0.47 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.632 -1.622 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.53 -19.22 14.58 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.014 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.503 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 73.9 t80 -130.05 121.36 26.3 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.805 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.44 121.8 43.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.826 0.346 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -105.0 -174.84 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.463 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.26 -113.27 0.01 OUTLIER Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.8 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -162.35 83.28 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.763 HD12 HD11 ' A' ' 84' ' ' LEU . 32.8 mt -111.95 121.46 64.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.278 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -58.99 -30.17 67.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.798 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -67.19 -24.82 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 81' ' ' ILE . 40.8 mt -95.2 152.1 18.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.7 p -95.49 167.92 11.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -45.5 -53.8 8.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.445 0.64 . . . . 0.0 109.508 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' HD12 ' A' ' 104' ' ' ILE . 26.0 mttt -117.42 81.95 1.74 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -59.91 -47.28 86.41 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.463 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.1 p90 -145.3 158.21 43.88 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.99 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.9 tt0 -135.77 139.59 43.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 101' ' ' LEU . 43.6 mt -116.32 132.67 65.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.774 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -120.12 149.15 42.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.05 0.452 . . . . 0.0 111.824 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.638 HD13 ' CG1' ' A' ' 33' ' ' VAL . 2.6 tp -125.02 122.8 38.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.378 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.58 -170.68 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.746 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.08 -27.76 16.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.748 0.309 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -83.45 54.89 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.228 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.18 -169.0 0.06 OUTLIER Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.857 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.8 172.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.88 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 99' ' ' LEU . 1.6 mm? -127.17 160.25 31.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.836 HD11 ' HA ' ' A' ' 121' ' ' ASN . 1.6 tm? -131.57 131.55 43.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.48 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.732 ' N ' HD13 ' A' ' 100' ' ' LEU . 24.3 mt -112.29 122.57 48.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.109 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.3 t30 -116.63 115.65 26.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.964 0.412 . . . . 0.0 111.735 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.3 p30 -77.13 137.35 38.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.615 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -144.2 38.11 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.61 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.45 154.96 17.49 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 120.979 0.418 . . . . 0.0 111.917 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 95.0 m -68.94 -33.56 73.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.924 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' B' ' 171' ' ' ALA . 7.9 m-20 -96.5 -19.76 18.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.08 159.76 12.02 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.544 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.7 m -117.43 137.83 52.24 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.4 148.52 37.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.39 18.25 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.213 177.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 9.0 m-80 44.11 43.34 5.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.29 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.34 -6.95 82.49 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.49 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 118.51 36.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.2 tptt -75.09 122.02 22.93 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.313 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -95.24 163.36 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.125 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.4 tp10 -69.85 125.96 28.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 19.9 tttm -53.49 163.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.73 34.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.893 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -112.12 145.0 40.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.003 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.836 ' HA ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -87.21 126.97 35.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.131 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.586 ' O ' HD22 ' A' ' 100' ' ' LEU . 36.6 mm-40 -129.14 145.96 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.573 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.8 tt -72.85 136.06 45.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.354 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.908 HD11 HG21 ' A' ' 145' ' ' ILE . 66.6 tp -72.02 156.78 38.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.505 0.669 . . . . 0.0 111.813 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.43 153.28 42.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.336 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.33 122.01 19.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.189 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.79 21.28 58.21 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.165 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 39.0 t0 -54.45 174.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -145.05 135.72 24.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.259 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 145' ' ' ILE . 13.1 mt -113.72 127.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.514 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.519 HG22 ' CG2' ' A' ' 140' ' ' ILE . 6.2 m -104.52 137.59 42.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.35 158.39 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.138 0.494 . . . . 0.0 112.308 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.26 25.83 30.01 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.239 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 140' ' ' ILE . 60.4 t -67.89 140.55 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.657 0.742 . . . . 0.0 112.505 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.62 -42.38 0.52 Allowed Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.211 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 138' ' ' SER . 44.6 t -126.36 136.22 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 114.897 -0.652 . . . . 0.0 109.244 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -50.64 -38.44 46.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.44 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.9 t -93.46 6.54 47.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -119.05 26.8 9.26 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.17 139.34 29.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.275 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.5 tt -124.18 134.25 53.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.392 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.536 ' H ' HG21 ' A' ' 40' ' ' THR . 44.6 t -109.25 150.87 27.31 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.596 0.712 . . . . 0.0 112.201 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 38' ' ' CYS . 75.3 mt -135.42 154.63 51.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.755 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.4 t -122.53 140.05 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.908 HG21 HD11 ' A' ' 124' ' ' LEU . 27.3 mt -106.47 120.98 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.911 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.06 112.81 25.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.589 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.84 134.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.79 108.85 15.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.69 -32.89 73.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -44.04 89.11 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.014 0.435 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 35.3 t80 -58.14 -44.05 87.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.848 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -60.71 -45.05 95.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.48 -45.19 92.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.7 t -60.86 -46.02 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.711 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -67.28 -35.96 80.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.91 -39.92 93.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -88.41 -37.16 16.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.3 p30 44.56 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -120.68 147.15 45.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.9 m -103.01 130.88 52.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -87.31 114.96 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.39 109.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.96 115.79 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.046 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.856 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tp 60.1 161.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.46 140.88 58.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.52 137.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.602 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -47.5 -61.2 2.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.558 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . 61.15 179.68 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -128.19 161.26 29.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.787 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.471 ' O ' HG22 ' B' ' 174' ' ' THR . . . -125.29 174.56 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.471 HG22 ' O ' ' B' ' 173' ' ' ALA . 15.3 t 44.77 37.31 2.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -134.95 82.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . 0.576 ' O ' HG13 ' B' ' 176' ' ' VAL . 9.5 p -156.17 65.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.882 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -155.35 -50.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -43.66 66.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -40.68 91.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -58.74 -40.69 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -32.05 69.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.27 -35.48 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -57.53 -39.26 76.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -67.22 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.706 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.42 79.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -67.75 -29.16 68.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.764 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.12 112.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -81.79 130.72 35.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -67.39 131.99 46.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -81.99 138.34 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.651 0.739 . . . . 0.0 111.62 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.07 80.34 1.21 Allowed Glycine 0 C--N 1.313 -0.744 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.344 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -74.08 -36.99 64.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.764 0.316 . . . . 0.0 111.147 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.5 m-20 177.34 40.08 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.5 mm -71.42 141.82 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 113.461 -1.7 . . . . 0.0 112.543 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.49 -49.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.84 -178.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -153.48 165.5 35.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.122 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.88 133.63 44.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.19 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.808 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.3 m -106.43 122.66 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.67 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.871 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -126.64 121.35 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.573 ' SG ' HD21 ' A' ' 141' ' ' LEU . 1.8 t -90.42 101.63 14.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.824 0.345 . . . . 0.0 110.303 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.5 p -83.68 -19.9 34.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.981 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.1 p -79.85 -2.82 45.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.671 0.272 . . . . 0.0 111.499 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 71.88 0.98 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.102 -0.571 . . . . 0.0 113.889 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -143.37 -42.14 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.7 mt -129.92 142.34 45.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.0 Cg_endo -71.34 146.2 50.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.322 2.015 . . . . 0.0 112.371 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' ILE . 34.6 mt -54.36 155.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.993 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 45' ' ' ILE . 4.7 ttt180 -151.15 164.13 37.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.13 119.86 31.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.019 0.438 . . . . 0.0 112.071 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.723 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.2 mp -86.79 134.08 33.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.61 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.67 156.74 46.15 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 122.364 1.078 . . . . 0.0 113.576 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -143.36 142.95 31.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.619 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -74.98 120.91 21.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.095 0.474 . . . . 0.0 111.186 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.717 HD13 ' SG ' ' A' ' 154' ' ' CYS . 35.1 mt -64.29 -40.25 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.898 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -40.15 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.61 -39.8 80.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.757 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.782 HG13 ' HD2' ' A' ' 63' ' ' LYS . 39.9 t -71.84 -42.41 69.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.066 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -25.93 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -55.39 3.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.81 119.34 11.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.953 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.52 29.68 7.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.756 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -156.67 153.25 28.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.71 168.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.94 152.05 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.782 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -83.11 -67.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -151.48 135.07 16.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.386 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.2 t -129.67 139.0 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.22 0.533 . . . . 0.0 111.854 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.723 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.09 140.14 36.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.188 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.989 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.74 127.76 56.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.808 ' CE2' HG11 ' A' ' 36' ' ' VAL . 3.0 m-85 -113.53 145.7 40.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.146 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 158.84 -171.92 35.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.907 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -81.51 2.65 28.0 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 22.8 t-20 -84.78 133.96 42.72 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.618 0.247 . . . . 0.0 110.999 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.9 Cg_exo -67.97 -10.05 27.62 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.624 2.216 . . . . 0.0 111.692 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.15 -43.86 15.73 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 122.09 0.947 . . . . 0.0 108.731 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -43.61 135.97 3.54 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.816 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -18.73 13.0 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.034 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.547 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 24.4 t80 -129.6 121.07 26.34 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.786 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.54 108.01 20.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.691 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.789 HD23 HD13 ' A' ' 84' ' ' LEU . 7.4 mp -67.2 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.153 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.1 -78.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -177.04 52.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.2 mm -88.73 113.51 25.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.1 t -54.94 -42.59 72.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.257 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -62.25 -28.88 70.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.17 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD13 HD23 ' A' ' 78' ' ' LEU . 40.9 mt -89.23 152.3 21.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.019 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.2 p -96.61 165.0 12.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.691 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.97 -52.46 5.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 67' ' ' THR . 10.1 mttt -119.08 84.08 2.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -62.92 -45.83 90.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.923 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.3 p90 -146.51 163.54 35.41 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.101 -0.64 . . . . 0.0 112.45 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.989 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.64 137.0 41.42 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.338 -179.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 65' ' ' VAL . 35.0 mt -113.55 129.35 69.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.373 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.69 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -120.9 143.04 49.15 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.159 0.504 . . . . 0.0 111.982 -179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.88 HD13 HG22 ' A' ' 33' ' ' VAL . 4.5 tt -125.21 122.88 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.13 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -121.19 -175.05 15.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.738 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -170.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 110.985 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.89 27.67 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.54 -163.36 7.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.54 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m120 61.09 166.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.373 . . . . 0.0 111.011 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' A' ' 93' ' ' LEU . 5.2 mp -126.52 160.16 31.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.682 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.715 HD22 ' HB3' ' A' ' 121' ' ' ASN . 9.3 mt -125.91 139.91 53.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.61 121.86 45.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.045 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.1 t30 -115.84 115.66 26.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 111.567 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.6 p30 -78.78 142.04 37.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.964 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -148.08 37.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.23 152.35 19.48 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 120.984 0.421 . . . . 0.0 111.71 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.5 m -68.73 -33.69 74.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.964 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -94.6 -19.76 20.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.16 157.58 11.18 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.51 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.51 137.82 52.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.41 148.48 37.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.4 18.31 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.169 177.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 44.24 43.73 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.417 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.8 -10.32 70.62 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.484 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 110.598 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -73.65 121.78 21.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.29 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.1 m -93.44 165.17 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.219 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 13.6 mt-10 -69.91 126.94 31.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.708 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.4 tttt -53.65 162.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' ASP . 8.9 m-80 34.1 35.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.226 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.3 145.1 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.078 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.715 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.2 m120 -90.18 127.37 36.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.791 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.713 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.26 148.33 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.2 tp -72.77 119.38 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.134 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 101' ' ' LEU . 1.2 mm? -57.74 164.77 1.95 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.748 0.785 . . . . 0.0 112.065 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -125.5 153.28 43.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.314 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.72 118.77 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.71 64.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.098 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' OD2' HD13 ' A' ' 111' ' ' LEU . 8.5 t70 -60.56 178.46 0.22 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.828 0.346 . . . . 0.0 111.011 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.1 tt0 -145.37 135.42 23.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.787 HD11 HD11 ' A' ' 101' ' ' LEU . 2.6 mt -112.01 128.36 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.22 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.561 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.42 138.51 40.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG23 HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.39 158.44 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.65 34.13 20.06 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.032 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -75.97 140.26 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 121.565 0.698 . . . . 0.0 112.408 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.92 -39.07 0.96 Allowed Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.44 126.87 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.108 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -50.5 -33.64 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.48 6.57 47.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -123.77 26.79 7.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -106.97 139.47 28.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.121 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.75 HD22 ' CD2' ' A' ' 143' ' ' LEU . 2.0 tt -121.81 134.33 54.9 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.398 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.7 OUTLIER -113.07 130.52 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 111.999 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.75 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.4 mm? -120.77 145.79 47.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.199 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.6 t -110.82 132.6 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.459 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.681 HG13 HD11 ' A' ' 130' ' ' ILE . 1.4 mm -106.24 123.52 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.792 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.78 114.4 26.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 99' ' ' LEU . 8.5 mt -84.62 129.45 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -75.93 123.04 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.02 -25.98 62.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -56.88 -36.52 70.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -66.99 -39.76 87.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.077 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -64.95 -50.18 67.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' CYS . 2.6 pt20 -60.6 -36.63 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.717 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.9 t -66.39 -44.57 82.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -35.92 82.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -41.29 83.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.821 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 4.1 tt0 -84.69 -30.83 24.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.85 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.672 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.1 tttp -106.31 154.3 20.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.26 129.91 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -123.74 78.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -98.86 138.02 36.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 pt -96.02 134.2 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.889 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.98 145.67 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -116.4 86.62 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.87 146.24 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -80.22 170.77 15.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.825 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.69 163.03 40.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.111 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.4 165.63 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.77 73.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 71.0 p -118.67 31.39 6.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.18 73.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.64 117.53 55.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.872 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.798 0.333 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.2 m -152.13 -52.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.95 -45.21 61.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -59.54 -37.59 78.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -67.36 -34.98 78.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.989 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.89 -42.09 99.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.81 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -66.96 -35.1 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.227 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.07 -42.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.987 0.423 . . . . 0.0 110.466 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -23.77 65.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.486 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.77 -47.46 80.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.146 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -75.96 -20.9 57.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.14 -69.58 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.814 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.08 120.93 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.742 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -82.44 101.94 10.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -84.39 138.37 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.63 0.729 . . . . 0.0 111.793 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.88 88.79 1.4 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.445 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.73 -39.02 87.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER 175.73 39.37 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.01 135.04 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.546 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.91 -60.2 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.677 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.708 ' SG ' HG22 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -152.77 149.81 28.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.127 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -114.18 137.18 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 0.0 111.395 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 30.5 t -102.8 122.74 55.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.865 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -122.61 126.74 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.391 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.742 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -85.6 113.2 21.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.541 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -82.06 -25.42 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.559 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 142' ' ' SER . 34.8 p -79.95 -2.01 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.633 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.82 76.87 0.24 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.785 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 43' ' ' ILE . 8.7 mt-30 -145.95 -45.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.883 0.373 . . . . 0.0 110.933 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.2 mp -114.86 141.42 26.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.0 Cg_endo -72.4 139.3 31.5 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.077 1.851 . . . . 0.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.37 140.35 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.682 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.19 161.34 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.283 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.24 119.78 36.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 111.567 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 36' ' ' VAL . 3.8 mt -93.33 136.98 33.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.306 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.46 158.01 43.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -156.26 141.87 17.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.279 -1.782 . . . . 0.0 110.572 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.895 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -81.28 132.44 35.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.076 0.465 . . . . 0.0 111.079 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.6 mp -64.42 -43.27 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.861 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.4 m -59.72 -41.13 90.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.252 0.548 . . . . 0.0 110.626 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.0 t -68.85 -41.24 82.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.004 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.06 -42.01 69.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -26.44 63.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 115.0 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.987 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.18 29.11 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -110.56 166.56 10.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -63.47 -24.88 68.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.016 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 65' ' ' VAL . 8.1 tp -133.73 153.41 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.314 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.693 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -112.67 -74.43 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.4 ttpt -135.03 132.74 38.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.5 t -132.31 139.4 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 121.339 0.59 . . . . 0.0 112.329 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -100.74 139.24 36.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.975 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 129.58 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -118.99 145.29 45.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.387 -178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -165.76 35.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.905 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.55 ' HG3' HD12 ' A' ' 78' ' ' LEU . 7.4 mtp-105 -90.24 35.5 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.706 0.289 . . . . 0.0 111.581 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 4.2 t-20 -116.93 140.52 27.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.553 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 57.4 Cg_endo -72.2 -13.62 28.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.067 1.845 . . . . 0.0 111.034 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.75 -44.23 15.85 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.84 136.76 7.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.418 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -56.58 -18.81 13.12 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.86 124.78 34.06 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.178 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.55 120.27 41.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.709 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HG3' ' A' ' 70' ' ' ARG . 5.9 mt -87.67 -166.66 1.64 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.44 13.08 63.04 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.828 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.49 76.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 111.55 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 84' ' ' LEU . 3.3 mp -100.73 127.06 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -54.68 -29.1 51.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.395 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.41 -45.57 38.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.207 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 81' ' ' ILE . 39.2 mt -72.71 152.18 41.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.0 p -95.62 165.58 12.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.686 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.9 -54.74 3.34 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -119.37 83.02 1.97 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -59.82 -46.31 89.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.563 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -145.41 159.27 43.32 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.921 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.87 140.64 44.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.335 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 65' ' ' VAL . 88.0 mt -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 O-C-N 122.388 -0.195 . . . . 0.0 111.095 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.691 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -119.0 141.99 48.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.179 0.514 . . . . 0.0 111.776 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 ' CG1' ' A' ' 33' ' ' VAL . 1.6 tp -125.28 123.63 39.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.361 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.61 -133.85 2.22 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.59 -69.76 0.15 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.712 0.292 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -157.08 -47.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.67 35.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.401 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -128.59 168.54 15.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.76 0.314 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -112.05 136.63 51.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mp -119.14 145.06 46.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.344 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.97 124.51 52.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.0 t30 -116.69 132.14 56.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 0.0 111.848 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.745 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.6 p30 -92.46 132.34 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.067 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -140.25 38.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.11 160.95 14.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 111.799 -179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.592 HG22 ' HB2' ' B' ' 171' ' ' ALA . 86.1 m -69.16 -38.6 78.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.689 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -98.3 -20.05 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.44 161.18 11.09 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.201 -1.0 . . . . 0.0 113.759 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.7 m -117.54 137.98 52.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.192 0.597 . . . . 0.0 109.594 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.889 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.78 148.34 36.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.57 18.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.126 177.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 44.43 43.23 6.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.53 -9.82 72.03 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.474 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.53 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.036 0.446 . . . . 0.0 110.757 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.889 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.7 tptm -74.78 128.16 34.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.263 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.745 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.6 m -99.92 165.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.312 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 24.9 tt0 -69.97 129.19 38.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.0 tttm -53.99 163.11 0.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 36.01 34.89 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.789 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.1 p -112.0 145.03 40.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.368 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.691 ' OD1' HD11 ' A' ' 92' ' ' LEU . 17.4 m-80 -98.45 133.57 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.937 0.399 . . . . 0.0 111.392 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -129.54 152.14 49.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.561 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.3 tt -72.57 127.96 34.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 123' ' ' LEU . 58.7 tp -57.24 156.12 7.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.467 0.651 . . . . 0.0 111.817 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.66 153.0 42.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.019 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.547 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.56 122.39 20.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.904 0.383 . . . . 0.0 110.448 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.69 24.9 49.86 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.194 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.511 ' HB3' HD13 ' A' ' 145' ' ' ILE . 12.5 t70 -54.85 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 111.078 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 27.0 tt0 -145.17 135.55 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CD1' HD11 ' A' ' 145' ' ' ILE . 1.9 mt -113.32 128.09 70.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.878 0.37 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.33 140.71 37.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.066 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.4 m -140.52 158.56 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.1 44.1 10.13 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.031 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.8 t -83.48 140.4 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.736 0.779 . . . . 0.0 112.519 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.58 -40.26 0.87 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.48 123.52 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.019 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -50.42 -29.39 10.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.43 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 t -93.57 6.47 48.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -126.39 25.99 6.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.662 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.85 139.34 28.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.968 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.05 134.27 53.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.604 ' C ' HD22 ' A' ' 143' ' ' LEU . 45.7 t -112.66 150.39 31.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.685 0.755 . . . . 0.0 112.682 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.1 mm? -136.21 147.47 47.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.592 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.56 135.48 59.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.708 HG22 ' SG ' ' A' ' 34' ' ' CYS . 1.5 mp -105.56 121.21 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.535 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.412 ' C ' ' HG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -104.85 129.38 53.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.628 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -91.47 134.22 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.277 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -80.61 121.32 25.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.795 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.65 -38.95 89.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.966 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -43.61 87.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.608 ' CZ ' HD21 ' A' ' 155' ' ' LEU . 31.8 t80 -59.07 -44.12 91.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -61.09 -34.02 74.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -47.1 75.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -68.12 -42.71 79.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.608 HD21 ' CZ ' ' A' ' 151' ' ' PHE . 3.6 mm? -63.38 -35.89 81.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.59 -44.23 93.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 7.0 mt-30 -84.99 -29.04 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.53 -91.11 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.65 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 9.8 mtpp -63.58 160.32 16.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.74 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.72 175.24 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 34.02 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.48 110.1 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.89 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 136.46 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.14 179.44 6.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.475 HG13 ' O ' ' B' ' 168' ' ' VAL . 12.2 p -62.9 121.73 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 157.47 13.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -163.62 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.02 163.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.466 ' O ' HG22 ' B' ' 174' ' ' THR . . . -153.72 154.46 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.466 HG22 ' O ' ' B' ' 173' ' ' ALA . 15.3 t 44.87 33.75 1.06 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.348 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.42 76.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.84 146.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.862 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.837 0.351 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.19 -62.72 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -32.21 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt85 -68.42 -35.9 78.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.36 -41.39 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -60.81 -31.92 71.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.98 -35.44 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -44.16 83.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.485 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -67.15 -23.81 65.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.74 -47.5 79.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.265 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t -57.88 -35.28 70.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.993 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.53 137.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.43 136.56 35.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.22 104.78 11.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -82.04 138.41 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.646 0.736 . . . . 0.0 111.79 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.68 26.49 56.37 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.02 -43.38 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.32 33.95 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.3 mm -73.15 132.88 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 113.848 -1.524 . . . . 0.0 112.465 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.984 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -90.67 -60.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.909 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -149.61 145.73 26.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.193 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 12.3 ttm180 -113.8 138.18 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.206 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -100.66 122.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.742 HD12 ' CD1' ' A' ' 146' ' ' PHE . 20.1 mt -122.64 117.28 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.388 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.7 ' HA ' HD13 ' A' ' 143' ' ' LEU . 19.8 t -80.47 111.66 17.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 110.673 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 129' ' ' GLU . 3.0 t -81.32 -25.49 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.411 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.547 HG21 ' H ' ' A' ' 142' ' ' SER . 7.0 p -80.01 -2.05 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.564 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.66 0.24 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.815 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -147.27 -42.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.982 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -113.52 141.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.879 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.7 Cg_endo -74.11 132.41 16.64 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.143 1.895 . . . . 0.0 111.771 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -50.04 138.37 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.651 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.14 164.14 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.293 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.54 119.83 34.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.053 0.454 . . . . 0.0 111.733 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.628 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.4 mt -96.02 135.79 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.27 158.23 43.87 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.08 141.81 23.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.567 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.0 OUTLIER -78.55 133.97 37.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.985 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.5 mp -64.19 -39.4 85.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.522 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 m -56.56 -40.85 75.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.825 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.49 -38.35 80.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' HG3' ' A' ' 63' ' ' LYS . 43.4 t -65.3 -45.01 94.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.155 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -32.64 69.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.045 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.21 -45.3 18.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -74.58 114.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 31.38 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -80.2 -62.31 1.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.55 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.995 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 tp -137.38 152.87 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.023 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.771 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.9 mmtm -98.33 -66.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.969 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -142.32 137.53 30.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.198 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.9 t -128.74 139.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.174 0.512 . . . . 0.0 112.057 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.3 m-90 -104.41 138.67 40.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.208 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.08 127.25 55.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.052 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' HE2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -111.27 145.45 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.91 -177.84 41.45 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.102 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.862 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.32 1.8 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.823 0.312 . . . . 0.0 111.354 179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.3 t-20 -84.85 136.46 38.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.85 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.9 Cg_exo -68.1 -7.62 20.38 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.89 -45.75 13.83 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.962 0.887 . . . . 0.0 108.991 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.54 137.67 3.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.765 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.43 -19.12 13.53 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.721 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -129.92 124.31 32.83 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.728 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.19 125.11 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.982 HD22 HD13 ' A' ' 43' ' ' ILE . 13.7 mt -102.79 -68.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.26 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.36 -99.74 0.12 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.723 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 7.0 p30 -178.89 53.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.048 0.451 . . . . 0.0 110.974 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 84' ' ' LEU . 33.6 mt -84.0 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.076 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 p -65.22 -39.99 93.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.804 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -49.08 77.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.551 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG23 ' A' ' 132' ' ' VAL . 2.4 mp -72.88 153.01 41.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 111.052 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 86' ' ' ASN . 60.7 p -99.37 147.11 25.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.396 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -22.05 -55.27 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.251 0.548 . . . . 0.0 110.936 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.601 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.6 mttp -120.12 83.63 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.59 -47.03 87.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.591 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.494 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.8 p90 -144.53 159.44 42.77 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.89 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.745 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.9 tt0 -135.7 139.96 44.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.391 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 55.4 mt -115.28 132.33 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.168 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.686 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -124.01 138.2 54.49 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.097 0.475 . . . . 0.0 111.661 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD22 ' CG1' ' A' ' 33' ' ' VAL . 2.0 tp -125.27 122.9 38.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.366 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.57 -131.62 2.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.657 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.31 -76.47 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.762 0.315 . . . . 0.0 110.763 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -146.1 -46.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.681 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.79 173.05 43.36 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.408 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 61.38 -179.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.99 160.13 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.925 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 122' ' ' GLN . 10.4 mt -133.17 141.0 47.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.377 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.91 123.97 51.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.8 t30 -115.54 115.64 26.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.674 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p30 -77.6 136.9 38.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 87' ' ' LYS . 7.9 pt -146.49 40.68 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -98.73 162.87 12.88 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.091 0.472 . . . . 0.0 111.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.4 m -69.05 -38.55 79.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.475 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -20.04 17.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.566 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.66 164.1 12.16 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.6 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.5 m -117.59 137.99 52.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.037 -0.581 . . . . 0.0 109.517 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.6 148.6 34.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.29 18.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.119 177.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 23.6 m-20 44.23 42.72 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.378 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.43 -8.64 78.28 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.542 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -105.62 118.46 36.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.105 0.452 . . . . 0.0 110.844 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -74.01 125.09 27.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.166 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.744 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -97.41 166.85 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 18.1 tt0 -69.92 126.96 31.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.497 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 10.2 tttm -53.78 163.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.5 36.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.785 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.92 144.9 40.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.686 ' ND2' HD11 ' A' ' 92' ' ' LEU . 28.4 m120 -93.89 128.06 39.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.64 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.783 ' O ' HD23 ' A' ' 100' ' ' LEU . 51.9 mm-40 -129.01 147.49 50.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.966 0.412 . . . . 0.0 110.579 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.83 123.62 23.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.236 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -54.62 162.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.665 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.64 153.43 42.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.728 179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.559 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.25 115.46 10.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 110.187 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.51 29.26 69.02 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.938 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.9 t70 -60.36 177.65 0.26 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.931 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.1 135.45 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.039 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 145' ' ' ILE . 14.4 mt -113.6 126.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.387 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.661 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.22 137.39 42.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.817 HG23 HD21 ' A' ' 84' ' ' LEU . 27.7 m -140.23 158.48 25.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.07 31.78 22.26 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.84 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.13 140.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.56 0.695 . . . . 0.0 112.381 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.5 -37.66 0.9 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 138' ' ' SER . 53.5 t -126.42 124.51 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 114.579 -0.811 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -33.74 21.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 111.583 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.509 ' H ' HG12 ' A' ' 136' ' ' VAL . 50.3 m -93.46 6.38 48.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.4 t0 -126.3 29.81 5.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.661 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.5 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.661 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.657 HD22 HD21 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -118.62 134.27 55.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.035 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.576 ' C ' HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -110.08 136.23 49.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.7 mm? -131.32 145.83 52.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.615 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.931 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.0 t -112.99 140.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 111.224 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 130' ' ' ILE . 14.4 mt -106.08 121.1 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.898 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.1 m-85 -107.26 109.43 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.635 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.665 HD11 ' O ' ' A' ' 125' ' ' SER . 4.0 mp -84.91 123.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.31 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.73 126.04 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.06 -26.95 60.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.0 -43.43 81.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 110.427 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.49 -44.13 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -36.55 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -69.04 -38.66 79.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -63.66 -45.48 89.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -35.98 81.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.69 -35.52 79.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -91.59 -37.07 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.57 -172.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.693 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.38 149.98 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.832 0.349 . . . . 0.0 110.93 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 162' ' ' ARG . 12.5 p -67.09 138.2 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.7 -28.52 11.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.024 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.413 ' HG2' HG22 ' A' ' 160' ' ' VAL . 4.3 mmt85 61.4 39.47 15.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -94.45 119.61 42.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.04 -179.1 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.797 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.02 169.19 18.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.19 153.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.466 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . 0.433 ' N ' HG23 ' B' ' 169' ' ' TPO . 22.5 mt-10 -96.19 178.42 5.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.06 -178.7 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.88 172.46 11.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.87 137.55 5.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.5 t -165.71 132.25 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 27.3 t80 60.67 102.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.61 147.39 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.836 -179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.9 m -133.21 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -69.42 -47.05 65.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -39.17 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.05 -37.09 85.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.7 -43.07 99.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 12.5 mm -68.52 -35.17 69.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.07 -36.94 71.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.441 . . . . 0.0 110.484 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.29 -23.81 65.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.714 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.65 -47.5 79.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.253 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -72.31 -32.57 66.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.32 99.94 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -76.72 120.99 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.96 129.4 36.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.95 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.694 0.759 . . . . 0.0 111.751 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.71 97.99 0.11 Allowed Glycine 0 C--N 1.313 -0.717 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.437 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.13 -34.32 77.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 0.0 110.963 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 174.44 40.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.65 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -73.39 134.97 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.617 -1.628 . . . . 0.0 112.49 -177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.01 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.46 -59.72 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.751 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 p -151.0 163.82 37.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.15 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -121.96 138.2 54.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 111.382 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.2 m -105.21 122.72 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.82 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -123.06 123.08 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.641 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' HA ' HD13 ' A' ' 143' ' ' LEU . 9.2 t -84.25 110.23 18.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.339 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.13 -21.15 40.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.2 p -80.0 -2.23 43.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.605 0.241 . . . . 0.0 111.495 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.32 61.23 6.82 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.909 -0.663 . . . . 0.0 113.175 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -134.3 -33.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.707 0.289 . . . . 0.0 111.251 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.569 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.4 mt -126.84 141.23 39.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.819 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 51.9 Cg_endo -71.48 143.34 42.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.15 1.9 . . . . 0.0 112.164 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 37' ' ' ILE . 39.3 mt -56.43 147.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.694 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.87 164.24 30.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.6 119.94 32.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 0.0 111.959 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 10.9 mp -87.83 130.94 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.01 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.06 156.3 48.57 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.282 1.039 . . . . 0.0 113.753 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.28 144.09 26.27 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.927 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.0 m-20 -78.32 129.14 34.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 111.139 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 154' ' ' CYS . 62.3 mt -64.39 -45.21 96.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.203 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -56.84 -40.22 75.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.261 0.553 . . . . 0.0 110.695 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 7.9 mm-40 -68.41 -36.99 79.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.9 t -71.1 -41.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.096 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.1 -31.08 67.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -78.19 -49.61 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -62.89 122.87 17.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.65 41.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.69 169.89 8.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.749 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -48.33 81.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 63' ' ' LYS . 33.0 mm -125.41 159.08 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.72 ' HE3' HG13 ' A' ' 55' ' ' VAL . 2.7 mppt? -126.38 -46.41 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.27 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.3 ttpt -139.26 128.46 23.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.894 0.378 . . . . 0.0 111.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG13 ' C ' ' A' ' 91' ' ' ILE . 11.6 t -128.91 139.3 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.462 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.4 m-90 -100.24 139.85 35.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.016 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.974 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.06 127.1 55.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.838 178.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.9 m-85 -110.73 145.61 37.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.17 -177.18 39.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.889 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' HG3' HD11 ' A' ' 78' ' ' LEU . 3.9 mtm105 -78.38 -1.34 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.86 135.5 39.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.693 0.283 . . . . 0.0 111.029 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.74 -7.59 20.99 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.772 2.315 . . . . 0.0 111.943 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.97 -43.7 16.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.968 0.889 . . . . 0.0 108.805 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -44.01 137.08 3.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.752 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.38 -18.9 12.43 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.99 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 46.7 t80 -129.64 125.11 35.32 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.73 123.52 45.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.8 pp -123.84 177.47 5.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.89 139.09 48.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.56 93.85 1.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 0.0 111.016 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.841 HD12 HD11 ' A' ' 84' ' ' LEU . 20.9 mt -109.81 128.84 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.53 -31.01 61.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -70.92 -46.42 62.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.841 HD11 HD12 ' A' ' 81' ' ' ILE . 22.7 mt -72.62 150.87 42.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.79 164.74 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.65 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.63 -53.53 3.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.492 0.663 . . . . 0.0 109.701 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.572 ' HB3' HG22 ' A' ' 67' ' ' THR . 11.8 mtmt -120.55 84.52 2.24 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 9.6 t60 -61.87 -45.63 92.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.875 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 11.0 p90 -146.0 163.05 36.42 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.28 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.974 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.65 137.02 41.43 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.162 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.871 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.6 mt -112.06 124.32 68.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.472 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.731 HD12 ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.52 144.33 31.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.052 0.453 . . . . 0.0 111.861 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.659 HD13 ' CG1' ' A' ' 33' ' ' VAL . 21.8 tp -125.35 122.97 38.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.371 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 160.87 -135.21 3.88 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.572 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 61.98 34.01 16.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.945 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.96 30.51 20.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.96 165.74 11.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 62.72 166.62 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.814 HD21 HG12 ' A' ' 33' ' ' VAL . 1.2 mp -110.64 159.98 17.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 92' ' ' LEU . 4.8 mp -129.08 144.43 51.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.442 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.76 120.16 40.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.019 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.69 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.4 t30 -113.85 115.55 27.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 111.485 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.717 ' OD2' HG23 ' A' ' 116' ' ' VAL . 22.6 p30 -79.94 136.71 36.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.293 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 87' ' ' LYS . 13.7 pt -144.61 39.84 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.608 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.14 157.89 16.05 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.962 0.411 . . . . 0.0 111.615 -179.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.666 HG22 ' HB2' ' B' ' 171' ' ' ALA . 88.1 m -68.89 -35.37 76.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.358 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.4 -19.82 17.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.13 162.93 12.0 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.554 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.66 137.97 52.29 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.124 0.57 . . . . 0.0 109.572 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -113.89 148.52 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -124.23 113.49 18.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.698 177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 46.22 36.67 3.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.029 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.02 77.6 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.482 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.06 118.56 36.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.064 0.432 . . . . 0.0 110.807 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 24.1 tptt -74.09 131.12 41.01 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.065 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.717 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -106.0 168.15 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.442 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.4 OUTLIER -70.04 127.4 32.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.376 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 43.9 tttt -54.39 164.2 0.74 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.192 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.51 36.76 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.722 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.8 p -111.85 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.634 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.2 m120 -90.43 128.47 36.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.716 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 51.5 mm-40 -129.44 148.07 51.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.1 tp -73.02 120.82 19.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 145' ' ' ILE . 63.4 tp -60.12 157.56 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.46 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -124.43 153.13 42.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.328 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.517 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.69 124.76 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.266 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.54 19.19 53.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.243 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.603 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.0 t70 -57.27 173.45 0.24 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.826 0.345 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.69 ' HG3' HG22 ' A' ' 144' ' ' VAL . 12.7 tt0 -145.19 135.64 24.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.301 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 145' ' ' ILE . 1.8 mt -112.07 128.12 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.698 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.49 137.53 42.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.976 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 25.6 m -140.24 158.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.07 26.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.008 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.1 t -70.85 140.42 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 121.772 0.796 . . . . 0.0 112.498 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.87 -42.46 0.63 Allowed Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.063 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 138' ' ' SER . 47.3 t -126.4 134.37 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.293 177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.54 -37.37 39.02 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.465 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.48 6.5 47.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 67.8 m-20 -117.87 23.62 11.56 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.698 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.23 29.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.393 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD21 ' SG ' ' A' ' 38' ' ' CYS . 2.2 tt -124.34 134.32 53.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.498 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.4 t -113.01 150.45 31.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.687 0.756 . . . . 0.0 112.446 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.1 mm? -136.08 140.16 43.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.549 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 129' ' ' GLU . 16.9 t -110.99 139.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.814 HD11 HD11 ' A' ' 130' ' ' ILE . 24.1 mt -106.26 121.01 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.01 103.85 12.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.817 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.97 125.18 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.27 133.35 38.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.36 -26.73 65.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -44.43 89.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.076 0.465 . . . . 0.0 110.704 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -59.56 -44.1 93.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.978 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -36.23 83.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -38.52 90.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.7 t -65.85 -46.13 79.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -35.95 82.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.775 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.84 -40.29 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.708 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.9 mt-30 -87.33 -30.92 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.33 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.602 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 157' ' ' GLN . 36.2 mttm -64.27 121.66 14.8 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.8 m -103.01 134.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -146.02 98.38 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -104.86 165.68 10.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.89 121.26 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.921 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 63.27 142.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -137.35 -54.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.423 HG13 ' O ' ' B' ' 168' ' ' VAL . 11.1 p -69.9 124.36 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.029 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 156.29 26.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.666 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -145.99 -59.22 0.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.44 176.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.26 101.76 4.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.111 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.3 p -117.01 104.25 11.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.15 47.18 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.7 110.57 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.121 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.5 p -60.41 -41.92 94.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.21 -44.83 82.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.813 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -64.47 -36.55 84.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.847 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -43.1 95.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -33.06 70.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 22.5 mm -70.93 -35.82 61.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -36.91 77.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 110.764 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -25.31 66.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.2 m-85 -56.87 -48.12 78.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.268 0.556 . . . . 0.0 111.067 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.6 t -62.66 -31.03 71.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.932 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.34 112.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -77.19 147.42 36.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.29 115.44 13.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.28 138.3 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-O 121.722 0.772 . . . . 0.0 111.634 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.7 73.22 1.28 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.353 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.9 -39.79 63.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.118 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.7 m-20 177.26 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 8.2 mm -71.26 143.22 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.587 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -108.56 -49.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.997 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -154.29 165.87 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.532 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 68' ' ' PHE . 21.8 t -106.99 122.74 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.778 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG12 ' A' ' 45' ' ' ILE . 18.6 mt -130.76 118.01 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.8 t -82.25 118.69 23.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.167 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -83.98 -25.16 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.81 -2.12 41.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.14 72.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.725 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -142.41 -44.66 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mt -112.63 140.82 24.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.701 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.3 Cg_endo -72.92 144.43 38.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.223 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -56.1 142.94 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.506 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -137.26 164.14 29.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.86 119.59 35.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.097 0.475 . . . . 0.0 111.539 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.767 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 3.4 mp -88.65 126.72 35.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.634 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.48 156.79 47.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.161 0.982 . . . . 0.0 113.208 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -129.4 160.81 31.94 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.142 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 4.9 m-20 -93.45 104.15 16.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.093 0.473 . . . . 0.0 110.799 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.619 HD13 ' SG ' ' A' ' 154' ' ' CYS . 66.9 mt -64.48 -44.3 96.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.07 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 m -58.75 -41.07 85.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.271 0.557 . . . . 0.0 110.766 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 8.1 mm100 -68.44 -39.72 81.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.656 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ASP . 30.7 t -72.66 -38.08 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.029 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tp -58.7 -32.35 69.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.66 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -69.11 -53.04 22.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.787 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -69.78 135.56 49.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -73.72 -42.84 60.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.029 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -159.65 112.36 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.716 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.2 m -176.75 39.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.75 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 61' ' ' SER . 2.2 tt 52.71 159.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.771 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.784 ' CB ' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -85.51 -80.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.796 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.5 tmmt? -155.35 156.53 35.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.9 t -130.7 138.99 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.444 0.64 . . . . 0.0 112.462 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 14.4 m-90 -106.42 139.65 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.221 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.7 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.1 125.51 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.767 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.46 145.84 36.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.932 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.86 -175.29 40.04 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -78.65 -1.34 33.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 3.1 t-20 -84.82 134.6 41.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.656 0.265 . . . . 0.0 110.937 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.4 Cg_exo -68.69 -7.8 21.52 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.293 . . . . 0.0 111.706 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.92 -43.93 15.93 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.956 0.884 . . . . 0.0 108.833 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.06 137.47 1.85 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.793 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -56.29 -19.13 12.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.896 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 30.2 t80 -130.04 124.51 33.06 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.725 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -99.49 107.9 20.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.532 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HA2' ' A' ' 69' ' ' GLY . 8.2 mt -81.67 -75.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.454 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.65 -126.82 0.96 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.634 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.08 58.54 1.59 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 111.666 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.23 114.24 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.865 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 p -54.86 -35.89 64.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.273 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -65.44 -27.81 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 ' CE1' ' A' ' 88' ' ' HIS . 53.5 mt -91.55 152.22 20.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.5 p -94.64 166.21 12.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.35 -53.93 4.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.403 0.621 . . . . 0.0 109.727 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.7 ptpp? -118.21 82.64 1.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -60.63 -46.83 88.83 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.776 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.0 p90 -146.1 159.9 42.64 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.805 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.7 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.8 tt0 -136.14 137.75 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' HG13 ' A' ' 65' ' ' VAL . 80.6 mt -112.5 129.3 68.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.962 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 102' ' ' ASN . 1.2 pp -120.17 131.51 55.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' CB ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -111.57 127.79 55.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.181 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.05 -133.93 1.71 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.697 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 62.92 -80.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.06 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -177.57 65.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.95 -26.3 21.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -75.3 -177.18 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.997 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -134.36 156.09 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.714 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.3 mt -133.2 143.6 49.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.578 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 91' ' ' ILE . 30.4 mt -112.66 124.03 51.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.926 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.586 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -117.17 115.62 25.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.691 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.798 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.5 p30 -78.2 143.08 37.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 67' ' ' THR . 18.4 pt -150.48 38.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.615 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.26 152.22 20.16 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 120.899 0.38 . . . . 0.0 111.648 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.712 HG22 ' HB2' ' B' ' 171' ' ' ALA . 94.9 m -68.79 -32.12 71.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.783 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -95.49 -19.69 19.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 114.56 157.54 11.87 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.456 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.2 m -117.46 137.89 52.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.82 148.31 36.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.04 113.45 18.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.336 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 43.22 5.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.11 -11.78 66.28 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.488 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.59 118.51 36.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.01 0.405 . . . . 0.0 110.637 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.8 tptm -72.87 122.48 21.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.335 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.798 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -92.88 164.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.148 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.93 126.8 30.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.629 179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 28.1 tttt -53.6 161.43 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.672 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.03 34.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.403 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.39 144.78 41.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.064 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.912 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.7 m120 -88.03 131.28 34.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.825 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.741 ' O ' HD23 ' A' ' 100' ' ' LEU . 35.5 mm-40 -129.53 147.22 51.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.86 124.91 26.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.191 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.832 HD23 ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -55.47 159.67 2.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.685 0.755 . . . . 0.0 112.368 -179.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -124.97 153.06 43.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.849 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -71.34 116.31 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.94 68.75 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.644 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t0 -52.39 172.06 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.987 0.422 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 12.3 tt0 -145.14 135.48 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 109' ' ' THR . 14.8 mt -116.44 126.88 74.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.948 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.645 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.73 139.48 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.1 m -140.33 158.4 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.64 32.5 21.68 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.5 t -73.66 140.49 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.679 0.752 . . . . 0.0 112.379 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.89 -41.04 0.74 Allowed Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.025 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.44 128.64 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -50.47 -33.5 21.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.646 0.26 . . . . 0.0 111.656 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.45 48.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.37 25.64 8.24 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.645 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.18 139.13 29.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.146 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.39 134.21 53.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.354 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.521 ' H ' HG21 ' A' ' 40' ' ' THR . 48.4 t -111.08 150.34 29.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.741 . . . . 0.0 112.305 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 38' ' ' CYS . 61.8 mt -135.78 149.93 49.3 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.8 t -119.84 138.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.9 mm -106.15 121.48 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.064 0.459 . . . . 0.0 111.082 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.18 104.07 13.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.853 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.832 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.9 mt -85.18 127.72 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -85.84 130.98 34.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -72.53 -20.53 61.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.21 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -58.53 -44.66 89.65 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.673 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.6 t80 -59.03 -43.95 91.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -62.2 -38.99 91.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -42.4 92.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.94 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.619 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.7 t -68.09 -46.22 71.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -37.68 77.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.48 -42.38 95.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 14.8 tt0 -84.1 -33.59 24.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.766 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.71 -90.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.656 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 2.9 tttp -68.21 160.67 28.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -82.36 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -67.18 -29.15 68.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 63.43 87.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.77 122.07 38.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.7 ptt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.885 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.765 0.317 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.507 HD12 ' N ' ' B' ' 166' ' ' LEU . 6.9 mp -87.61 164.23 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.25 80.56 7.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.63 149.91 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -73.29 138.13 45.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -140.74 128.55 21.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.37 -172.59 2.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -169.96 87.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.0 t -151.05 119.33 6.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 38.3 t80 60.47 106.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.79 123.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.054 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.89 179.9 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -116.52 -50.61 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -70.62 -39.43 73.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -59.06 -43.84 91.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.69 -35.3 80.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.89 -40.19 87.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.874 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -71.62 -34.99 54.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.193 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -57.11 -36.7 70.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.365 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.27 -23.97 65.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.691 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.68 -47.55 79.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.154 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.07 -40.65 23.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -98.21 72.22 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -83.05 121.01 26.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -78.18 139.65 38.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.11 138.21 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.61 0.719 . . . . 0.0 111.75 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.49 35.33 2.28 Favored Glycine 0 C--N 1.312 -0.777 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.366 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -41.55 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.981 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.2 m-20 177.77 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.625 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.9 mm -71.08 143.37 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.136 -176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -105.24 -49.01 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.624 -178.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -159.6 163.45 34.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.457 179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -129.22 135.47 48.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 0.0 111.51 -179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.0 t -104.57 122.58 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.528 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.745 HG23 HG12 ' A' ' 45' ' ' ILE . 16.9 mt -126.14 118.56 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.735 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 141' ' ' LEU . 53.8 t -82.99 112.23 19.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.443 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 3.0 p -80.93 -18.84 45.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 142' ' ' SER . 80.7 p -79.96 -2.41 43.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 111.517 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 62.87 72.19 0.7 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.462 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 9.5 mt-30 -147.18 -46.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.768 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.606 HD12 HD21 ' A' ' 143' ' ' LEU . 3.5 mt -105.33 140.13 20.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.3 Cg_endo -74.48 137.13 22.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.163 1.909 . . . . 0.0 111.925 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.745 HG12 HG23 ' A' ' 37' ' ' ILE . 34.1 mt -54.43 141.31 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.701 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 1.6 ttt180 -132.75 164.12 27.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.239 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -120.21 119.78 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.146 0.498 . . . . 0.0 111.709 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.673 HD22 ' CD1' ' A' ' 66' ' ' TRP . 12.4 mt -91.58 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.349 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.04 156.88 44.18 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.39 1.09 . . . . 0.0 113.924 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -151.95 141.75 21.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.384 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -84.7 133.52 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.13 0.49 . . . . 0.0 111.184 -179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.1 mp -64.11 -41.49 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.812 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -37.42 69.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.913 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.41 -37.0 79.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.052 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.646 HG22 ' HG2' ' A' ' 63' ' ' LYS . 46.3 t -72.98 -50.06 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.265 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 52' ' ' ILE . 86.2 mt -60.58 -29.9 69.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.94 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -81.61 -54.04 5.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -63.71 128.62 36.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.21 32.64 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -69.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -175.32 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 65' ' ' VAL . 8.7 tp -122.78 151.88 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -112.26 -69.98 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.1 ttpt -141.28 131.58 25.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.7 t -126.22 138.78 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.103 0.477 . . . . 0.0 111.725 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.673 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-90 -100.7 134.57 43.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.371 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.36 126.36 55.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -116.45 145.6 43.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.239 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.16 -170.32 40.1 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.519 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -78.22 -3.04 40.69 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.717 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.6 t-20 -84.94 133.24 43.68 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.724 0.297 . . . . 0.0 111.315 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.85 -9.99 27.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.563 2.175 . . . . 0.0 111.721 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.717 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.71 -43.05 17.3 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.798 0.808 . . . . 0.0 108.851 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 139.78 0.62 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 113.795 -1.548 . . . . 0.0 110.562 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -56.26 -19.42 13.97 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.664 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.1 t80 -130.44 132.74 45.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.945 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -105.24 107.9 19.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.465 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 HD22 HD13 ' A' ' 43' ' ' ILE . 40.0 mt -71.65 -72.06 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.385 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.94 -107.88 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.629 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.57 69.38 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 111.255 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.0 mm -110.4 114.13 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.21 -27.56 55.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.292 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -74.39 -20.41 60.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.347 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 HG23 ' A' ' 132' ' ' VAL . 23.2 mt -99.18 151.59 20.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.706 0.289 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 p -97.08 166.53 11.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.727 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.65 -52.94 6.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.756 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.0 mttt -119.17 82.21 1.83 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -61.1 -46.8 89.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.692 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -147.84 160.53 42.67 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.983 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 tt0 -135.53 149.42 49.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.039 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 65' ' ' VAL . 82.1 mt -125.53 128.77 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.102 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 121' ' ' ASN . 0.4 OUTLIER -112.56 138.02 49.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 111.612 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.1 tt -125.08 122.96 38.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.438 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.39 -125.77 1.44 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.597 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.87 -71.06 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.796 0.332 . . . . 0.0 110.952 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -151.5 -63.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -159.21 27.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -131.88 -177.28 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.757 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.832 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.08 153.32 36.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.914 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.3 mt -133.14 142.62 48.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.514 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 pp -112.94 127.62 56.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.182 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.3 t30 -117.68 115.85 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -76.7 139.08 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.64 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -148.05 37.82 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.613 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.83 153.22 18.44 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 120.926 0.394 . . . . 0.0 111.742 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.75 -31.79 71.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.915 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -96.24 -19.87 18.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.04 158.73 11.63 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.546 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.8 m -117.33 137.8 52.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.871 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.06 148.51 38.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.48 18.37 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.306 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 44.06 43.14 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.21 -11.55 67.19 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.58 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -104.6 118.62 37.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.152 0.501 . . . . 0.0 110.685 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -73.05 124.84 26.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -94.53 166.2 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.247 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 125.96 28.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.8 tttp -52.98 163.31 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.698 0.285 . . . . 0.0 110.375 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 33.41 36.65 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.811 -179.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 p -111.98 145.16 40.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.914 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.6 m120 -92.19 128.51 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.86 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 100' ' ' LEU . 53.7 mm-40 -128.96 147.69 50.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.435 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.61 121.33 19.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.358 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 147' ' ' ILE . 63.6 tp -52.4 157.04 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.425 0.631 . . . . 0.0 111.737 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -124.48 153.35 42.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.206 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.627 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.03 121.06 17.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 109.994 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.62 22.37 59.26 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.859 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -49.93 170.23 0.03 OUTLIER 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 14.3 tt0 -145.05 135.43 24.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 145' ' ' ILE . 18.1 mt -116.63 127.22 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.7 m -104.58 139.45 39.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.598 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.38 158.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.33 28.13 28.52 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.184 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.3 t -69.78 140.45 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.621 0.724 . . . . 0.0 112.332 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -41.74 0.61 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.092 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.31 133.23 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.905 -0.648 . . . . 0.0 109.32 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.59 -36.35 34.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.687 0.28 . . . . 0.0 111.734 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.6 6.38 48.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.66 26.03 9.38 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.8 mt -106.12 139.4 27.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.171 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD13 ' N ' ' A' ' 142' ' ' SER . 0.7 OUTLIER -124.08 133.77 53.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.179 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.773 ' N ' HD13 ' A' ' 141' ' ' LEU . 47.8 t -110.42 150.22 29.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.729 . . . . 0.0 112.233 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 43' ' ' ILE . 76.4 mt -135.91 143.81 45.17 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 39' ' ' THR . 21.2 t -113.88 138.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.689 0.28 . . . . 0.0 110.775 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.639 HG21 HD11 ' A' ' 124' ' ' LEU . 19.9 mt -106.22 121.24 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 120.985 0.421 . . . . 0.0 111.358 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.96 122.59 47.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.26 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.644 HG13 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -92.17 134.12 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.524 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.39 109.13 17.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.673 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -57.67 -28.64 63.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.029 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.96 92.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.98 0.419 . . . . 0.0 110.681 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' CE2' HD11 ' A' ' 93' ' ' LEU . 36.9 t80 -58.34 -44.13 88.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.983 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -63.47 -37.76 88.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -64.74 -42.33 95.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.08 -45.93 72.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.523 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -68.19 -35.83 78.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.1 -40.52 96.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -86.19 -31.85 21.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.711 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 23.4 mmtt -117.24 117.72 30.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.28 129.68 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.33 173.52 11.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -119.13 -56.0 2.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.82 128.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.901 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.86 0.362 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 tp 62.34 118.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.87 38.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.9 p -74.65 151.79 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 143.16 57.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -150.92 121.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.192 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.59 171.16 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -162.8 153.99 17.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.3 p -126.33 114.78 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.801 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.08 47.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.51 110.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.859 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.13 -53.62 35.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -59.84 -43.17 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -35.87 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.89 -43.48 81.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 mt -58.12 -32.97 68.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.14 -35.36 47.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -35.92 70.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.389 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -67.1 -23.95 65.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.83 -47.4 80.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.249 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -72.53 -33.11 66.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.71 91.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.31 138.52 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.9 132.1 48.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.8 mm -82.07 138.43 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 111.714 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.73 105.2 1.0 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.2 -33.9 63.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.968 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-80 177.25 40.16 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.1 mm -71.37 141.41 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 113.584 -1.644 . . . . 0.0 112.516 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.725 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.99 -50.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.709 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' HD22 ' A' ' 48' ' ' LEU . 27.8 p -156.02 165.19 37.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.012 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.531 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.7 138.25 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 111.436 -179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG23 HD13 ' A' ' 48' ' ' LEU . 26.3 t -107.34 122.51 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 19.1 mt -130.29 125.06 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.481 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -91.8 105.03 17.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 t -77.75 -24.65 48.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.597 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 142' ' ' SER . 73.6 p -79.95 -2.61 44.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 111.487 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 74.34 0.52 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.673 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' NE2' ' HG ' ' A' ' 141' ' ' LEU . 5.4 mt-30 -143.23 -39.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.1 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 143' ' ' LEU . 6.7 mt -124.37 141.99 39.04 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.4 Cg_endo -70.85 144.97 49.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.12 1.88 . . . . 0.0 112.267 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 39.4 mt -61.33 147.73 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.558 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 164.34 31.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.279 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.96 119.6 34.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.776 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.1 mp -87.59 135.78 33.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -140.65 156.85 46.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.438 1.113 . . . . 0.0 113.854 -179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -150.72 141.83 23.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.447 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 17.7 m-20 -84.37 135.46 34.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.8 mp -64.07 -42.73 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.79 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 m -56.57 -37.31 70.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.308 0.575 . . . . 0.0 110.603 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 2.3 mm-40 -68.54 -38.56 80.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.416 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG13 ' HG2' ' A' ' 63' ' ' LYS . 55.1 t -72.99 -42.03 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 52' ' ' ILE . 2.7 mp -71.07 -35.89 72.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.849 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.56 -46.34 39.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.38 116.0 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 30.21 3.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.829 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.38 173.04 6.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 t -72.05 -24.94 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.812 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.1 tp -120.64 150.11 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.829 ' HG2' HG13 ' A' ' 55' ' ' VAL . 5.0 mptt -121.41 -70.24 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -138.56 129.83 27.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.381 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.812 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.3 t -132.28 139.12 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 121.208 0.528 . . . . 0.0 111.962 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.776 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.9 m-90 -100.9 139.37 36.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.511 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.37 127.1 55.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.912 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.4 m-85 -108.19 145.62 33.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.762 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.32 178.53 39.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.912 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.1 mtp-105 -75.69 -4.59 41.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.534 0.207 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.8 t30 -84.74 137.62 38.25 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.793 0.33 . . . . 0.0 111.331 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.0 Cg_exo -69.62 -5.74 16.84 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.921 2.414 . . . . 0.0 111.993 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -45.58 14.11 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.091 0.948 . . . . 0.0 108.732 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -45.67 137.51 5.23 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.487 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.41 -18.77 12.17 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 12.0 t80 -129.52 117.11 19.95 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.463 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -85.83 137.74 32.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.938 0.399 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 84' ' ' LEU . 8.8 mp -109.64 176.87 4.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.57 -84.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.265 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -179.13 73.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.864 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -108.04 111.83 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.576 ' O ' HG22 ' B' ' 169' ' ' TPO . 10.7 p -56.45 -37.48 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.144 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -32.13 71.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.864 HD12 HD13 ' A' ' 81' ' ' ILE . 61.6 mt -81.34 152.27 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -93.43 166.73 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.76 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -43.36 -53.8 5.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.374 0.607 . . . . 0.0 109.588 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.41 83.52 2.05 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.7 t60 -59.51 -46.33 89.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.696 -176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.4 p90 -147.27 160.05 42.94 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.742 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.725 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.1 tt0 -135.56 141.92 45.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.912 HD12 ' CE1' ' A' ' 68' ' ' PHE . 6.0 mt -118.65 126.69 75.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.159 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -107.88 150.64 26.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.073 0.463 . . . . 0.0 111.896 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD13 HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.05 123.56 40.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.256 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.11 1.29 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 57.21 -171.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.718 0.294 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.61 46.04 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' CA ' HD22 ' A' ' 155' ' ' LEU . . . 112.13 38.07 1.43 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.467 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.406 ' C ' HD12 ' A' ' 99' ' ' LEU . 58.9 m-80 -146.49 -180.0 7.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.92 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.0 mp -132.18 160.06 37.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD22 ' O ' ' A' ' 99' ' ' LEU . 4.5 mm? -132.29 146.99 52.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.327 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD1' HG12 ' A' ' 91' ' ' ILE . 27.3 tp -112.5 128.22 56.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.103 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -118.97 115.66 24.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 0.0 111.988 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.786 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.89 139.71 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.584 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.6 pt -146.93 38.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.619 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.56 151.33 20.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.914 0.388 . . . . 0.0 111.589 -179.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' B' ' 171' ' ' ALA . 96.2 m -68.7 -31.89 71.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.882 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -96.29 -19.68 19.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.7 156.95 10.77 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.588 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.2 m -117.42 137.86 52.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.887 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.82 148.45 38.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.3 113.41 18.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.199 177.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' N ' HD12 ' A' ' 111' ' ' LEU . 83.6 m-20 44.45 42.88 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.36 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.15 -9.56 74.41 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.592 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -104.89 118.63 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.887 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.1 tptm -74.37 121.57 21.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.0 m -93.68 165.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -70.06 128.0 34.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.444 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 27.4 tttt -53.99 163.5 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.719 0.295 . . . . 0.0 110.285 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 34.02 36.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.823 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -111.85 145.03 40.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.485 HD22 HD21 ' A' ' 92' ' ' LEU . 31.2 m120 -91.9 126.38 36.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.709 ' O ' HD13 ' A' ' 100' ' ' LEU . 54.5 mm-40 -129.16 148.48 51.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.753 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.72 133.42 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.193 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.92 HD13 ' HB2' ' A' ' 99' ' ' LEU . 1.7 pt? -63.67 162.46 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.77 0.795 . . . . 0.0 111.947 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.618 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -125.1 153.35 43.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.833 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.1 mm-40 -71.49 114.33 9.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.959 0.409 . . . . 0.0 110.114 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.94 73.35 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.945 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.6 t70 -59.11 174.29 0.39 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.988 0.423 . . . . 0.0 111.323 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.29 135.49 23.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.459 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.2 mt -112.61 128.26 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.333 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.696 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.3 m -104.31 139.26 39.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.123 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.27 158.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.59 25.67 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.102 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 66.1 t -72.44 140.43 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.606 0.717 . . . . 0.0 112.428 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.81 -38.78 0.85 Allowed Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.52 128.52 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.123 178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -50.5 -35.94 31.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.744 0.307 . . . . 0.0 111.734 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.466 ' H ' HG12 ' A' ' 136' ' ' VAL . 8.9 t -93.63 6.5 48.08 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -121.4 26.18 9.01 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.696 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.2 139.52 28.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.943 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 142' ' ' SER . 1.8 tt -121.4 134.33 55.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.82 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.715 ' N ' HD23 ' A' ' 141' ' ' LEU . 2.9 m -108.85 142.99 38.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.146 0.498 . . . . 0.0 111.805 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.669 ' CD2' HD22 ' A' ' 141' ' ' LEU . 1.8 mm? -135.4 137.0 41.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.3 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.76 136.92 45.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.22 131.31 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.31 112.2 23.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.358 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.772 HG12 HD12 ' A' ' 124' ' ' LEU . 4.3 mt -84.86 133.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.568 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -92.96 115.96 28.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -63.96 -18.92 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.27 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -59.89 -46.05 90.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.947 0.403 . . . . 0.0 110.812 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.628 ' CE2' HD11 ' A' ' 93' ' ' LEU . 39.1 t80 -58.47 -44.32 89.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.812 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -65.09 -33.92 77.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -65.83 -42.57 90.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.95 -44.15 77.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.005 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.565 HD22 ' CA ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -59.5 -48.4 81.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -34.76 77.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -74.57 -21.49 59.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -125.41 105.97 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.936 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -74.07 147.5 42.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.79 138.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.5 106.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -88.32 -176.34 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.7 pt -101.86 134.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.766 0.317 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 mt -152.87 122.79 6.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.21 91.7 3.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.4 t -105.48 158.75 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.084 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.576 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 107.21 2.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.419 ' HB2' ' CG2' ' A' ' 106' ' ' THR . . . -107.73 -0.57 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 60.46 177.22 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.857 0.361 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.69 80.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 4.9 t -105.4 119.61 39.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.93 77.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.25 162.92 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.194 -0.907 . . . . 0.0 110.732 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.4 m -159.73 -52.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -35.63 71.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -67.35 -38.33 84.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.72 -39.96 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.49 -31.86 70.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.11 -35.26 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.53 -41.65 81.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 110.484 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -67.2 -23.95 65.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.639 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.045 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -80.84 -25.8 37.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.965 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -97.55 29.56 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.23 127.01 31.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.817 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.55 101.9 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.786 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -82.59 138.33 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.686 0.755 . . . . 0.0 111.68 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 107.92 117.32 4.13 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.446 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.01 -24.11 22.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.726 0.298 . . . . 0.0 111.194 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 175.38 40.1 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -73.4 135.23 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.381 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.22 -61.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.143 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.81 32.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.514 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 17.4 ttm180 -117.44 136.85 52.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.208 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -103.87 122.93 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 45' ' ' ILE . 17.5 mt -122.07 118.87 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.417 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HA ' HD23 ' A' ' 143' ' ' LEU . 49.9 t -82.33 107.05 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.829 0.347 . . . . 0.0 110.368 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.82 -24.43 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.961 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.541 HG21 ' H ' ' A' ' 142' ' ' SER . 38.4 p -79.82 -2.11 41.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.0 111.622 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.61 75.91 0.34 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.795 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -144.14 -45.23 0.26 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.765 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 78' ' ' LEU . 3.9 mp -114.76 141.15 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.844 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.72 133.56 20.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.198 1.932 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.822 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -51.37 133.46 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.711 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -128.54 163.65 24.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.21 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.74 119.84 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.444 . . . . 0.0 111.652 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.9 mt -91.94 137.3 32.48 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.97 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.78 158.15 43.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.25 143.48 27.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.668 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -74.78 131.52 40.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.287 0.565 . . . . 0.0 111.235 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.712 HD13 ' SG ' ' A' ' 154' ' ' CYS . 83.8 mt -64.21 -41.5 92.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.287 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -56.91 -42.2 79.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.6 mt-30 -68.68 -42.51 77.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.782 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.747 HG13 ' HG3' ' A' ' 63' ' ' LYS . 40.1 t -64.41 -38.27 82.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 52' ' ' ILE . 11.5 mt -69.75 -30.32 67.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 -50.48 6.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.922 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -65.28 120.67 13.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 31.47 3.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -152.08 151.01 30.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t 61.99 -82.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.139 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 93' ' ' LEU . 9.7 tp -179.63 151.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -75.18 -67.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.793 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.3 ttpt -151.63 137.44 18.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -126.81 139.28 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.313 0.578 . . . . 0.0 112.221 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.5 m-90 -100.79 139.17 36.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.872 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.01 131.14 55.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -119.91 145.5 46.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.368 -177.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.3 -167.61 35.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.067 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.9 mtp-105 -80.92 4.08 20.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.75 128.59 60.28 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.486 0.184 . . . . 0.0 110.711 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.47 -13.55 40.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.2 1.934 . . . . 0.0 111.528 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.03 -42.74 17.14 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.786 0.803 . . . . 0.0 108.863 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -41.11 138.15 1.18 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.861 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 67' ' ' THR . 14.2 m-20 -56.5 -18.77 12.61 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.741 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' ILE . 5.4 t80 -129.61 121.87 27.93 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.903 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.6 114.65 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD23 HD13 ' A' ' 84' ' ' LEU . 7.3 mp -81.59 -78.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.42 -87.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.565 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -177.34 53.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 84' ' ' LEU . 3.5 mp -91.49 116.3 32.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.406 ' O ' HG22 ' B' ' 169' ' ' TPO . 1.2 m -55.32 -29.05 57.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mmp_? -69.17 -34.25 74.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 81' ' ' ILE . 20.5 mt -90.71 152.1 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.834 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.7 m -93.42 163.35 13.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.498 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.45 -52.92 4.49 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.48 0.657 . . . . 0.0 109.691 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD12 ' A' ' 104' ' ' ILE . 11.8 mttt -118.95 83.08 1.97 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -62.8 -45.7 91.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.828 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.4 p90 -145.46 158.48 43.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.08 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.1 tt0 -135.76 142.03 44.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.942 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.612 ' C ' HG13 ' A' ' 65' ' ' VAL . 70.4 mt -118.35 128.68 75.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.163 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.8 OUTLIER -111.79 147.67 35.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 111.577 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp -125.12 126.61 45.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA2' ' HG2' ' A' ' 63' ' ' LYS . . . 173.8 -133.33 2.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.538 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.04 -70.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.927 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -178.66 43.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.775 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.96 -28.57 10.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.404 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.55 ' O ' HD12 ' A' ' 93' ' ' LEU . 65.7 m-20 -72.08 -178.5 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -131.74 148.63 52.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.886 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 121' ' ' ASN . 3.7 mp -126.7 145.5 50.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.53 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.77 125.8 54.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.088 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.7 t30 -116.04 115.7 26.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.868 0.366 . . . . 0.0 111.706 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.814 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.6 p30 -77.67 135.52 38.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 87' ' ' LYS . 14.2 pt -141.45 39.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.65 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.47 151.03 21.59 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 120.937 0.399 . . . . 0.0 111.667 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.6 m -68.8 -32.03 71.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.775 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.44 -19.75 18.93 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.51 157.56 11.05 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.49 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.7 m -117.55 137.9 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -113.41 148.47 35.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.47 18.4 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.47 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.417 ' N ' HD12 ' A' ' 111' ' ' LEU . 92.0 m-20 44.03 43.53 5.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.23 -12.72 63.67 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.578 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -104.36 118.58 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.459 . . . . 0.0 110.588 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.09 129.24 38.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.465 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.814 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.3 m -99.03 164.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.988 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' SER . 33.0 mt-10 -69.96 126.24 29.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.465 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 71.3 tttt -53.89 162.46 0.93 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.4 m-80 35.11 34.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.126 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.29 145.17 40.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.075 179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.72 ' HB3' HD23 ' A' ' 100' ' ' LEU . 9.9 m120 -91.63 132.11 36.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.058 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 52.6 mm-40 -129.37 152.1 49.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.404 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.61 136.15 45.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.755 0.312 . . . . 0.0 110.325 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.898 HD21 HG12 ' A' ' 147' ' ' ILE . 50.6 tp -62.31 153.72 30.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.588 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -125.2 152.62 44.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.546 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.37 122.31 20.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.324 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.82 25.66 45.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.07 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.8 t70 -52.08 171.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.903 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.0 mt-10 -144.98 135.58 24.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.966 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -116.55 125.85 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.838 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.535 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.69 141.31 36.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.187 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.0 m -140.29 158.27 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.079 0.466 . . . . 0.0 112.212 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.39 43.41 8.59 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.998 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.472 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.3 t -84.42 140.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 121.724 0.773 . . . . 0.0 112.575 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.28 -40.47 0.69 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.41 122.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 114.613 -0.794 . . . . 0.0 109.11 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 140' ' ' ILE . 1.6 tt0 -50.54 -26.82 5.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 0.0 111.343 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 136' ' ' VAL . 11.9 m -93.51 6.46 48.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -131.24 28.18 4.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.535 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.3 mt -105.54 139.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.82 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 142' ' ' SER . 6.3 tt -123.45 134.4 53.93 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.675 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.541 ' H ' HG21 ' A' ' 40' ' ' THR . 47.4 t -111.22 150.33 29.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.621 0.724 . . . . 0.0 112.118 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.1 mt -135.94 153.37 51.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.749 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.903 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -122.73 134.61 65.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 124' ' ' LEU . 1.4 mm -106.46 121.12 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.844 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.16 124.79 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.898 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -89.88 134.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.82 114.66 15.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -61.36 -37.41 83.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -60.13 -46.0 91.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -60.19 -44.16 95.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.956 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -65.17 -39.94 93.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.005 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -60.67 -40.43 92.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.712 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.5 t -64.16 -45.99 86.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.034 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.19 -39.03 78.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.025 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.78 -44.65 95.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 23.2 mm-40 -84.44 -31.03 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.2 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.2 mmpt? -64.81 138.4 58.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.855 0.359 . . . . 0.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.61 130.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.28 159.12 16.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.24 76.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.28 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.869 0.366 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.583 HD23 ' H ' ' B' ' 167' ' ' GLU . 0.4 OUTLIER -136.96 150.11 47.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.583 ' H ' HD23 ' B' ' 166' ' ' LEU . 36.2 mt-10 -78.24 -69.12 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.6 152.93 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.406 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.73 128.35 33.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.54 -37.73 3.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 60.6 172.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.09 65.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 3.5 t -127.3 55.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -89.34 55.63 3.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . 0.586 HG22 ' O ' ' B' ' 176' ' ' VAL . 10.7 p 43.05 50.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.636 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.863 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.743 0.306 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.5 p -67.15 -36.45 81.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -60.22 -47.01 87.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -37.57 88.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.842 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 1.2 m-85 -57.01 -35.04 68.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.679 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.11 -37.27 80.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.555 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -73.26 -40.32 57.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.403 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -58.0 -34.12 69.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 110.58 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -67.42 -23.94 65.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.46 -48.05 77.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.374 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -60.5 -36.05 77.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.81 35.08 4.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -86.13 138.5 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -64.85 121.23 14.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.9 138.23 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 121.676 0.751 . . . . 0.0 111.861 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 148.28 102.45 0.28 Allowed Glycine 0 C--N 1.312 -0.75 0 CA-C-N 114.427 -1.261 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -85.11 -29.11 25.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 111.031 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 176.33 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.715 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.7 133.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.523 -177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -89.8 -60.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.864 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 99' ' ' LEU . 3.2 p -147.24 159.47 43.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.112 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.29 138.1 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 111.4 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 68' ' ' PHE . 32.4 t -105.83 122.78 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.775 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 45' ' ' ILE . 19.4 mt -124.29 120.15 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.468 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.86 113.61 18.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.589 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.46 -23.69 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.533 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 43.9 p -79.99 -1.99 42.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.424 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.56 75.16 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.972 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -146.39 -42.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 111.055 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -118.2 141.35 29.34 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.1 Cg_endo -72.82 142.45 35.39 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.147 1.898 . . . . 0.0 112.235 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 37' ' ' ILE . 34.9 mt -58.22 134.91 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.672 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -127.21 161.34 28.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.039 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.08 119.91 35.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.141 0.496 . . . . 0.0 111.994 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -94.97 137.1 34.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 159.19 43.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -153.91 141.84 20.19 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.295 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.788 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -87.94 138.79 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 111.379 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.5 mp -64.28 -45.09 97.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.748 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -38.35 73.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.288 0.566 . . . . 0.0 110.351 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 16.4 mm-40 -68.57 -36.82 79.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.273 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.7 t -68.4 -49.96 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.75 -28.01 68.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.021 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -38.98 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.07 114.91 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -101.73 -26.45 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -176.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 62' ' ' ILE . 64.5 p -68.93 132.51 46.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.96 HD13 HD12 ' A' ' 92' ' ' LEU . 7.8 tp 51.69 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.958 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.755 ' HG2' HG13 ' A' ' 55' ' ' VAL . 13.4 mptt -108.51 -72.86 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 49' ' ' SER . 17.3 ttpt -135.85 113.9 11.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.795 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.659 HG22 ' HG2' ' A' ' 90' ' ' GLN . 12.7 p -110.74 140.07 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 121.726 0.774 . . . . 0.0 113.073 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.566 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -100.61 139.17 36.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.927 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.47 127.78 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -114.99 145.4 42.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.432 -178.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.5 -170.18 38.0 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.949 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.0 mtm105 -80.65 -0.32 37.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.85 134.15 42.17 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.227 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.3 Cg_exo -68.32 -10.23 28.33 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.767 2.312 . . . . 0.0 111.885 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.78 -43.61 16.54 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.96 0.886 . . . . 0.0 108.72 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.02 138.08 1.67 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.641 -1.618 . . . . 0.0 110.531 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -56.3 -19.14 12.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.975 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 64.2 t80 -129.97 127.97 41.14 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -104.87 124.77 50.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.816 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -126.83 179.79 5.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.83 141.8 47.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.482 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -73.49 92.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 111.051 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 83' ' ' ARG . 34.8 mm -104.68 131.38 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.0 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -38.77 80.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -67.42 -31.84 72.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.161 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD22 ' CE1' ' A' ' 88' ' ' HIS . 54.3 mt -86.18 152.27 22.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -97.84 167.35 10.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.748 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.653 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 5.1 m-20 -43.3 -56.77 3.34 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.279 0.562 . . . . 0.0 109.705 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 67' ' ' THR . 1.8 mtpp -115.8 83.3 1.91 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.1 t60 -60.15 -45.59 92.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.714 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.2 p90 -144.43 157.56 44.18 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.907 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.0 tt0 -135.8 140.51 44.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.357 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 65' ' ' VAL . 70.0 mt -116.33 127.94 73.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.619 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.96 HD12 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -113.0 142.57 45.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 111.605 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 33' ' ' VAL . 24.3 tp -122.7 124.44 43.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.535 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.9 -119.54 0.93 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.438 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 67.78 -68.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.807 0.337 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.51 -46.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.79 49.22 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.53 -175.53 5.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.559 HD11 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -114.81 147.98 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.896 HD22 ' HB3' ' A' ' 121' ' ' ASN . 3.3 mt -132.99 147.54 52.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.26 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.445 HD11 HG12 ' A' ' 130' ' ' ILE . 6.7 tt -112.25 124.7 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -114.82 115.68 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.62 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.809 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -77.79 132.79 38.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.722 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.3 pt -140.34 40.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.641 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.18 153.07 19.55 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.959 0.409 . . . . 0.0 111.585 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.533 HG22 ' HB2' ' B' ' 171' ' ' ALA . 90.1 m -68.7 -33.25 73.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.934 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -96.51 -19.86 18.81 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.2 159.27 11.4 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.508 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.7 m -117.57 137.9 52.29 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -113.96 148.43 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.48 18.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.285 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.78 43.05 6.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.51 -11.09 67.03 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.55 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -104.79 118.52 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.627 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.51 129.96 39.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.367 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.809 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.0 m -100.65 165.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.003 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 120' ' ' SER . 8.5 mt-10 -69.97 126.2 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 48.0 tttm -52.53 162.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.5 36.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.956 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.89 145.08 40.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.861 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.896 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.9 m120 -91.29 127.1 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.795 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.412 ' C ' HD23 ' A' ' 100' ' ' LEU . 50.9 mm-40 -129.29 147.05 51.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.753 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.1 tt -72.93 127.81 33.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.076 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.736 HD22 HG12 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -56.86 160.57 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.416 0.627 . . . . 0.0 111.92 -179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.758 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.88 153.37 42.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.952 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.571 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -70.97 118.17 13.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.26 26.24 61.27 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.007 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 10.9 t70 -56.77 174.06 0.17 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.957 0.408 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 12.8 mt-10 -145.1 135.53 24.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 1.2 mt -110.51 126.39 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -104.58 137.84 41.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.8 m -140.36 158.44 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.44 33.98 18.09 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.981 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.6 t -75.33 140.37 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.657 0.741 . . . . 0.0 112.339 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.05 -37.38 0.81 Allowed Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 55.3 t -126.32 132.52 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.244 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -41.63 54.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.3 m -93.33 6.38 48.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.2 t0 -117.1 26.82 9.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.2 139.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.102 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.7 134.46 54.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.415 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.646 ' C ' HD22 ' A' ' 143' ' ' LEU . 44.0 t -113.57 150.48 32.97 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.723 0.773 . . . . 0.0 112.504 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.788 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.4 mm? -135.98 150.26 49.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.44 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.0 t -115.71 140.57 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.358 . . . . 0.0 111.271 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 41.5 mt -105.91 120.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.009 0.433 . . . . 0.0 111.236 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 37' ' ' ILE . 2.6 m-85 -108.43 107.56 18.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.186 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 125' ' ' SER . 3.8 mp -84.9 129.62 37.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.8 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -78.19 128.96 34.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.771 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.03 -29.63 62.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -45.39 92.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.772 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.54 -44.05 89.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.975 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -62.31 -33.87 75.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.073 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -66.76 -47.0 73.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -63.85 -43.78 95.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 155' ' ' LEU . 3.1 mm? -59.48 -35.92 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.41 -42.44 95.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.796 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 1.8 mt-30 -84.75 -31.08 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.29 -90.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.656 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.1 OUTLIER -69.38 145.29 53.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -102.53 137.43 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -50.06 7.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 tt -79.59 138.02 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.827 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.09 69.9 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.84 79.24 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 25.4 t -78.23 137.63 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.112 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.74 143.33 42.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.533 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -147.02 168.29 21.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -123.91 165.15 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -147.83 71.27 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.9 p -113.64 -36.86 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.1 85.86 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 t 62.96 148.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.823 0.344 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -81.87 -45.41 15.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.2 -45.09 94.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -67.38 -44.65 78.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -59.96 -34.92 73.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -41.47 87.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.8 mm -69.61 -35.16 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -57.42 -40.01 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.252 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.33 -23.73 65.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.556 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.62 -47.54 79.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -28.06 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.857 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 63.68 145.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.35 129.32 37.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.968 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.64 134.67 34.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.94 138.46 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.596 0.712 . . . . 0.0 111.831 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.22 44.17 0.06 OUTLIER Glycine 0 C--N 1.313 -0.713 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -38.75 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.5 38.65 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -77.01 134.84 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.272 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.021 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.97 -59.94 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.1 p -147.69 160.06 43.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.8 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -120.52 137.99 54.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 111.713 -179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 68' ' ' PHE . 34.7 t -103.84 122.62 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.636 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -128.94 120.77 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.439 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.4 t -87.91 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 110.471 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -83.83 -21.45 32.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.761 HG21 ' OG ' ' A' ' 142' ' ' SER . 7.5 p -80.02 -2.85 45.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.522 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.98 71.45 0.97 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.235 -0.507 . . . . 0.0 114.038 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' CB ' HD11 ' A' ' 141' ' ' LEU . 4.0 mt-30 -142.05 -40.27 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.676 HG23 ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -129.57 143.44 48.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.8 Cg_endo -69.97 146.11 57.92 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.281 1.988 . . . . 0.0 112.165 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -52.85 155.49 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.959 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -150.96 164.12 37.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.943 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -131.79 120.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.121 0.486 . . . . 0.0 112.241 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.8 mp -86.44 131.89 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.207 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.021 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.73 155.7 47.2 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.21 141.87 35.89 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.726 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.0 m-20 -81.4 113.99 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.135 0.493 . . . . 0.0 111.157 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.7 mt -64.35 -37.05 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.449 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -56.61 -42.0 78.03 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 0.0 110.905 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 10.0 mt-30 -68.53 -36.81 79.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.629 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 51' ' ' ASP . 51.3 t -59.3 -49.61 82.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 mt -59.57 -32.91 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.969 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.52 -40.44 92.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.07 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -98.59 127.84 44.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.2 30.77 2.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -176.63 -165.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 62.58 156.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -71.97 124.91 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -46.67 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.5 ttpt -155.14 145.68 22.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.226 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 62' ' ' ILE . 13.4 t -130.13 138.17 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.252 0.548 . . . . 0.0 112.007 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.822 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.1 m-90 -104.61 139.13 39.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.818 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.91 126.58 55.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.53 145.58 40.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.993 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.38 -170.52 37.17 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.283 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.3 ttp85 -78.44 0.18 26.85 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.69 127.8 63.75 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.792 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.2 Cg_exo -66.19 -10.08 26.0 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.245 1.963 . . . . 0.0 111.483 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.46 17.37 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -40.43 137.45 1.09 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.469 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -56.44 -18.92 12.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.066 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 40.7 t80 -130.05 123.7 31.11 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.854 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -99.8 119.22 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.729 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' HA2' ' A' ' 69' ' ' GLY . 12.5 mt -80.31 -69.87 0.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.3 -91.52 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.559 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -165.2 64.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 111.191 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.957 HD13 HD12 ' A' ' 84' ' ' LEU . 3.7 mp -106.09 111.74 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.798 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -32.02 66.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -28.1 67.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.957 HD12 HD13 ' A' ' 81' ' ' ILE . 25.0 mt -90.75 150.18 21.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.822 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.9 p -91.49 165.62 13.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.755 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -43.0 -53.35 4.83 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.535 0.683 . . . . 0.0 109.748 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.1 mtpt -120.44 82.2 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.8 t60 -59.82 -46.9 87.79 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.65 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 23.2 p90 -146.86 157.28 43.61 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.728 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 65' ' ' VAL . 6.0 tt0 -135.85 139.47 43.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.182 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 65' ' ' VAL . 54.3 mt -112.9 129.21 68.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.218 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.19 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -115.22 138.39 50.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.922 0.392 . . . . 0.0 111.334 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 33' ' ' VAL . 13.5 tp -117.36 128.55 55.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.74 164.34 12.95 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.65 113.19 11.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t0 61.54 112.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.9 33.31 0.65 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.68 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 60.01 -170.6 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -108.43 160.45 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.783 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.1 mt -118.75 147.54 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.375 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -111.95 124.4 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.93 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.611 ' HB2' HD23 ' A' ' 92' ' ' LEU . 53.8 t30 -113.67 115.81 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 0.0 111.881 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -77.34 134.72 38.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.749 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 87' ' ' LYS . 14.8 pt -142.44 37.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.86 149.95 21.82 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.003 0.43 . . . . 0.0 111.853 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.58 HG22 ' HB2' ' B' ' 171' ' ' ALA . 92.8 m -68.79 -31.97 71.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.764 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -94.92 -19.86 19.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.1 156.49 10.86 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.443 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -117.51 137.7 52.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.816 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.03 148.59 40.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.91 113.46 18.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.436 177.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.7 m-20 44.53 43.19 6.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.71 61.23 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.476 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.5 118.6 36.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.121 0.486 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.816 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.24 135.64 47.59 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.371 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.8 m -105.23 165.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.967 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -70.0 126.25 29.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.435 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 51.0 tttt -54.05 162.64 0.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.004 0.431 . . . . 0.0 110.637 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.2 m-80 34.98 33.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.151 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.43 145.14 40.69 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.252 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.783 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.4 m120 -87.28 130.43 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.768 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 100' ' ' LEU . 29.0 mm-40 -129.17 145.67 51.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.701 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 120.78 19.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.256 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD11 HG21 ' A' ' 145' ' ' ILE . 1.3 tp -56.53 154.4 8.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.521 0.677 . . . . 0.0 111.521 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -121.35 153.49 37.7 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.101 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.7 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.12 123.92 23.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.027 0.442 . . . . 0.0 110.371 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.72 19.84 50.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.376 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 25.9 t70 -56.99 170.93 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.053 0.454 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.9 tt0 -145.32 135.75 24.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.025 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.855 HD11 HD11 ' A' ' 101' ' ' LEU . 3.8 mt -108.64 127.71 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.513 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.53 140.46 37.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.5 m -140.29 158.5 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.067 0.461 . . . . 0.0 112.088 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.93 40.01 11.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.073 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 68.8 t -80.59 140.37 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-O 121.662 0.744 . . . . 0.0 112.412 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.15 -42.88 0.88 Allowed Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.615 -0.792 . . . . 0.0 108.975 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.31 -25.02 3.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.679 0.276 . . . . 0.0 111.61 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -93.17 6.32 48.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -129.23 24.47 5.55 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.07 139.27 29.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.051 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -124.3 134.42 53.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.499 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.761 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.5 OUTLIER -111.23 128.91 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.611 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.1 mm? -121.84 135.15 54.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.399 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.54 140.28 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.151 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.715 HG21 HD11 ' A' ' 124' ' ' LEU . 8.7 mt -105.93 136.31 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.269 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.766 ' CD1' HD12 ' A' ' 37' ' ' ILE . 3.5 m-85 -116.16 116.07 27.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.343 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -84.79 131.99 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.516 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.07 107.83 19.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.702 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.82 -26.38 68.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.32 -43.92 88.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.973 0.416 . . . . 0.0 110.714 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -58.94 -44.12 91.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -36.46 81.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -40.95 98.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -61.09 -46.06 92.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.605 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -63.99 -36.14 83.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -60.32 -36.13 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -92.06 -37.05 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.6 p30 44.3 -171.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.654 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 131.27 50.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.915 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 164' ' ' ARG . 11.2 p -99.54 132.84 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.93 -54.96 1.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -136.61 -50.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.0 132.11 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.59 ' HB3' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.341 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.04 122.02 26.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.25 106.55 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.64 147.29 11.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.61 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.37 114.58 8.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.725 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.58 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -113.72 152.06 31.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -92.52 164.8 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.46 79.43 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 66.1 p -110.5 -43.11 3.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.784 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -140.19 67.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.787 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.81 -28.72 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.853 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -138.18 -52.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -72.12 -37.8 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.8 ttt85 -60.13 -39.29 85.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -39.97 90.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.76 96.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.2 mm -68.48 -34.94 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.229 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -57.23 -36.03 70.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.906 0.384 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -23.89 65.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.6 -47.58 79.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p -80.99 -31.54 34.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -177.05 4.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -79.93 130.26 35.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -87.89 142.28 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 136.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 CA-C-O 121.262 0.553 . . . . 0.0 110.559 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.23 43.99 0.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.158 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.21 -41.65 84.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.657 0.265 . . . . 0.0 111.312 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER -178.37 37.03 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.8 mm -73.73 136.63 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.881 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.7 t -92.13 -59.08 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.637 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.13 148.95 29.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.2 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.412 HH11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -113.8 138.07 50.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG21 ' HE2' ' A' ' 68' ' ' PHE . 4.8 t -105.84 122.7 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.61 126.77 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HA ' HD23 ' A' ' 143' ' ' LEU . 20.6 t -85.21 120.06 26.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.652 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.562 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.1 p -87.62 -26.13 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.412 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.602 HG21 ' H ' ' A' ' 142' ' ' SER . 6.5 p -79.88 -2.1 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.534 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.88 75.81 0.33 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.832 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.44 -45.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.931 HD13 HD22 ' A' ' 78' ' ' LEU . 6.5 mt -112.96 140.8 24.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.9 Cg_endo -74.39 142.15 29.54 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.205 1.937 . . . . 0.0 112.058 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.782 HG12 HG23 ' A' ' 37' ' ' ILE . 40.2 mt -55.16 141.26 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.6 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -133.36 164.07 27.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.128 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.87 119.77 33.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 112.092 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.5 mt -97.84 136.25 38.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.003 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.19 158.13 43.84 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.19 142.84 33.97 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.583 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.5 m-20 -74.95 133.79 41.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 111.122 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' SG ' ' A' ' 154' ' ' CYS . 78.6 mt -64.31 -43.36 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.027 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -38.96 73.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.3 0.571 . . . . 0.0 110.526 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 4.9 mm100 -68.67 -36.88 79.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.484 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.8 t -69.67 -46.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.975 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.632 ' HG ' HG12 ' A' ' 160' ' ' VAL . 4.2 tp -65.44 -39.45 92.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -38.35 90.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 124.7 21.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -94.79 87.15 4.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 61.0 33.03 19.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 t -118.42 175.85 5.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 tp -68.95 143.8 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.053 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.626 ' HE3' HG13 ' A' ' 55' ' ' VAL . 4.5 mttp -95.72 -70.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt -155.03 145.98 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.083 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 90' ' ' GLN . 13.4 t -129.48 138.73 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 121.305 0.574 . . . . 0.0 112.119 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.531 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.8 m-90 -105.8 139.19 40.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.57 126.44 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -112.05 145.75 39.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.953 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.55 -173.58 40.5 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.599 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtm105 -80.62 -0.58 38.61 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t-20 -84.92 133.99 42.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.643 0.259 . . . . 0.0 111.107 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.36 -8.63 23.55 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 111.879 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -43.68 16.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.36 138.41 2.36 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.37 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -56.15 -19.07 11.89 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.582 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.97 130.46 45.08 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.538 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -101.23 110.48 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.785 0.326 . . . . 0.0 110.737 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.931 HD22 HD13 ' A' ' 43' ' ' ILE . 36.1 mt -82.37 -70.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.35 -97.15 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.338 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -177.68 50.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 111.178 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' HD12 ' A' ' 84' ' ' LEU . 28.9 mm -79.02 129.29 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.6 -43.86 84.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.219 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -41.83 97.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD12 ' CG1' ' A' ' 81' ' ' ILE . 39.8 mt -73.0 152.09 41.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 98.2 p -96.88 168.91 10.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.545 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.2 m120 -44.02 -58.74 2.64 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -114.51 83.78 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.1 t60 -58.96 -45.64 90.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.851 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.3 p90 -147.16 159.24 43.85 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.799 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.674 ' HG3' HG23 ' A' ' 67' ' ' THR . 5.1 tt0 -135.99 139.9 43.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.529 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 65' ' ' VAL . 59.0 mt -113.76 130.56 67.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.683 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.84 149.68 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.084 0.468 . . . . 0.0 111.648 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.853 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp -125.08 122.74 38.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.344 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.4 123.56 2.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.441 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -177.95 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -175.42 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.838 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.94 47.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.562 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -168.79 -174.49 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.814 ' CD2' HD13 ' A' ' 93' ' ' LEU . 3.6 mm? -106.87 159.23 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.718 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.4 mp -133.12 145.99 51.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.394 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.9 126.09 55.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.93 115.53 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.308 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 24.1 p-10 -78.28 139.66 38.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.826 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -150.09 39.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.19 163.73 12.79 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.973 HG22 ' HB2' ' B' ' 171' ' ' ALA . 90.8 m -68.87 -39.34 79.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.685 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -19.96 17.41 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.525 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.41 162.77 11.58 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.589 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.1 m -117.59 137.89 52.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -114.6 148.54 37.91 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.761 HD12 HG11 ' A' ' 116' ' ' VAL . 1.3 mt -124.36 113.43 18.19 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.639 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 46.8 36.67 4.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.03 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.44 81.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.506 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -105.73 118.61 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.092 0.446 . . . . 0.0 110.718 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 21.3 tptt -74.83 126.56 31.18 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.133 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 6.7 m -104.22 165.7 3.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 120' ' ' SER . 30.1 mt-10 -69.86 128.47 36.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.423 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 64.8 tttt -54.8 164.12 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.51 36.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 6.0 p -111.75 145.11 39.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.776 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.57 ' HB3' HD23 ' A' ' 100' ' ' LEU . 10.6 m120 -86.43 132.01 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.683 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 25.4 mm-40 -129.42 146.08 51.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.565 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.2 tt -72.77 129.04 37.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.246 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 123' ' ' LEU . 32.3 tp -60.93 153.07 25.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.558 0.694 . . . . 0.0 111.432 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.1 t -125.25 152.77 44.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 124.65 25.52 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.41 22.38 44.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.203 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.504 ' OD2' HD23 ' A' ' 111' ' ' LEU . 15.5 t70 -52.95 170.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 tt0 -145.1 135.78 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.989 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 145' ' ' ILE . 1.9 mt -111.98 127.4 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.638 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.53 138.14 41.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.722 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.519 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.5 m -140.37 158.6 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.13 29.73 27.4 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.418 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.6 t -70.11 140.36 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.652 0.739 . . . . 0.0 112.209 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 146.02 -40.64 1.06 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 127.73 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.21 178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -50.44 -32.24 17.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.713 0.292 . . . . 0.0 111.551 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.9 m -93.5 6.31 48.63 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.22 23.7 9.72 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.638 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.05 139.26 29.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.125 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 142' ' ' SER . 1.6 tt -124.05 134.07 53.5 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.485 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.602 ' H ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -108.88 133.4 52.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.173 0.511 . . . . 0.0 111.462 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 43' ' ' ILE . 38.5 mt -127.09 140.58 52.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.557 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.562 HG21 ' CG2' ' A' ' 39' ' ' THR . 18.4 t -113.06 140.56 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.014 HD11 HD11 ' A' ' 130' ' ' ILE . 32.9 mt -105.99 137.22 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.248 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.29 115.17 23.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.528 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 124' ' ' LEU . 3.1 mt -84.96 134.07 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -92.09 100.95 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.42 -25.94 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -44.66 88.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.09 -44.33 87.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -33.85 76.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.012 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.0 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.639 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -65.95 -45.99 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 0.0 111.055 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.75 -36.53 79.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.825 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -34.48 73.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.788 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.68 -27.28 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -123.41 100.24 6.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.65 159.19 15.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 56' ' ' LEU . 27.1 m -78.53 133.35 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.2 110.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -111.38 65.27 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.35 129.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.977 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.736 0.303 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.472 ' O ' HD12 ' B' ' 166' ' ' LEU . 3.7 pp -105.88 129.91 53.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 116.82 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 169' ' ' TPO . 21.7 t -76.39 159.09 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.483 ' N ' HG12 ' B' ' 168' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.04 134.04 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.95 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.973 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -144.41 134.77 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -147.46 -178.5 6.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -161.19 85.57 0.67 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.99 160.18 43.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.93 97.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.806 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 11.0 p -172.4 137.45 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.89 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.794 0.33 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 m 71.08 -63.42 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.971 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' HA ' HD12 ' A' ' 19' ' ' LEU . 1.6 tt0 -59.89 -35.95 75.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -70.88 -38.24 73.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.886 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -40.27 76.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.615 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 16' ' ' GLN . 11.5 mt -59.72 -31.92 70.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.545 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 7.8 mt -68.92 -45.49 80.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.704 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.83 -32.45 67.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.376 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -22.26 8.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.944 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 1.9 p90 -55.64 -45.19 77.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.604 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -81.04 -37.23 29.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.822 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.4 146.55 47.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -100.99 154.83 18.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 120.7 17.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 mm -84.79 138.37 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.686 0.755 . . . . 0.0 111.93 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.16 63.2 0.73 Allowed Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.152 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -23.82 47.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.566 0.222 . . . . 0.0 111.52 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.0 35.93 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -88.77 96.49 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.558 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -56.2 -66.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 p -145.46 165.15 29.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 128.71 45.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.772 HG23 HD13 ' A' ' 48' ' ' LEU . 25.4 t -93.19 122.88 45.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.802 HG23 HG12 ' A' ' 45' ' ' ILE . 20.5 mt -127.92 123.16 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.488 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -91.78 111.46 23.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.396 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.9 p -87.95 -20.91 25.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.594 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.783 HG21 ' OG ' ' A' ' 142' ' ' SER . 2.4 p -79.92 -2.16 42.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.571 0.224 . . . . 0.0 111.533 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.09 74.07 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.864 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -146.65 -41.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.763 0.316 . . . . 0.0 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.824 HD13 HD22 ' A' ' 78' ' ' LEU . 16.7 mt -124.95 140.94 36.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.068 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.9 Cg_endo -73.43 137.42 25.52 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.183 1.922 . . . . 0.0 112.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -53.53 139.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.727 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 76' ' ' TYR . 2.2 ttt180 -133.59 164.09 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.042 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.4 119.92 37.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 112.074 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.772 HD13 HG23 ' A' ' 36' ' ' VAL . 5.0 mp -96.88 129.64 44.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.759 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.9 156.08 44.31 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -140.01 153.93 46.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.309 -1.769 . . . . 0.0 110.939 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.842 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -91.21 141.11 29.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 111.074 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.23 -44.9 95.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.268 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -43.13 95.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.928 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.65 -36.9 79.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.668 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.3 t -70.44 -44.78 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.04 -30.12 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -66.65 -43.32 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.84 114.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -79.63 -31.22 41.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.72 177.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 m -80.7 137.46 36.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.631 HD12 ' CB ' ' A' ' 92' ' ' LEU . 32.2 mm 66.28 152.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.254 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -143.37 -54.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.589 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.9 ttpt -122.42 120.73 34.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.855 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG21 HD23 ' A' ' 92' ' ' LEU . 4.8 t -122.16 139.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 0.0 111.891 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.689 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.9 m-90 -100.71 136.42 40.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.147 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.688 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.86 127.21 55.76 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -110.89 145.27 38.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.504 -178.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.21 -173.3 40.19 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.232 -0.985 . . . . 0.0 113.638 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.737 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.62 -7.37 52.96 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 1.1 t-20 -84.68 134.34 42.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.773 0.321 . . . . 0.0 111.624 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 10.0 Cg_exo -69.84 -6.42 18.6 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.727 2.284 . . . . 0.0 111.786 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.65 16.61 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.13 138.33 1.15 Allowed 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.311 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -56.6 -19.03 13.97 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.87 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CD1' HD23 ' A' ' 78' ' ' LEU . 2.7 t80 -130.1 128.74 42.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.835 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.18 107.8 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.435 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.824 HD22 HD13 ' A' ' 43' ' ' ILE . 9.5 mt -84.93 178.63 7.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.026 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.02 -101.29 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.452 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -167.59 72.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 110.953 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.1 mm -101.23 119.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -39.4 93.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.318 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HD2' ' CB ' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -60.92 -26.48 67.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.235 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' CE1' ' A' ' 88' ' ' HIS . 65.6 mt -84.3 152.58 24.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.4 p -91.77 163.87 13.91 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.787 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -40.37 -52.69 2.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.351 0.596 . . . . 0.0 110.007 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.5 ptpt -121.12 82.07 1.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.609 ' CE1' HD22 ' A' ' 84' ' ' LEU . 13.6 t60 -59.48 -46.72 87.98 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.777 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.3 p90 -147.7 161.08 41.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.964 -0.695 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -135.68 142.44 45.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.944 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.9 mt -116.95 129.07 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.004 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.29 144.42 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 111.662 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -125.19 122.95 38.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.638 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 161.68 -176.79 38.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.57 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.17 89.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.92 -166.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.1 56.17 5.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.785 ' O ' HD22 ' A' ' 99' ' ' LEU . 15.4 m120 -131.97 -178.96 5.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 98' ' ' ASN . 3.2 mm? -135.0 157.25 47.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.781 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 92' ' ' LEU . 1.1 mp -132.94 138.11 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.477 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -113.0 125.7 54.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.112 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.725 ' HB2' HD11 ' A' ' 92' ' ' LEU . 41.8 t30 -116.05 115.64 26.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -78.41 137.66 38.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.802 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 67' ' ' THR . 19.5 pt -148.09 38.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.9 152.42 19.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.728 HG22 ' HB2' ' B' ' 171' ' ' ALA . 98.4 m -68.86 -31.94 71.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.807 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -95.47 -19.99 19.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.32 154.9 10.35 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.766 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 4.9 m -117.6 137.82 52.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.05 148.55 40.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.09 113.51 18.48 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.35 177.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.8 m-80 45.18 43.12 7.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.213 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.38 80.82 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.42 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -106.1 118.58 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -72.93 114.98 11.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.174 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.9 m -88.11 164.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -69.78 125.94 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 39.3 tttt -53.53 163.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.596 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 35.22 33.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.93 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.17 145.07 40.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.204 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.584 HD22 HD13 ' A' ' 92' ' ' LEU . 2.4 m120 -91.23 129.95 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.8 mm-40 -129.55 148.29 51.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.745 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 124' ' ' LEU . 6.0 tt -72.73 120.05 17.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.276 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 123' ' ' LEU . 65.4 tp -54.56 158.03 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.6 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.418 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.19 153.44 41.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.269 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.714 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.39 119.99 16.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 0.0 110.2 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.25 20.62 65.38 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.147 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.7 t70 -55.48 171.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.99 0.424 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 144' ' ' VAL . 24.1 tt0 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.163 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.505 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.5 mt -109.65 125.5 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.501 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 92.1 m -104.64 140.2 38.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.374 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.545 HG11 ' CD2' ' A' ' 88' ' ' HIS . 35.6 m -140.34 158.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.55 41.64 12.84 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.08 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.4 t -82.65 140.39 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.62 0.724 . . . . 0.0 112.325 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.81 -40.02 1.23 Allowed Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.5 120.11 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 114.532 -0.834 . . . . 0.0 109.119 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.42 -25.03 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.689 0.28 . . . . 0.0 111.573 -178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 p -93.34 6.45 48.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HD2' ' A' ' 83' ' ' ARG . 1.7 m-20 -130.4 25.19 5.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 137' ' ' GLU . 7.6 mt -105.8 139.21 27.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.061 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 142' ' ' SER . 7.2 tt -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.501 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -113.36 128.49 56.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.141 0.496 . . . . 0.0 111.677 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.507 HD11 HD12 ' A' ' 43' ' ' ILE . 19.6 mt -121.86 136.12 54.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.591 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.9 t -110.64 140.17 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.0 mt -106.08 135.89 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.179 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.26 112.04 21.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 126' ' ' GLN . 5.9 mt -84.95 134.14 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.16 130.62 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.716 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.64 -30.24 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.003 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.89 -46.09 90.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.034 0.445 . . . . 0.0 110.706 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.56 -44.19 89.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 147' ' ' ILE . 62.7 mttm -63.68 -38.69 92.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.12 -46.73 87.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.1 t -67.89 -42.4 81.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 0.0 111.161 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -65.81 -36.03 82.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.02 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.39 -47.94 68.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -78.11 -36.96 47.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.33 33.72 0.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.458 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 132.9 53.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 127.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -151.72 159.33 44.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.33 169.58 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.8 mm -98.92 126.54 52.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.194 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.897 0.379 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.17 126.33 47.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.08 85.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.61 145.25 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.024 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . 0.603 ' O3P' HG22 ' B' ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.22 122.81 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.829 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.728 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -123.02 168.87 11.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.98 0.419 . . . . 0.0 111.081 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -174.8 169.46 3.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -164.34 112.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.2 p -140.08 178.81 7.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.24 77.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 21.4 m -108.49 -37.62 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 stop_ save_